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1. Introduction 
 
Nowadays nanotechnology is omnipresent: from nanodevices in technology to nanorobots for 
medicine, a lot of materials have found their way into our daily life. Sunscreens based on 
nanoparticles made of titanium dioxide or zinc oxide or clothes with nanosilver, which are able to 
kill bacteria and eradicate unwanted odor are only two examples of nanomaterials making our daily 
life more comfortable. A special feature of nanotechnology is its cross section character. It contains 
pulses from almost every scientific-technical disciplines and in many branches this promising 
technology is indispensable. Accordingly the importance of nanotechnology increases steadily. 
While nanomaterials already enhance the properties of many products in present life, future 
techniques are under development. What Ostwald described in 1914 as “The world of neglected 
dimensions” is today known as nanochemistry. [1] He saw the opportunities, new properties and 
interesting application of these materials. 
Even though it is a relatively young topic, nanotechnology has become a widely inquired branch of 
science. The number of publications with “nanoparticles” as buzzword exponentially increased 
during the last decades. In 2014 a special issue for Nanotechnology & Nanomaterials, 
Nanotoxicology & Nanomedicine appeared in Angewandte Chemie Int. Ed. summarizing the 
versatile applications. [2]  
The term nano emanates from the Greek word for dwarf and is on prefix at the metric scale for the 
factor 10
-9
 (1 nm = 10
-9
 m). For comparison, the diameter of a human hair is about a thousand times 
larger but still visible to the naked eye, red blood cells are even smaller and the size of a virus is 
about 20 nm to 100 nm (Figure 1). Objects with a size less than 100 nm are typically called 
nanomaterials. 
 
 
Figure 1: Length scale for classification of nanomaterials. Adapted from [3] 
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Besides the size, their large surface area is characteristic for these materials compared to the bulk 
material and the physicochemical properties are directly dependent. The surface properties are 
characteristic for nanomaterials and due to the increased surface-to-volume ratio they are different 
compared to their bulk material. Nanoparticles resemble both bulk material and molecules, they 
combine the ability to move (molecule) with specific properties of solids, e. g. catalytic activity, 
magnetism, surface. 
 
The interaction of nanoscale materials with biological systems is currently the focus of a fast-
growing area of investigation and progress in nanomedicine increased rapidly in the last years. As 
these interactions are mostly governed by the surface of the particles, modifications of those can 
tune the properties. Nanoparticulate materials are in a comparable size range relative to proteins or 
enzymes, they can selectively intervene in cellular processes in a way that small molecules cannot. 
Engineered nanoparticles have shown versatile applications for e. g. drug delivery. Compared to 
conventional therapeutics nanoparticles can overcome problems like poor solubility, lack or 
targeting or non-specific distribution. Remarkable progress has been made in the development of 
new nanomaterials with enhanced water-solubility, bioavailability and reduced toxicity. Although 
nanomaterials are currently widely used, there is a lack of information concerning environmental 
implications and it is necessary to spend investigations on the behavior. Gold nanoparticles haven 
been used for biomedical applications since their colloidal synthesis. Because of their high 
biocompatibility they have versatile applications. A lot of synthetic approaches have been 
developed to prepare size- and shape-controlled particles. Future challenges will be to find new 
methods of functionalizing gold nanoparticles with compounds that involve sufficient 
biocompatibility and are efficient pharmaceutical agents. 
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2. Basic Knowledge 
 
2.1 Nanomaterials 
 
The development of colloidal chemistry is closely related to the advances in methods and 
techniques and colloidal gold for example is no invention of modern times. It was Michael Faraday 
who reported on the earliest experimental studies on noble metals and their interactions with light 
giving a first description of colloidal solutions. [4] He reduced tetrachloroaurate (AuCl4
-
) with 
phosphorous in CS2 and obtained a deep red solution. He described it as finely disperse gold, not 
knowing that the optical phenomenon was caused by nanoparticles. Scientists assumed much earlier 
that gold must be present in such a degree that it is not visible to the human eye. [5] The term 
colloid, from the French word colle (glue), was introduced by Thomas Graham in 1861. [6] Some 
colloidal phenomena are known unconsciously since applications in ancient times, e. g. inks or 
cosmetics and manufacturing of colored glass based on dispersions of pigments. The Lycurgus cup 
is a fascinating example for nanomaterials from ancient times (Figure 2). Dated back in the 4
th
 
century B.C. it is a masterpiece of handcraft for this time. It appears in different colors depending of 
the incident of light; if it is reflected it appears jade green, if it is transmitted it appears ruby red. 
The material consists of metal nanoparticles of gold and silver. [7] Another example for 
nanomaterials in daily use is the Purple of Cassius. It was popular in the 17
th
 century as colorant for 
glasses consisting of gold particles and tin oxide. [8] 
 
  
Figure 2: The Lycurgus cup contains nanoparticles of gold and silver (British Museum). [9] 
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At the nano-scale not only miniaturization but also changes in properties are possible. The TiO2, 
which is applied as UV/Vis protector in sunscreens, is only about 50 nm in diameter. Absorption of 
solar radiation is much higher in materials composed of nanoparticles than it is in thin films. At this 
size it appears no longer white but transparent and can be applied to the skin.  
Nanoparticles with a diameter roughly between 10 nm and 100 nm are natural bridges between 
molecules and extended solids and are also called advanced molecules. They combine the molecular 
ability to move with properties of bulk material, like fluorescence. Besides their size, the vast 
surface area is also characteristic. Nanoparticles possess a high surface-to-volume ratio. For 
example 10 nm nanoparticles have about 20% of the atoms at the surface, whereas for 2 nm 
nanoparticles this value increases up to 80% surface atoms. These surface atoms are different in 
energy and mainly govern the properties of the material. [3] At the nanoscale the electronic energy 
states become discrete to unique optical, electronical and mechanical properties of the materials. 
Thus miniaturization has drastic effects for the physical and chemical properties. Not only for metal 
nanoparticles, but for all nanomaterials the characteristics at the submicroscopic scale are different. 
Gold as bulk material appears with a metallic glance, gold at the nanosize appears as a purple 
solution (Figure 3). In addition gold nanoparticles melt at much lower temperatures (~300 °C for 
2.5 nm size) than the gold slabs (1064 °C). This is due to the increasing number of surface atoms. 
Solid gold is inert against oxygen and is used for jewelry or tooth crowns. When presented in 
nanostructures it is very affine to oxygen and therefore applied as catalyst. The optical appearance 
at the nanoscale is also no longer metallic but red caused by quantum effects. 
 
 
 
Figure 3: Gold as bulk material and dispersed in water as colloids. 
 
Quantum effects are based on the fact that electrons behave both as particle and as wave resulting in 
the wave-particle-duality. When electrons are trapped in a space similar to their wavelength their 
energy levels are no longer continuous but discrete. The values depend on the size and shape of the 
particle. Other size-dependent property changes include quantum confinement in semiconductor 
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particles (CdSe, CdTe), surface plasmon resonance in some metal nanoparticles (Au, Ag) and 
superparamagnetism in magnetic materials (Fe2O3, Fe3O4). 
Within a colloidal system, nanoparticles are uniformly dispersed in an agent. Classification is made 
in dispersion, molecular and association colloids. Dispersion colloids are thermodynamically 
instable systems consisting of crystalline or amorphous solids in a liquid agent. Micelles and 
biocolloids belong to the category of associative colloids. The stabilization force of dispersion 
colloids basically derives from the repulsive interactions of the charge distribution around the 
particles or a stabilizing shell. [10] In this context colloid describes the characteristics and nano 
gives the indication for size and quantum effects. 
Nanoparticles can be understood as a small unit of a solid, accordingly they can be synthesized by 
two different routes. While in the top-down method a macrocrystalline material is crushed down to 
nanoscale under mechanical action, in the bottom-up method nanoscopic structures are built from 
atomic components (Figure 4).  
 
 
Figure 4: Top-down and bottom-up approach for the synthesis of nanoparticles. 
 
In a top-down approach usually the nanoparticulate material is generated from the bulk material by 
physical methods, e. g. lithography. Contrastingly, bottom-up methods have a chemical approach. 
The bottom up synthesis starts with the nucleation step, and then the surface is saturated with 
further atoms (surface growth). The growth mechanism has to be stopped at the nanoscale and the 
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resulting nanoparticles have to be stabilized to avoid further particle growth. Nanomaterials are 
synthesized from molecular/atomic precursors usually in solution by self-organization. The growth 
mechanism can be controlled during the synthesis. The nanoparticles need to be stabilized at the 
surface to prevent coalescence.  
The synthesis of nanoparticles is typically divided into a number of different steps: nucleation, 
nucleus growth and Ostwald ripening. Syntheses in the liquid phase can usually be adjusted, e. g. 
via the monomer concentration and reaction temperature. For monodisperse nanoparticles, 
nucleation, nucleus growth and agglomeration process have to be controlled precisely. The reactive 
surfaces can be saturated directly with stabilizers or ligands added to the solution. LaMer and 
Dinegar set up a model to describe the steps of nucleation and growth (Figure 5). [11] 
 
 
Figure 5: LaMer diagram to describe nucleation and nucleus growth. Adapted from [12] 
 
The mechanism starts with the reduction or decomposition of the precursor and the increase of the 
monomeric building blocks. When a certain concentration is reached, nucleation starts and 
homogeneous crystal nuclei are formed. Thermodynamic control results in the most stable product, 
whereas the reduction of reaction velocity (kinetic control) can result in other structures. This can 
for example be achieved by a weak reducing agent. Subsequently, free atoms accumulate at the 
surface of the nuclei always alternating in loss of volume energy and increase of surface energy. 
Surfactants can control and stabilize the surface.  
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Figure 6: Growth and stabilization of nanoparticles. Adapted from [3] 
 
As colloidal solutions are thermodynamically instable and aim for a stable, state the surface must be 
immediately saturated. This process can be suppressed by stabilization. This can either be achieved 
sterically or electrostatically (Figure 6). Within a colloidal system there are repulsive and attractive 
forces. Attractive actions result from dipole-dipole interactions and are also called van-der-Waals-
forces. Repulsion results from electrostatic interactions from charged particles. Dispersed particles 
in a medium have a charge at their surface called charge cloud. It is symmetrically placed around 
the particle. When the particles move through a homogeneous phase the static and a part of the 
diffuse layer move along. Within this motion a potential barrier occurs between the layer and the 
surrounding medium. It increases linearly in the Stern-layer, a rigid layer around the particle, and 
falls exponentially in the diffuse layer. The resulting difference is called zeta-potential, which is a 
characteristic value for the stability of colloidal solutions and can be measured by electrophoresis or 
streaming potentials. It depends on the properties of the surface as well as of the solvent. Ligands 
surrounding the nanoparticles must be able to stabilize the colloidal solution either electrostatically 
or sterically. This can be achieved by surface tailoring. The stabilization of nanoparticles is 
described in the literature with various methods, mostly using polymers. A proper monolayer is 
often needed to shield the surface. The surface energy is decreased, which reduces the formation of 
aggregates.  
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2.2 Metal Nanoparticles 
 
Compared to bulk metals, metallic nanoparticles have different properties due to their size and thus 
the resulting high surface-to-volume ratio. Nanostructured materials of coinage metals such as gold 
and silver have unique optical properties due to strong surface plasmon absorption in the visible 
region of light. [13] They have versatile applications in modern research and technology and are no 
longer indispensable. They are applied in catalysis, electronic compounds, sensors or medicinal 
devices. [14, 15] Their properties are based on physical parameters and can easily be tuned. Size, 
shape and structure are the mainly contributing parameters. 
 
2.1.1 Synthesis of Coinage Metal Nanoparticles 
 
Various synthetic procedures have been published. In the majority of reports, HAuCl4 proved to be 
the favored starting material due to its ready availability, despite the disadvantage of limited control 
over nucleation process and possible chloride contamination in the resulting particles. This method 
was first described by Turkevich and enhanced by Frens. [16, 17] It is based on the chemical 
reduction of tetrachloroaurate with citrate in aqueous solution. Citrate is both reducing agent and 
ligand for the stabilization of the formed nanoparticles. Nanoparticles with a diameter between 
10 nm and 100 nm can be prepared. Frens also showed that the colloidal stability strongly depends 
on the size of the nanoparticles. [18] Mechanistic studies on the formation of the nanoparticles 
showed that in the synthesis acetone is formed and stabilizes the surface. If NaBH4 is used as 
reducing agent different particle sizes could be obtained and the surface can be covered with 
different ligands added during the synthesis. The reduction of AuCl4
-
 with NaBH4 in a two-phase 
system was described by Brust and Schiffrin. [19, 20] Nanoparticles of Au, Ag, Pt, and Ir in toluene 
can be readily synthesized using a biphasic reduction procedure. [21–23] A noble metal salt (e. g., 
HAuCl4) dissolved in water is first extracted into an organic phase with the help of a phase transfer 
reagent, tetraoctylammonium bromide (TOAB). Upon reduction with NaBH4 it is possible to obtain 
uniform-sized metal nanoparticles. Small gold nanoparticles with a diameter of <10 nm can be 
synthesized in organic solvents. 4-Dimethylaminopyridine (DMAP) is often used for the 
stabilization of the resulting nanoparticles in aqueous solution. [24, 25]  
Stucky and co-workers developed a method for the reduction of a gold salt in organic solvents using 
an amine-borane complex and n-dodecanethiol for stabilization. [26] The resulting nanoparticles 
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have a narrow size distribution and are nearly spherical. Reaction time, temperature, molar ratios, 
and solvents can be varied to adjust the size of the gold nanoparticles. In addition, other metal 
nanoparticles like Ag, Pd, and alloy compositions can be synthesized. Furthermore, the synthesis 
can be easily upscaled to get multigrams of nanoparticles for applications. Gold nanoparticles 
smaller than ~1.5 nm consist of a distinct number of atoms and the compounds are called clusters. 
These gold clusters can either behave like discrete molecules or exhibit properties of nanoparticles, 
depending on the number of atoms. The well-known Schmid-cluster Au55 consists of a phosphine 
stabilized gold cluster Au55(PPh3)12Cl6 with a stable closed shell. It is a molecule with a well-
defined formula weight, unlike the colloidal solutions. Different to nanoparticles they have no 
weakly bound ligands on the surface. In cluster structures metal-metal bonding interactions can be 
found. [27] Apart from spherical nanoparticles, other shapes of gold nanostructures can be 
synthesized. Nanorods can be prepared by a seeding growth mechanism. [28] Hollow gold 
nanospheres can be prepared by sacrificial galvanic replacement of cobalt nanoparticles. [29] 
Colloidal stability of the nanoparticles is the key challenge in synthesis and can be controlled by the 
ligands at the surface. Weakly capped nanoparticles agglomerate faster than those with strongly 
bound ligands. Citrate-capped gold nanoparticles are stabilized via weakly physisorption of citrate 
ions, whereas dodecanethiol-stabilized gold nanoparticles are stabilized via strongly chemisorbed 
thiolate ligands. [30] This thiol stabilization of gold nanoparticles and the self-assembly of organic 
sulfur compounds on gold surfaces was first reported by Giersig and Mulvaney and gave access to 
highly stable colloidal solutions. [31] 
 
2.1.2 Optical Properties of Gold Nanoparticles 
 
A characteristic of all gold colloids is the color, which can vary from light red via purple-red to 
blueish-red. The optical properties of gold nanoparticles, first described and attributed to those by 
Faraday in the 19
th
 century, are unique and caused by quantum sized effects. The color results from 
absorption and scattering of electromagnetic irradiation by local surface plasmon resonance, a 
collective oscillation of the free electrons in the conduction band. The expression plasmon consists 
of the physical terms for plasma and vibration. For gold nanoparticles with different core size, the 
absorption maximum shifts. For larger nanoparticles it shifts to a longer wavelength, meaning lower 
energies (Figure 7). The maxima are also broadened. It is also possible to determine the particle size 
via the correlation with λmax of the surface plasmon. [32] This phenomenon is very characteristic for 
both gold and silver nanoparticles, which appear red and yellow, respectively. 
Basic Knowledge 
10 
 
Figure 7: UV/Vis spectra (normalized) for Au nanoparticles with different core sizes in aqueous solution. 
Adapted from [32] 
 
When small spherical metallic nanoparticles are irradiated by light, the oscillating electric field 
causes the conduction electrons to oscillate coherently. The displaced electron cloud has a restoring 
force which arises from the Coulomb attractions between negatively charged electrons and 
positively charged nuclei (Figure 8). An oscillation caused by the displacement appears relative to 
the nuclei framework. When incoming light enters into resonance with the vibration of the electron 
cloud an amplification proceeds and the absorption is intensified.  
The frequency is related to the size and shape of the resonance body and the density and effective 
mass of electrons. Thus metal nanoparticles of different sizes appear in different colors. For gold 
nanoparticles the maximum lies at around 520 nm, for silver nanoparticles at 420 nm with respect to 
a particle size of 20 nm. 
 
 
Figure 8: Plasmon resonance: scheme for oscillation of the electron cloud at a spherical nanoparticle. 
Adapted from [33] 
Au 
Au 
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2.3 Semiconductor Nanoparticles 
 
From a historical perspective the research on semiconductor-based nanomaterials is much younger 
than those based on metals, but many principles from metal nanoparticles could be transferred. In 
the beginning of the 1980s CdS colloids were synthesized and analyzed by Grätzel, Brus and 
Henglein. [34–36] A few years later the quantum size-effect has been introduced by Brus. [37] It 
describes the relation of size and electronic band gap and is based on a strong confinement of 
electrons and holes in a small particle with a diameter below the exciton Bohr radius, the average 
diameter between electron and hole. As the size is reduced the electronic excitation shifts to higher 
energies. It means that the larger the core diameters of semiconductor nanoparticles the lower the 
energy of the emitted light and the longer the wavelength. [38] 
Semiconductor nanoparticles between 2 nm and 10 nm are quasi zero-dimensional single crystals 
and are often called quantum dots (QDs). These colloidal nanocrystals exhibit strong fluorescence 
with a size-dependent emission wavelength. The energy states become discrete (Figure 9). They 
possess unique optical properties and are often used in electronic and optical devices. QDs are 
applied for LEDs and solid-state lighting, displays, photovoltaics, transistors, quantum computing, 
medical imaging, biosensors, among many others. 
 
 
Figure 9: Density of states in a semiconductor crystal in dependence of the dimension. Adapted from [38] 
 
The optical properties are a result of the quantum confinement effect and depend on size, shape and 
composition of the nanocrystals. Most common quantum dots are CdTe and CdSe. When the core 
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diameter of the QDs is smaller than the exciton Bohr radius, the energy levels become discrete and 
recombination on the band gap causes emission. Larger QDs emit longer wavelengths (Figure 10). 
For both materials at the nanoscale the emission wavelength lies in the visible part of the 
electromagnetic spectrum making these materials suitable for imaging of biological tissues. [39], 
[40] The photo- and electroluminescence properties can be fine-tuned to emit any color of light by 
changing the material’s crystallite size. 
 
 
Figure 10: Size-dependent photoluminescence (a + b) and absorption and emission spectra (c) of CdSe. 
Adapted from [41] 
 
The size-dependent optical properties allow the synthesis of quantum dots covering the entire 
visible to near-IR wavelength range. A different growth of the nanocrystals, and therefore different 
optical properties, can be achieved by the use of different ligands in the synthesis. [42, 43] One 
major disadvantage of this tuning method is that each maximum is related to a different core size, 
which makes a direct comparison difficult. This could be avoided by the use of mixed crystal 
systems, multicomponent materials with gradient composition. A ternary system of CdTe and CdSe 
varies in chemical composition of the nanocrystal and the optical properties of both binary 
compounds can be combined. [44] In the core-shell structure of two component materials the 
external shell improves the quantum yields and gives stability to the nanocrystal. 
Originally QDs were prepared by a hot-injection method, a bottom-up synthesis using dimethyl 
cadmium and a selenide or telluride precursor in a coordinating solvent with trioctylphosphine 
(TOP) and trioctylphosphine oxide (TOPO). [39] Besides the extremely toxic precursor the 
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resulting nanoparticles are capped with a hydrophobic shell, which makes them unsuitable for 
biological applications. Different cadmium precursors like CdO, Cd(OAc)2 or CdCO3 have been 
applied in the organic approach, but for biological applications solubility in water and stability are 
required. Synthesis in organic solvent must be followed by ligand exchange at the nanoparticles or 
they have to be synthesized directly in aqueous solution. The direct synthesis of cadmium 
chalcogenide nanoparticles in aqueous solution was achieved by thiol-capping of the nanocrystals 
yielding size-controlled and highly luminescent QDs. [45] First described by Weller and further 
investigated by Zhang CdTe nanocrystals were synthesized in aqueous solution. [42, 46] A freshly 
prepared NaHTe precursor solution is added to a mixture of Cd
2+
 ions and thiol ligands under inert 
conditions leading to highly luminescent CdTe quantum dots. Later different synthetic approaches 
using hydrothermal synthesis, ultrasonic or microwave irradiation were developed but mainly based 
on the procedure by Weller. [47–50]  
To obtain water soluble quantum dots from organic synthesis the hydrophobic shell must be 
replaced by ligands providing both solubility in water and stability of the colloidal solution. 
Mercaptopropionic acid capped CdTe/ZnS nanocrystals could be synthesized via ligand 
exchange. [51] One major disadvantage of this method is the decreasing photoluminescence upon 
site exchange of the ligands. The impact of thiol ligands on the photophysical properties of quantum 
dots has been studied intensively. [52] They mainly depend on the concentration and pH value in 
solution.  
Optical properties of quantum dots are mainly determined by the elements in the core material and 
are size-dependent. For some applications tuning of optical properties without changing the size is 
important, e. g. in cell uptake studies. This can be achieved by a variation of the core components. 
CdTe and CdSe nanocrystals are both versatile materials for biological applications, both emit in 
the visible to near infra-red spectra (Figure 11). Both compounds crystallize in cubic structures and 
a combination of both can lead to combined optical properties. Mixed crystal systems with a 
homogeneous internal structure allow fine tuning of optical properties. [53] 
Compared to binary compounds like CdTe, CdSe or other semiconductors, ternary systems are only 
scarcely explored. Until now some ternary and quaternary systems have been synthesized and 
characterized. [54] Aqueous and microwave-assisted syntheses are known for the preparation of 
these CdTexSe1-x quantum dots. [55, 56]  
 
Basic Knowledge 
14 
 
Figure 11: Quantum dot core materials and their emission wavelengths. Adapted from [57] 
 
Semiconductor quantum dots (QDs) with high photoluminescence and narrow size distribution are 
versatile diagnostic and therapeutic tools for a variety of in vitro and in vivo bioapplications. [58] 
Due to their bright photoluminescence and their high photostability they have major advantages 
when compared to organic dyes. Nonetheless it should also be considered that upon 
functionalization of the QDs the hydrodynamic diameter of the particles increases and can have an 
effect the cell uptake. 
 
 
Figure 12: Confocal fluorescence microscopy images of cells incubated with quantum dots. Two different kinds of 
modified CdTe coloring nuclei (red) and cytoplasm (green). Adapted from [59] 
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In vitro they can be applied for labeling of cells or biomolecules and immunostaining. In vivo they 
can be used as vessels and for tumor imaging, visualization of the bio distribution of QDs and 
tracing of labeled cells in a body [60] and they are also applied for cell imaging (Figure 12). In 
contrast to organic dyes they are stable against photo bleaching (Figure 13). Fluorescein 
isothiocyanate (FITC) luminescence for example fades in color after only a few minutes whereas 
CdTe/CdS/ZnS quantum dots show luminescence for more than 30 min under the same irradiation 
conditions. 
 
 
Figure 13: Photostability of a traditional dye compared to quantum dots. Adapted from [61] 
 
QDs can also be linked to biomolecules such as antibodies, peptides or small molecules, allowing a 
highly sensitive and specific targeting or detection. [57] 
Another important aspect for biological applications of QDs is their biocompatibility. Cadmium-
based quantum dots can leak cytotoxic Cd
2+
 ions and have the tendency to aggregate, which are two 
major factors essentially for biocompatibility. Both can be prevented by a core-shell structure. 
Passivation of the bare QDs with a polymer coating or the growth of a ZnS shell can reduce the 
cytotoxicity. [62] Cytotoxic effects can not only result from the core material but also from ligands 
at the surface. [63] However there are also a number of studies where no cytotoxic effects of 
quantum dots were observed. [59] 
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2.4 Surface Functionalization 
 
Surface functionalization of nanomaterials is in important topic of current research. The interaction 
of nanoscale materials with (biological) systems is mostly governed by the surface of the materials. 
Modifications of these can tune properties. Nanoparticles are well suited as templates for the 
immobilization of bioactive ligands, e. g. amino acids, peptides or enzymes, and their multiple 
presentations to receptors for a simultaneous binding. [64–66] Figure 14 shows a general scheme 
for the functionalization of nanoparticles.  
 
 
Figure 14: General scheme for the functionalization of nanoparticles. 
 
Various core materials like noble metals (Au, Ag), quantum dots (CdTe, CdSe) or metal oxides 
(Fe3O4, TiO2) can be synthesized and applied as multivalent scaffolds. For both noble metal and 
semiconductor nanoparticles ligands with a sulfide anchor are often used due to their excellent 
stability. For iron oxide nanoparticles catechol-like ligands exhibit high stability. [67] The spacer 
between the nanoparticle and the active moiety usually consists of alkyl or polyethylene glycol 
chains, while the length of which may vary. The spacer must provide enough stability to the 
colloidal solution. Bifunctionalized ligands with both a moiety on one end anchoring at the 
nanoparticle and a free functionality at the other end offer an additional moiety for the further 
attachments of bioactive ligands. Functionalization of gold nanoparticles is mainly based on the 
work on self-assembled monolayers (SAMs) of molecules on planar gold surfaces. The dynamics 
and conformations of these assemblies have been studied intensively. [68, 69] A variety of 
functional ligands is available including thiolates, dithiolates, dithiocarbamates, amines, 
carboxylates, or phosphines. These molecules can be attached to the nanoparticle’s surface via 
ligand exchange reactions. For stable conjugations thiol-based anchoring groups are favored.  
It could be an advantage when the ligand used in the synthesis is only weakly bound to the surface. 
Citrate- or DMAP-stabilized gold nanoparticles are good precursors for these reactions, but also 
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thiol-stabilized gold nanoparticles can undergo an exchange. [25, 64, 70, 71] Even if gold 
nanoparticles synthesized with the method by Turkevich are only weakly covered by citrate, 
chloride ions and acetone dicarboxylate, the oxidation product of citrate, are also present. [72, 73] 
These species bind strongly to the surface and give certain stability to the colloidal solution. For a 
successful exchange ligands with stronger affinity to the gold surface must be used. 
Schiffrin et al. described for the first time a two-phase synthesis of gold nanoparticles. Thiol-
stabilized gold nanoparticles were synthesized in aqueous solution and transferred into an organic 
phase in a single synthesis step. [19] Monolayer protected nanoparticles smaller than 5 nm can be 
synthesized with this method. Thiol-gold interactions and van-der-Waals attractions stabilize the 
nanoparticles. Ionic and polymeric stabilization are much weaker. Through ligand-exchange 
reactions at the surface citrate-capped gold nanoparticles can be stabilized. However, upon 
chemisorption of thiolate ligands desorption of charged ligands like citrate sacrifices the 
electrostatic stability and can cause irreversible aggregation. [74] 
Ligand exchange reactions at gold nanoparticles are carried out by adding an excess of thiolate 
ligands into the aqueous solution of the colloids. Suitable are ω-functionalized thiols, which offer 
both the ability to bind at the surface via the thiol moiety and stabilization via van-der-Waals 
interactions. Colloidal solutions with ligands which do not shield the nanoparticles properly turn 
steel blue in their optical appearance indicating particle aggregation. A two-step approach for the 
functionalization can be used. [70] Negatively charged ligands provide enough electrostatic stability 
whereas ligand exchange with neutral or positively charged ligands is critical and often results in 
aggregation of the colloidal solution. Especially mercaptocarboxylic (Figure 15) acids turned out to 
be excellent ligands. [75]  
 
 
Figure 15: Mercaptocarboxylic acids for ligand exchange reactions. 
 
Studies on the stability of gold nanoparticles showed that methylene chains from mercaptoacetic 
acid (thioglycolic acid, TGA) or mercaptopropionic acid (MPA) are too short and do not establish 
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enough steric stabilization for the colloids. [76] 6-Mercaptohexanoic acid (MHA) is still not 
sufficient, however 11-mercaptocarboxylic acid (MUDA) with its long alkyl-chain protects the 
surface sufficiently and stabilizes the nanoparticles, because it possesses more methylene units. [77] 
Vibrations C-H bond in the IR spectrum appears at 2918 cm
-1
 indicating a polymethylene 
monolayer of trans-zigzag chains. [78] This effect was also observed on gold surfaces with self-
assembled-monolayers (SAM).  
To obtain gold nanoparticles with short-chained ligands, other synthetic strategies must be selected. 
The biphasic reduction of a metal salt (HAuCl4 or AgNO3) with NaBH4 and the addition of organic 
ligands give access to these colloidal solutions. [79, 80] Positively charged gold nanoparticles 
cannot be synthesized via ligand exchange reaction. The opposite charges interfere with each other 
and destabilize the solution. [70] This type of nanoparticles has to be synthesized directly from the 
precursor salts or via a two-step modification. [81] 
The dynamic and mechanism of place-exchange reactions at the surface of gold nanoparticles has 
been studied intensively. Kinetic studies have revealed that either an associative SN2-like, a 
dissociative SN1-like or a combination of both takes place when long alkythiolate ligands are used. 
The rate depends on the concentration of the incoming ligand and decreases with the size of it. [71] 
Detailed 
1
H NMR studies by Murray and coworkers examined the ligand exchange on monolayer 
protected gold clusters in dependence of concentration and ligand chain length and concluded an 
SN2-like associative mechanism. [82] Later, this was confirmed by Montalti et al., who examined 
the kinetics of the release of a pyrene derivative from the surface via fluorescence 
spectroscopy. [83] 
Through reactions at the ligand periphery bioactive molecules can be attached to the surface of the 
nanoparticles. The molecules are covalently bound to the ligand and stable against detachment. 
Depending on the free functional groups of ω-functionalized thiols at the nanoparticle’s surface, 
there are a variety of reaction types possible (Figure 16). [84], [85] The synthetic methods require 
highly reactive species like active esters or nucleophiles but reaction conditions are always limited 
to the protection of the colloidal stability. The reaction between carboxylic acids and amino groups 
results in a very stable amide bond. This is a rather common method for the immobilization of 
biomolecules, because many of them possess a free amino group. MUDA-stabilized nanoparticles 
can be coupled directly in solution with the respective amine. Usually carbodiimide based agents 
are used for the activation of the carboxylate, followed by the reaction with N-
hydroxysuccinimide. [86] Then the active ester reacts with the amine immobilizing the molecule via 
a covalent bond. This method can be applied for reactions both in aqueous and organic solvents. 
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Esterification between both alcohol and carboxylate functionality can also yield in a covalent 
attachment between bioactive molecule and ligand. [87]  
Nucleophilic substitution at ω-functionalized halogen alkanes is also an approved strategy for the 
immobilization of bioactive molecules. As in organic synthesis the steric demand of the ligand 
directs the reaction to be SN1 or SN2-like. [88] Another powerful synthetic method for incorporating 
bioactive molecules on the surface of nanoparticles is the 1,3-dipolar cycloaddition between azides 
and alkynes. Although these click-reactions are usually catalyzed by a Cu(I) salt, triazole formation 
can also occur at room temperature and uncatalyzed. [89]  
 
 
Figure 16: Different reaction types for covalent attachment of bioactive molecules. 
 
Besides covalent linkage of active molecules to the surface of nanoparticles also physical methods 
like hydrogen bonding and electrostatic or hydrophobic interactions can be used for the adsorption 
of molecules. This process plays an important role in protein and enzyme adsorption. [57] For 
example negatively charged DNA can be linked to gold surfaces via electrostatic interactions. [90, 
91] Compared to covalently bound moieties, the stability of the resulting nanoparticles is weaker 
and strongly depends on the solvent, pH value, and ionic strength. Furthermore, the number of 
immobilized molecules can vary significantly. 
Basic Knowledge 
20 
In general functionalization depends on the type of molecule which is to be immobilized and the 
type of application. In some cases, for example drug delivery, a weakly bound ligand is favored. For 
all synthetic methods the molecules need to possess functional groups which are either already there 
or must be inserted through chemical modifications. Functionalized molecules can be qualitatively 
verified by a number of characterization methods, e. g. vibrational spectroscopy, thermogravimetric 
analysis, determination of hydrodynamic diameter and zeta potentials. 
 
2.5 Characterization 
 
There are different methods to characterize nanoparticles or colloidal solutions, generally all those 
which can be used for bulk materials. For functionalized nanoparticles with an inorganic core and 
an organic ligand shell, a technique can only characterize either core or shell. For a complete 
characterization a combination is necessary. The different methods for characterization used in this 
work are shown in Table 1. The precise determination of size, dispersity, state of aggregation and 
composition of the ligand shell is crucial for applications not only in biological media. For all 
techniques only small amounts in the nanomolar range are available and the method has to be 
sensitive enough to analyze these quantities. 
 
Table 1: Summary of the nanoparticle characterization methods. 
 
 
Core 
  
Shell 
 
TEM dcore H NMR δH 
EDX composition IR νbond 
DLS dhydr MS m/z 
UV/Vis λabs ζ-potential charge 
Fluorescence λem   
 
 
For the characterization of the core size transmission-electron-microscopy (TEM) is mainly used. 
The mean core diameter of the nanoparticles can be determined. The sample is penetrated by a high 
energy electron beam which is scattered at the atoms of the core. High accelerating voltage and the 
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low wavelength of the electrons can lead to single atom resolution. For the measurement of 
biological samples the voltage needs to be lower to avoid destruction of the material. TEM 
measurements with lower resolution can give an overview of the sample and give a statistical 
distribution of the nanoparticles. High-resolution TEM can visualize single nanoparticles in 
structure and crystallinity. Lattice planes indicate crystalline materials and allow lattice parameter 
determination. Due to complex interference patterns the determination can be very complex. 
Elements with a high atomic number and therefore a heavy core like gold or silver have a high 
scattering rate and appear with high contrast, whereas organic compounds, like single ligands, 
mainly consisting of carbon do not appear. In addition, energy-dispersive X-ray emission 
spectroscopy (EDX) can be done to obtain the elemental constitution of the sample. For alloyed 
systems or mixed crystals the respective content can be determined using this technique. 
Dynamic light scattering (DLS) gives the hydrodynamic diameter of the nanoparticles, where the 
volume of the whole nanoparticle including the core and ligand shell is determined, compared to 
TEM measurements where only the core diameter is measured. For ionic shells, coordinating 
solvent molecules can also be depicted. The method is nondestructive and can be assessed directly 
of the sample. DLS measurements give the average diameter of all the nanoparticles included in the 
sample, for a reliable result the nanoparticles should be monodisperse. Furthermore, the colloidal 
solution can be characterized by their surface potential. Streaming potential measurements indicate 
the charge at the surface. 
Optical properties of nanoparticles can be determined with UV/Vis spectroscopy and fluorescence 
measurements. As mentioned above, the optical properties strongly depend on the shape of the 
nanoparticles. For metal nanoparticles the plasmon resonance causes the color appearance, quantum 
dots can either absorb or emit light with distinct wavelengths. Gold nanoparticles larger than 3 nm 
develop the characteristic plasmon resonance. The maximum shifts towards longer wavelength and 
therefore smaller energies for bigger nanoparticles. The position of the maximum can be used for 
the determination of the nanoparticle’s size, the shape for the dispersity. Monodisperse colloidal 
solutions have a narrow absorption band. By comparison with reference solutions the concentration 
of the nanoparticles can be calculated. Anisotropic gold nanoparticles appear in different colors and 
possess more than one maximum. The optical properties of quantum dots also strongly depend on 
the size and shape. Besides absorption they also have an emission maximum when irradiated with a 
distinct wavelength. With fluorescence spectroscopy the size and size distribution can also be 
calculated. Another figure for high quality fluorophores is the quantum yield (QY). It is defined as 
the ratio between emitted and absorbed photons. QY below 100% means that some electrons in 
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excited states relax without radiation. It is drastically reduced by any kind of defect in the crystal 
lattice.   
The ligand shell of the nanoparticles can be characterized with the same methods used in organic 
chemistry. NMR (nuclear magnetic resonance) and IR (infra-red) spectroscopy give information 
about the composition of the shell. The signals of immobilized ligands are typically broadened 
compared to the free ones. Broadening is caused by the chemical environment and the 
inhomogeneity of the shifts caused by tightly bound molecules. Close to the core the signals are 
even more broadened. [92] Due to only small concentrations of the particles mostly only proton 
NMR is recorded, for significant signals in carbon NMR analysis the concentrations are too low. 
IR spectroscopy also characterizes the organic compounds of the nanoparticle. Both NMR and IR 
can monitor the surface and indicate changes after ligand exchange or coupling reactions. 
Characteristic vibrations of functional groups, e. g. S-H or C-H bonds or the carbonyl group in 
amide bonds, can help to identify the ligand.  
Mass spectrometry can be used for the characterization of the single ligand before immobilized on 
nanoparticles. Depending on the reaction way the complete ligand can be synthesized separately, 
characterized and then attached to the surface. Elemental analysis also helps to characterize the 
organic compound. 
The number of ligands can be determined with thermogravimetric analysis (TGA). The loss of 
weight depending on the temperature can be attributed to the amount of organic compound. With 
the diameter from TEM measurements, the assumption of a spherical shape and the molecular mass 
of the ligand, the number of ligand molecules can be calculated. This analysis needs a relatively 
large amount of sample. 
 
2.6 Nanoparticles in Biological Systems 
 
The synthesis and controlled functionalization of nanoparticles allows their application in biological 
systems. Due to the small size and large surface their properties are beyond the performance of 
previously used materials and offer new opportunities but also render them to unexpected 
interactions and unanticipated consequences. [93] Depending on the material, the application 
possibilities are widespread. For example, gold nanoparticles can be used for labelling, delivering, 
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heating and sensing [94] and quantum dots can be used as fluorescent markers for in vitro and in 
vivo imaging. 
Traditionally, gold nanoparticles were used for visualization due to their strong interactions with 
light. Applied on tissue and enriched in areas of interest, they provide enough contrast. 
Consideration should also be given to the toxicity of nanomaterials which is also a significant part 
in drug development and has to be elucidated carefully. The term nanotoxicology originated and 
describes the effects of nanomaterials on living tissues. Since to their size similar to biological 
components (cells, proteins) nanoparticles can interact at a cellular level. They also possess 
dynamic properties. Nanoparticles have the ability to move in the system allowing a wide 
distribution, but they also have the ability to build agglomerates, which are less mobile. Through 
functionalization of the ligand shell stabilization in biological media can be achieved. Liposomes, 
polymeric nanoparticles and gold nanoparticles have already found their way into medicine as 
powerful carrier systems. [95–98] The first FDA-approved nanodrug was Doxil®, a liposom based 
nanocarrier. [99] Iron oxide nanoparticles are already approved as MR imaging agent and targeted 
polymeric nanoparticles entered clinical trials. In the second generation of nanomedicine 
nanoparticles were developed for specific ligand targeting of organs, tissues, or cells. The ligand is 
presented at the surface of the carrier, which is accumulated at the site of action. [100] Third-
generation nanoparticles act at the subcellular and organelle-level. [101] Ligand-functionalized 
nanoparticles are the focus of current research and have a huge potential application. 
Biofunctionalized nanoparticles can overcome natural barriers in organisms, e. g. biological 
membranes, skin, lung, or the blood-brain barrier. Like small molecules they can diffuse through 
the lipid bilayer depending on size, shape, and charge. This can be used in therapeutic applications 
and medical diagnostics, but the nanoparticles need to have efficient binding, biocompatibility, and 
long-time safety. [102] Transport across a membrane can either proceed in vesicles, mostly found 
for oxidic nanoparticles, or directly without modification. The charge and zeta-potential of the 
nanoparticles have a vast effect on the cell uptake. Solubility of the nanoparticles in the biological 
medium is decisive for average residence time in the organism. Depending on the size and 
composition nanoparticles can enter the cell by different endocytic pathways. There are several 
internalization mechanisms like phagocytosis, macropinocytosis, and clathrin- and caveolae-
mediated endocytosis. [103] The processes are triggered by cell-surface receptors either targeted 
directly by the nanoparticle or indirectly by effective molecules (e. g. growth factors). When the 
nanoparticle is incorporated in a vesicle, the natural digestion mechanism starts. Phagocytosis 
engulfs foreign particles and disables the pathogen. This process is a natural defense mechanism in 
Basic Knowledge 
24 
organisms. Furthermore pinocytosis is also a pathway for materials entering eukaryotic cells. [103] 
Through lysosomes and phagocytosis the nanoparticle is infiltrated into the cell, where the pH value 
is lower. Depending on their chemical properties, oxidic and metallic nanoparticles are not stable 
under acidic conditions and toxic ions can be released. Heavy metal ions in the cytosol cause stress 
and have an influence on production and activation of reaction oxygen species (ROS). [104] 
Through passivation of the core with polymers or zinc oxide, this can be prevented. For the 
development of nanocarrier systems an in-depth understanding of cellular uptake is of great 
importance. 
 
2.7 Multivalent Ligands 
 
Multivalency is a key interaction in biological systems. [105] It means polyvalent interactions in 
(biological) systems and often results in an amplification of binding strength. Multivalency is the 
simultaneous interaction of multiple ligands on one entity with multiple receptors on another. The 
valency of a particle is determined by the number of separate active moieties. This concept plays a 
central role in recognition processes, self-assembly of matter and in signal transduction pathways. 
The recognition element on the central scaffold can be a carbohydrate, peptide, protein or small 
molecule, any moiety binding to the receptor. The scaffold defines the geometric features of the 
multivalent ligand, e. g. shape, size, orientation, flexibility and valency. Nanomaterials provide a 
versatile platform for immobilization of bioactive molecules. Due to the high surface-to-volume 
ratio a multitude of molecules can be assembled on them. For the immobilization of effector 
molecules, a central particle is needed. Several inorganic and organic scaffolds belong to the class 
of nanomaterials: dendrimers, fullerenes, liposomes, SPIONS, Au NP, polymer NP, QDs, nano 
hollow spheres, or self-assembled peptides. 
Multivalent ligands can act as effectors or inhibitors of biological processes. The terms are different 
to bioactive monovalent molecules which are often referred to as agonists (activating) or 
antagonists (inhibiting). High functional affinities and binding part density can result in an 
amplification of the effect. The potency of a multivalent ligand can depend on the mechanism of 
interaction (Figure 17). For monovalent ligands single site receptor binding or hetero dimerization 
are typically found. In multivalent presentation there are different interaction modes between ligand 
and receptor. For example, natural occurring multivalent vaccines are able to cluster cell surface 
receptors and have a high effectiveness. The inhibitory activity of pentameric Shiga-like toxins 
derives from the ability to occupy multiple binding sites. Steric stabilization is given when the size 
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ligand prevents further interactions. Subsite binding and chelating effects are secondary binding 
effects in regions of the receptor different to the primary binding site. Statistical effects can also 
occur when rebinding of the multivalent ligand is favored through high local 
concentration. [106, 107] Different binding modes can result because of the structural complexity of 
multivalent ligands. There are many biological systems in which multivalency plays a crucial role. 
Understanding the molecular features that influence the binding can help to develop new systems. 
The scaffold structure mainly determines the effects on activity. Small multivalent scaffolds may 
not be capable of spanning a large distance between several receptors but may effectively occupy 
multiple subsites. 
Receptors are usually proteins embedded in cell surfaces and transmit information from outside into 
the inside of a cell. Signal transduction is predominantly mediated by ligand-gated ion channels. 
Many receptors act as part of oligomeric complexes and the interaction with multiple ligands may 
have an effect on signal transduction. Multivalent ligands provide new opportunities for the 
activation or inhibition of receptor interactions. [108] The valency and orientation of recognition 
sites and the stability of the resulting complex can influence the interactions. [109]  
 
 
Figure 17: Different mechanisms of binding with monovalent and multivalent ligands. 
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Nanoparticles offer a versatile platform for multivalent action. When functionalized with ligands 
including both a bioactive moiety and an anchor for the surface they are a highly multivalent 
system. Size, shape and physical properties can be selectively adjusted. For example multivalent 
presentation of carbohydrate mimetics on gold nanoparticles for selectin inhibition exhibited IC50 
values in picomolar range with high selectivity. [110] 
Although nanoparticles with terminally functionalized ligand shells are used for a large number of 
applications in the life sciences gold nanoparticles have only been used as multivalent ligands for 
the presentation of bioactive amines in receptor binding interaction. [111]  
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3. Motivation and Goals 
 
Due to their similar size to biological systems, e. g. enzymes or receptors, nanoparticles are 
interesting tools for studying the interaction with each other. Functionalized nanomaterials might 
help to answer fundamental questions in biochemical and cell biology to understand molecular 
mechanisms and might also find their way into medicinal applications. The behavior of 
nanomaterials in biological systems is still not completely understood and currently under 
investigation.  
These nanomaterials, especially nanoparticles, can be functionalized with simplified binding 
moieties of biologically active compounds. This type of functionalization implies a multivalent 
presentation allowing polyvalent interactions between ligand and receptor. The concept of 
multivalency proved to have special effects in biological interactions. The newly developed 
conjugates possess different properties compared to monovalent analogues. Besides studies on the 
multivalent interactions of natural molecules, e. g. carbohydrates or selectin inhibitors, only little is 
known about the interactions of neurotransmitters multivalently presented to their receptors. 
Neurotransmitters belong to an essential class of natural products and represent an appealing class 
of small molecules for immobilization on nanomaterials. These molecules are endogenous 
chemicals which enable transfer of information in biological systems. They are chemical 
messengers transmitting a signal. Their biosynthesis is rather simple and they are readily available 
in living organisms. There are different types of neurotransmitters, e. g. amino acids, peptides or 
amines. Investigations are to be focused on biogenic amines. Histamine, dopamine and serotonin 
are only three examples with important functions in the central nervous system. All 
neurotransmitters have distinct receptors for signal transductions. These native amines act as 
agonists activating a receptor response. Their monovalent ligand-receptor interactions are well 
studied and understood. 
Gold nanoparticles proved to be versatile tools for the application in biological systems due to their 
high biocompatibility. The surface can easily be modified and furthermore, size and shape of the 
nanomaterials can be adjusted during synthesis. By the determination of the size, the number of free 
active moieties can be varied. 
In this work gold nanoparticles are to be synthesized, functionalized and fully characterized. 
Different synthetic approaches can be used to obtain various core sizes, yet water solubility and 
stability must be ensured. Subsequently these nanoparticles should be functionalized with the 
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biogenic amines mentioned above. It has to be tested, which core sizes are suitable for application. 
The effect of these newly developed conjugates on the ligand-receptor interactions should be 
studied. Therefore a cooperation project between chemistry and veterinary medicine will be 
established, where the biological functionality of the gold nanoparticles can be tested. These results 
can be compared to the effects of the native amines. Immobilization of the amines also involves a 
loss of recognition attribute as the amino group will be bound to the nanoparticles. But 
simplification of binding moieties is also common in multivalent presentation. As there is no 
information about multivalent contribution in these interactions, these investigations can give new 
insights in this phenomenon. Depending on the results the scaffold and geometry of the components 
can be improved. The particular aim is the development of new nanoscaled materials for medical 
application. 
Besides the interaction of gold nanoparticles in biological systems another class of nanomaterials is 
to be investigated. Quantum dots of low nanometer scale are able to penetrate biological barriers 
and can be used for cell imaging. The physical properties of these materials are size- and shape-
dependent, which can be precisely adjusted during the synthesis. Optical characteristics like 
emission and absorption ability of different quantum dots should be investigated and improved, as 
these are important for upcoming use. The quantum dots can be applied as cell dyes and the cellular 
uptake can be studied. Additionally, the synthesis should be followed by surface functionalization 
with bioactive amines. Fluorescence microscopy can be used for a visualization of the behavior in 
biological systems. 
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4. Gold Nanoparticles 
4.1 Syntheses of Gold Nanoparticles 
 
In this work various gold nanoparticles with a nearly spherical shape were synthesized using 
different gold precursor materials. The size of the nanoparticles varies between 4 nm and 25 nm 
and they are either already water soluble or dispersed in an organic solvent. Three different 
synthetic approaches were chosen to obtain nanoparticles with different diameters. For 
biomedical applications a uniform size is required. Thus the size distribution of the resulting 
particles should be very narrow. Additionally, the colloidal solution must be stable in water and 
under physiological conditions. Therefore ligand exchange reactions have to be performed. The 
size of the colloids can be adjusted from smaller to larger spheres depending on the reaction 
conditions. Figure 18 gives an overview of the synthesized gold nanoparticles from 4 nm to 
25 nm obtained by different synthetic approaches. 
 
 
Figure 18: TEM images of colloidal gold nanoparticles with different sizes synthesized via the Stucky approach 
(A, B), the Brust-Schiffrin method (C) and the Turkevich method (D, E). 
 
The most popular and frequently used concept for the synthesis of gold nanoparticles is the 
reduction of tetrachloroaurate AuCl4
-
 in aqueous solution using NaBH4 or trisodium citrate. This 
method provides gold nanoparticles which are already water soluble. First published by 
Turkevich in 1951 and improved by Panigrahi et al. these gold nanoparticles were synthesized 
size-selective. [16], [112]  
A B C D E 
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Figure 19: Reaction scheme for the synthesis of citrate-stabilized gold nanoparticles. 
 
For the synthesis HAuCl4∙3 H2O was dissolved in ultrapure water and heated up to 110 °C 
(Figure 19). Under vigorous stirring a solution of trisodium citrate was added at once and the 
mixture was stirred at 80 °C. The reaction time and the molar ratios of Au(III) and trisodium 
citrate determined the size of the resulting particles, less reduction agent gave bigger 
nanoparticles. The reaction volume was kept at 50 mL for each synthesis. Trisodium citrate 
serves not only as a reducing agent but also as the stabilizing ligand. The formation of the 
nanoparticles in solution can be monitored by the change of the color from pale yellow over 
greyish after a few minutes to final red. After a certain time the solution was cooled down with 
an ice bath to stop the reaction. Three different reactions were performed via this approach 
yielding three different sizes (Table 2).  
 
Table 2: Reaction conditions for the synthesis of Au-Citrate nanoparticles in aqueous solution. [112] 
dexpected n(HAuCl4) n(Na3Cit) Au:Lig T t 
8 nm 12.5 µmol 76 µmol 1:6 110 °C 30 min 
14 nm 12.5 µmol 50 µmol 1:4 110 °C 30 min 
25 nm 12.5 µmol 28 µmol 1:2 110 °C 30 min 
 
The size of the gold nanoparticles was characterized by TEM and DLS and summarized in 
Table 3. All synthesized gold nanoparticles are mostly of a spherical shape with an average size 
distribution. The larger particles of 25 nm and 14 nm diameter were reproducible with respect to 
the literature; only the smaller particles with a diameter of 8 nm could not be synthesized 
successfully. To obtain gold nanoparticles from the citrate reduction a reversed addition of the 
compounds is needed. [113] The hydrodynamic diameter is slightly larger than the core 
diameter determined by TEM due to the ligand shell and coordinated solvent molecules. 
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Table 3: Three different gold nanoparticles synthesized through reduction of HAuCl4 with different amounts 
of Na3Citrate. TEM and DLS values are given for the determination of the core size. Scale bar is 20 nm. 
dexpected = 8 nm dexpected = 14 nm dexpected = 25 nm 
   
TEM: d = 17.4 ± 1.2 nm TEM: d = 14.0 ± 0.9 nm TEM: d = 25.3 ± 2.4 nm 
DLS: d = 19 ± 6 nm DLS: d = 16 ± 3 nm  DLS: d = 26 ± 10 nm 
 
Smaller gold nanoparticles can be synthesized via the Stucky method. Au(PPh3)Cl and 
1-dodecanethiol were used in different ratios and different solvents (Figure 20). [26] This 
method gives access to nanoparticles smaller than 10 nm dispersed in organic media. Two 
different sizes were prepared and the substitution of benzene through toluene was investigated. 
 
 
Figure 20: Reaction scheme for the synthesis of dodecanethiol-stabilized gold nanoparticles in organic solution. 
 
All syntheses were carried out under atmospheric conditions. The gold precursor was dissolved 
with the capping ligand in chloroform or benzene, heated up to 55 °C and then the amine-borane 
complex was added. The resulting gold nanoparticles are summarized in Table 4, A-C. All three 
types are monodisperse with a narrow size distribution and nearly perfectly spherical. This can 
be explained by the use of the amine-borane complex. Compared to commonly used reducing 
agents like NaBH4 this is a milder alternative. The reducing ability is weaker and the formation 
process is slowed down resulting in a constant growth. [26] This process is visible in the color 
change of the reaction mixture and is much slower than in the citrate reduction. At lower 
temperatures small gold nanoparticles of 4 nm can be synthesized. The slightly bigger 6 nm 
gold nanoparticles were synthesized in benzene. The substitution of toxic benzene by toluene 
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results in monodisperse 7 nm gold nanoparticles. Characterization was done with TEM 
microscopy and DLS measurements. All gold nanoparticles synthesized via this method are 
dispersed in organic solvents and a phase transfer into aqueous solution must be done 
afterwards. 
 
Table 4: Different gold nanoparticles were synthesized in different organic solvents. TEM and DLS values are 
given for the determination of the core size. 
dexpected = 4 nm dexpected = 6 nm dexpected = 7 nm dexpected = 6 nm 
    
TEM: d=3.8 ± 1.3 nm TEM: d=6.4 ± 0.4 nm TEM: d=7.2 ± 0.4 nm TEM: d=6.0 ± 1.5 nm 
DLS: d = 5 ± 0 nm DLS: d = 13 ± 2 nm DLS: d = 12 ± 2 nm DLS: d = 35 ± 10 nm 
Chloroform Benzene Toluene Toluene/Water 
 
A third method for the preparation of gold nanoparticles was performed in a two phase liquid-
liquid system via the Brust-Schiffrin method. [19] Using the phase transfer agent TOAB AuCl4
-
-
ions where transferred into an organic phase were they were reduced with NaBH4 and stabilized 
(Figure 21). With DMAP the gold nanoparticles were transferred back into the aqueous phase. 
[114] The resulting gold nanoparticles were about 6 nm in diameter, spherical but rather 
disperse in size and prone to agglomeration (Table 4, D).  
 
 
Figure 21: Reaction scheme for the biphasic synthesis of DMAP-stabilized gold nanoparticles  
 
A 
 
A 
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Nevertheless these gold nanoparticles are good precursors for ligand exchange reactions due to 
the weak interactions of ligand and surface. 
 
4.2 Optical Properties  
 
Figure 22 gives an overview of the UV/Vis absorption spectra of the colloids, measured in 
quartz cuvettes. Spherical gold nanoparticles exhibit a characteristic surface plasmon band 
around 520 nm induced by the collective oscillation of electrons in the conducting band. 
Depending on the size of the nanoparticles the absorption maximum can shift. The characteristic 
plasmon resonance bond can be seen in all synthesized sizes. The gold nanoparticles of 6 nm 
and 7 nm size cannot be distinguished in the spectra; they show no difference in the position of 
the maximum. 
 
 
Figure 22: UV/Vis absorption spectra of all gold nanoparticles synthesized. For bigger nanoparticles the 
maximum of the plasmon resonance shifts to longer wavelengths (inset). 
 
Only for the 4 nm gold nanoparticles is the shape of the absorption spectrum different (Figure 
22). The maximum is not as distinct as for the other particles. For small nanoparticles no 
plasmon resonance can be observed. 
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4.3 Alloyed Metal Nanoparticles 
 
Besides these gold colloids also silver nanoparticles were synthesized in aqueous solution. 
Again citrate reduction of the metal salt was performed (Figure 23). To prevent the formation of 
the insoluble AgCl precipitate all educts have to be added quickly. Alloyed nanoparticles of Au 
and Ag can also be synthesized via this method by co-reduction of both the gold and silver 
precursor salts. [115] [116, 117] Co-reduction of the precursor salts gives simple access to 
different compositions and the elements are equally distributed.  
 
 
Figure 23: Reaction scheme for the synthesis of alloyed nanoparticles with the citrate reduction route. 
 
Optical properties of the alloyed nanoparticles are plotted in Figure 24. The absorption 
maximum shifts from 521 nm for pure gold nanoparticles to 413 nm for pure silver 
nanoparticles corresponding to the surface plasmon resonance respectively; the particle size is 
nearly the same for all different particles. The maximum shifts linearly in dependence of the 
molar ratios of Au and Ag indicating a constant distribution of both elements. 
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Figure 24: UV/Vis absorption spectra of Au/Ag alloy nanoparticles. The photograph shows the colloidal 
solutions. The maxima of the plasmon resonance shift linearly between both Au and Ag nanoparticles. The 
spectra are normalized for a better comparison between the different alloys. 
 
4.4 Ligand Exchange Reactions at Gold Nanoparticles 
 
After the synthesis of the gold nanoparticles ligand exchange reactions were performed. Ligand 
exchange reactions offer an effective way to modify the properties of nanoparticles such as 
solubility and stability. For biological applications they need to be stable at physiological 
conditions meaning water-solubility and pH stability. As the ligands used in the syntheses 
cannot be functionalized with biomolecules they must be exchanged by different ligands giving 
both stability and an anchor for further linkage to biomolecules.  
Water soluble gold nanoparticles coated with mercaptocarboxylic acids are well-known and 
versatile for the preparation of multivalent species. [110] The particles can either be obtained by 
simple ligand exchange starting with Au-Citrate nanoparticles or can be synthesized directly in 
solution by the reduction of gold(I) or gold(III) salts with suitable ligands. Using the second 
approach the core size of the nanoparticles can be tuned during the synthesis, but also the size of 
Au-Citrate nanoparticles can be varied between 3 nm and 60 nm and the size distribution is 
excellent. [112] Au-Citrate nanoparticles are known to be excellent precursors for ligand 
exchange reactions but also Au-DMAP and Au-DT exhibit those characteristics. [118]  
The gold colloids were stirred at room temperature under atmospheric conditions and the new 
ligand was added in large amount, while the pH was controlled and held constantly over 8. The 
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stability of the nanoparticles in solution is extremely affected by the ligands on the surface. 
There is a risk of aggregation during ligand exchange reactions. A typical reaction is shown in 
Figure 25. The ligand is added to the nanoparticles solution in excess and the exchange is 
performed for at least 16 hours at room temperature. The progress of the reaction can be 
monitored by UV/Vis spectroscopy. Within a ligand exchange the maximum slightly shifts 
between 2 nm and 5 nm. This is due to the change in dielectric permittivity of the gold 
nanoparticles caused by the formation of the thiolate monolayer. [119] 
 
 
Figure 25: Reaction scheme for the ligand exchange at citrate-stabilized gold nanoparticles with 
mercaptocarboxylic acids. 
 
The exchange of the citrate ligand by the respective mercaptocarboxylic acids proceeds 
completely due to the stronger affinity of the thiol moiety to the gold surface and the huge 
reactant excess. The binding strength between O and Au is more like an electrostatic interaction 
whereas S and Au form covalent-type bonds. The thiol ligand is bound very tightly on the 
surface. [75, 120] The stability of the nanoparticles strongly depends on the spacer length. 11-
Mercaptoundecanoic acid (MUDA) appeared as a very suitable ligand due to its capability of 
shielding the core with its flexible chain. The fatty acid chain presumably surrounds the surface, 
forms a monolayer assembly and stabilizes the nanoparticles. This ability decreases with shorter 
chain length. With 6-mercaptohexanoic acid (MHA) the stability in aqueous solution is still 
given but the shortest ligand 3-mercaptopropionic acid (MPA) does not stabilize the particles 
enough under the reaction conditions of the ligand exchange.  
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Figure 26: UV/Vis absorption spectra of gold nanoparticles stabilized different ligands compared to Au-
Citrate are shown. For short chained ligands MHA and LA no stable solution could be obtained. 
 
In Figure 26 the UV/Vis spectra of both Au-Citrate 14 nm and the gold nanoparticles with the 
respective ligands are shown. For Au-Citrate the maximum appears clearly at 522 nm. It shifts 
to 524 nm after the ligand exchange with MUDA. The resulting gold nanoparticles are stable 
under atmospheric conditions. For the shorter ligands with a chain length of three and six 
carbon atoms no stable dispersion in water could be achieved with the in situ exchange. In both 
spectra no maximum of the plasmon resonance is observable indicating aggregation of the 
nanoparticles. A black precipitate is formed which is also visible with the naked eye. Only for 
MHA-stabilized nanoparticles is a slight absorbance indicated but no stabilization of the 
particles could be achieved. In addition a ligand with a disulfide anchor was also tested. Lipoic 
acid (LA) contains two thiol moieties which can be attached at the surface giving more stability 
for the nanoparticles. A stable colloidal solution with a maximum at 531 nm could be 
synthesized via the ligand exchange protocol.  
Ligand exchange reactions with MUDA at gold nanoparticles with different core sizes were 
performed. The smaller 4 nm and 7 nm gold nanoparticles were transferred into aqueous 
solution via two-phase ligand exchange reaction, the bigger 14 nm and 25 nm gold 
nanoparticles were already dispersed in water and only modified at the surface. All kinds of 
nanoparticles are stable in aqueous solution and no agglomeration is observable indicated by the 
plasmon resonance maxima (Figure 27).  
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Figure 27: UV/Vis absorption spectra of gold nanoparticles with different sizes after the ligand exchange 
reaction with MUDA. All colloidal solutions are stable. 
 
Silver nanoparticles and the alloyed compounds were also tested in the ligand exchange with 
MUDA. Again a red shift for the absorption maxima can be observed. The maxima shift linearly 
between both pure gold and silver nanoparticles. 
 
 
Figure 28: UV/Vis absorption spectra of Au/Ag alloy nanoparticles after the ligand exchange with MUDA. All 
colloidal solutions are stable. The spectra are normalized for better comparison between the different alloys. 
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Since MUDA-stabilized gold nanoparticles show excellent stability, a ligand with similar chain 
length but a terminal alcohol group was also tested. Unfortunately, 11-mercaptoundecanol 
(MUDOL) is only barely soluble in water even under basic conditions and the resulting gold 
nanoparticles agglomerate immediately. The absorption spectra show the differences at the 
plasmon resonance maximum (Figure 29). However with a sulfated hydroxyl group the 
solubility and stability of the gold nanoparticles in water is good. Within two steps 
11-mercaptoundecanol can be sulfated (MUDOLS) with SO3∙DMF in good yields and coupled 
to the surface of gold nanoparticles (see publication chapter 4.10). 
 
 
Figure 29: UV/Vis absorption spectra of gold nanoparticles after the ligand exchange with MUDA, MUDOL 
and MUDOLS. No stable solution of alcohol-terminated nanoparticles could be obtained. 
 
Three different sizes of gold nanoparticles were synthesized with MUDOLS at the surface. 
After the ligand exchange the plasmon resonance of all three types is still visible and red shifted 
compared to the precursor (Figure 30). The colloidal solution is stable in water. 
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Figure 30: UV/Vis absorption spectra of gold nanoparticles with different core sizes after the ligand exchange 
with MUDOLS. All colloidal solutions are stable. 
 
Besides MUDA also LA anchoring with two sulfur atoms at the surface showed good colloidal 
stability. Following the idea to stabilize the nanoparticles with a bidentate anchor the 
dithiocarbamate (DTC) linker is a useful ligand. Due to its simple synthesis it gained attention 
for the functionalization of metal nanoparticles. It is formed in situ from CS2 and an amine and 
can be directly coupled to the gold nanoparticles. [121] DTCs are unstable in their acidic form 
and are often prepared as metal salts under strong basic conditions. [122] Primary as well as 
secondary amines can condense with CS2. The ligands have a stronger affinity to gold surfaces 
and form stable conjugates. [123] Thus this method allows for a wide variety of conjugation 
with biomolecules containing an amine moiety. The method has been used for dopamine 
functionalization of gold nanoparticles which can be applied in sensoring, detection and 
quantification of small molecules. [124], [125] Not only gold nanoparticles but also quantum 
dots can be functionalized in the same way with this method. [126] Compared to the previously 
used alkyl chained linker this can be seen as a zero-length-linker which binds the biomolecules 
close to the surface. For some interactions this might be too short. With γ-aminobutyric acid 
(GABA) a spacer can be placed between surface and biomolecule. It can be linked to CS2 via its 
amino functionality and the carboxylic acid is free for further coupling steps (Figure 31). 
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Figure 31: Reaction scheme of the formation of DTC-anchors followed by the ligand exchange at citrate-
stabilized gold nanoparticles. 
 
The intermediate product of GABA and CS2 was formed in situ in aqueous solution with 
ultrasonic treatment. It was not characterized but added directly to gold nanoparticles 
functionalized with citrate, which were synthesized separately via the Turkevich method. The 
ligand can be exchanged easily using this method and the newly formed conjugates are stable in 
aqueous solution due to the free carboxylic acid moiety. UV/Vis spectra before and after the 
reaction are shown in Figure 32.  
 
 
Figure 32: UV/Vis absorption spectra of gold nanoparticles after the exchange with DTC-ligands. 
 
The maximum shifts slightly indicating the modification at the ligand shell. The nanoparticles 
are still dispersed and did not suffer in size. The DTC linker was also tested with dopamine as 
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representative for an amine reaction. The UV/Vis spectrum shows a larger shift of the maximum 
indicating a growth of the particles. Due to the sensivity of dopamine towards oxidation, the 
reaction was done under argon atmosphere in degassed water. Nevertheless autooxidation might 
occur. This problem will be discussed in detail in chapter 4.8 where gold nanoparticles 
functionalized with biogenic amines are presented. In general multidentate ligands enhance the 
longtime colloidal stability of nanoparticles in comparison to monodentate ligands. [127] The 
bidentate lipoic acid (LA) ligand can be compared to DTC-GABA ligands due to nearly the 
same chain length and the free carboxylic acid giving similar water solubility properties.  
 
4.5 Gold Nanoparticles with Positively Charged Ligands 
 
Besides the already mentioned mercaptocarboxylic acid terminated ligand shells also gold 
nanoparticles with a free amine moiety were synthesized. Free amino groups can also serve as 
an anchor for ligands via peptide bond formation for multivalent presentation. 
The first attempt for the preparation of amine functionalized gold nanoparticles was a ligand 
exchange reaction with N-acetylcysteamine (NAc-CA) at citrate-stabilized gold nanoparticles 
followed by deprotection, which was done directly after the coupling reaction (Figure 33). The 
major advantage of this synthetic strategy is the size control of the particles. This can be set in 
the synthesis route after Turkevich. Moreover, ligand exchange reactions with functionalized 
thiols are favored and rather efficient. In Figure 33 the reaction way is shown. 
 
 
Figure 33: Reaction scheme for the ligand exchange with NAc-CA at Au-Citrate followed by deprotection of 
the amino moiety. 
 
The first step of ligand exchange proceeds completely and the resulting N-acetylcysteamine-
functionalized gold nanoparticles are stable in aqueous solution. However the deprotection of 
the amine group could not be realized, even if different methods were tested (Table 5). 
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Table 5: Reaction conditions for the deprotection of the amino moiety at gold nanoparticles. 
Reagent pH value result 
NaOH, RT >10 No deprotection 
NaOH, reflux, 24 h >10 Slight deprotection 
NaOH, reflux, 3 d >10 Slight deprotection 
4 M HCl, RT <4 NP not stable 
 
Reaction under basic conditions gave only slight deprotection after three days; reaction in acidic 
media destroyed the stability of the nanoparticles. Any other deprotection methods in organic 
solvents were not possible due to the aqueous media needed. 
Ligand exchange reaction with cysteamine (CA), 2-aminoethanthiol, gave immediate 
agglomeration of the nanoparticles. Nevertheless, there are some synthetic routes to gold 
nanoparticles with cysteamine known in the literature. [90, 128, 129] Most of them refer to the 
work by Niidome et al. about the preparation of amine modified gold nanoparticles. [81] They 
report the synthesis using HAuCl4, CA and NaBH4 under atmospheric conditions yielding 
30 nm nanoparticles (Figure 34). A reproduction of these results under the given conditions was 
not possible. The resulting nanoparticles were relatively monodisperse but squared, the mean 
diameter was about 50 nm. 
 
 
Figure 34: Reaction scheme for the synthesis of gold nanoparticles with free amino moieties. 
 
In the following reaction conditions were varied to obtain smaller nanoparticles. The influence 
of reaction temperature and molar ratios of the reactants were tested. Heating to 40 °C gave no 
improvement but at 80 °C and 110 °C nearly monodisperse but still squared gold nanoparticles 
were formed (Figure 35).The molar ratios of gold precursor and the ligand given in the paper 
were 1:1.5 with only a ratio of 0.002 for the reducing agent NaBH4. This resulted in star-like 
squared nanoparticles but rather polydisperse.  
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RT 40 °C 80 °C 110 °C 
    
Figure 35: Variation of the reaction temperature for the synthesis of amino-stabilized gold nanoparticles. 
 
The variation of molar ratios did not result in any monodisperse nanoparticles. The size 
distribution was very broad and a mixture of both small and bigger nanoparticles was achieved 
when the amount of the reducing agent was increased (Figure 36). The high diversity in sizes 
can also be observed when NaBH4 is used as reducing agent in the Brust-Shiffrin method. [19] 
Also cysteamine does not seem to be the best ligand for the stabilization of the nanoparticles as 
can be concluded from these results. The system is also highly pH-dependent due to the free 
amino moiety. 
 
1:1.5:0.5 1:1.5:1 1:1.5:10 1:1:0.002 
    
Figure 36: Variation of the molar ratios for the synthesis of amino-stabilized gold nanoparticles. 
 
Even if nearly monodisperse gold nanoparticles could be obtained at higher reaction 
temperatures the synthesis itself needs to be further optimized. Further parameters have to be 
found to adjust the diameter of the gold nanoparticles. Nevertheless cysteamine is an promising 
ligand for functionalization of gold surfaces. The linker itself can be built separately and then 
immobilized at the surface. 
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4.6 Mixed Ligand Shells on Gold Nanoparticles 
 
Interactions of nanoparticles with their environment are mainly influenced by the properties of 
their surface and the functional groups of the ligand shell. These properties can be tuned by the 
choice of the ligands. A particle shell with (two) different ligands may thus combine different 
properties, e. g. hydrophobic and hydrophilic properties. [130] Portilla et al. presented a simple 
synthesis approach for mixed ligand monolayers by adding different concentrations of precursor 
ligands to the nanoparticle solution and solubility and stability in different solvents has thus 
been achieved in this way. For multivalent presentation of active molecules a surface with only 
partial functionalization and therefore a reduced density is interesting. It could be shown that the 
density of active moieties is an important parameter and does have an influence on the potency 
of multivalent interactions. [107] This concept can be applied for gold nanoparticles with citrate 
ions at the surface and the ligand exchange with thiolate ligands. The idea was to modify the 
surface with less than 100% coverage with carboxylic acid anchors but still ensuring water 
solubility, to investigate whether the degree of coverage has an effect on the interactions. 
 
 
Figure 37: Surface structure of gold nanoparticles with two different ligand containing either carboxylic acid 
(MUDA) or sulfated alcohol (MUDOLS) termination. 
 
Both MUDA and MUDOLS functionalized gold nanoparticles exhibit excellent stability in 
aqueous solution. For coupling with biomolecules only free carboxylic acid moieties are 
relevant and the active surface can be thinned out. Ligand exchange reaction was performed 
with two different ligands. Stoichiometric mixtures of both MUDA and MUDOLS were added 
to citrate-stabilized gold nanoparticles and stirred at room temperature. Five different gold 
nanoparticles were obtained (Figure 37). The solutions were dialyzed against water and 
characterized with UV/Vis, DLS and zeta-potential analysis. As the diameter of the 
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nanoparticles did not change no characteristic shifts are observable in the UV/Vis spectra 
(Figure 38). 
 
 
Figure 38: UV/Vis absorption spectra of gold nanoparticles with a mixed ligand shell of both MUDA and 
MUDOLS are shown. All colloidal solutions are stable. 
 
The composition of the ligand shell was characterized via zeta-potential analysis because the 
surface modifications can be monitored via the change of this value. The zeta-potential 
describes the electrostatic potential near the surface of particles in solution. It depends on the 
ligands terminating the shell. Compared to citrate-stabilized gold nanoparticles the values for 
the potential of MUDA and MUDOLS are higher. For both Au-MUDA and Au-MUDOLS it 
differs significantly. The potentials of the mixed ligand shell nanoparticles correlate linearly 
(Table 6). With increasing content of negatively charged MUDOLS the value rises. DLS 
measurements show slightly different diameters of the nanoparticles in solution. 
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Table 6: Zeta-Potential measurements of gold nanoparticles with different mixed ligand shells. 
Type Shell d
hydr
 / nm ζ potential / mV Conductivity / µS/cm 
Au-Citrate - 17 ± 3 -28 ± 6 1.11 
1 Au-MUDA 1:0 24 ± 7 -57 ± 17 8.91 
2 Au-MUDA/OLS 2:1 34 ± 4 -58 ± 23 0.67 
3 Au-MUDA/OLS 1:1 38 ± 4 -63  ± 12 0.58 
4 Au-MUDA/OLS 1:2 32 ± 4 -68 ± 12 0.55 
5 Au-MUDOLS 0:1 19 ± 3 -70 ± 13 0.23 
 
Functionalization through coupling of biomolecules to the nanoparticles could be used to 
evaluate the effect of coverage. The concept could also be transferred to other ligands building a 
buffer system which might lead to expanded stability in aqueous solution under different pH 
values. 
 
4.7 Functionalization at the Ligand Periphery 
 
After the synthesis of the gold nanoparticles functionalization of the free carboxylic acid 
moieties was performed. Peptide coupling using an amine or a biomolecule with an amino 
moiety can be conducted. There are two strategies of functionalization: full functionalized 
ligand synthesis prior to reaction with gold nanoparticles using ligand exchange or step by step 
reactions at the periphery. Both pathways have advantages and each ligand system has to be 
evaluated independently. Complex molecules are better to be synthesized separately, not only 
due to required comprehensive characterization of the organic structure. Coupling at the 
periphery in solution includes simple work up via dialysis but needs full stabilization of the 
nanoparticles during synthesis. N-Hydroxysucchinimide (NHS) or the sulfonated analogues and 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) are used to prepare amine-reactive 
esters in solid-phase immobilization applications. Both are soluble in aqueous and organic 
solvents and in the presence of carbodiimides they form a semi-stable NHS-ester with 
carboxylates. It hydrolyzes within hours depending on the pH of the reaction solution but it is 
sufficiently stable for a coupling process in solution. [131, 132] Reaction of the o-acylisourea 
with amines is also possible but with less yield. 
 
Gold Nanoparticles 
48 
 
Figure 39: Reaction pathway of the formation of the stable amide bond between carboxylate and amine 
mediated by EDC and NHS. A: unstable reactive o-acylisourea ester, B: semi-stable amine-reactive NHS ester, 
C: stable amide bond. 
 
Au-MUDA nanoparticles were mixed together with NHS and EDC under the addition of NaOH 
and the active ester was formed (Figure 39). Purification and isolation of the product was not 
possible. Au-MUDA-NHS is not stable enough in aqueous solution. To obtain active-ester 
coordinated nanoparticles the linker has to be synthesized and then coupled onto the surface of 
nanoparticles dispersed in organic solvents like DMF. These particles can be coupled with an 
amine and then transferred into aqueous solution. [133] Dodecanethiol-stabilized gold 
nanoparticles can serve as precursor material. 
 
 
Figure 40: Formation of Au-MUDA-NHS active ester in solution. The product is not stable and hydrolyzed 
within hours. 
 
As the active ester is stable for only hours coupling with the respective amine has to be done in 
situ. An equivalent of amine can be added to the reaction solution and the amide bond forms 
immediately (Figure 40 & Figure 41). To ensure full reaction another equivalent of NHS, EDC 
and amine is added after two hours. After that the solution is purified via dialysis against water. 
For the stability of the resulting nanoparticles a basic pH is needed, so TMAH or NaOH are 
added.  
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Figure 41: Coupling of amines to MUDA-functionalized gold nanoparticles by a NHS/EDC mediated reaction. 
The resulting nanoparticles are stable in aqueous solution. 
 
4.8 Functionalization with Bioactive Amines 
 
Gold nanoparticles with a free carboxylate group were functionalized with four different 
neurotransmitters, bioactive amines responsible for communication between cells (Figure 42). 
[134] Histamine, dopamine and serotonin are biogenic amines derived from amino acids by 
decarboxylation. Carbachol is structurally similar to acetylcholine and a stable derivate. It binds 
to acetlycholinic receptors and acts as a cholinergic agonist. Because of its amino moiety it can 
be coupled to the gold nanoparticles in the same way as the biogenic amines. All four types are 
frequently found in organisms. By binding onto the surface the free amino group gets coupled 
and can no longer participate in receptor recognition. Only a simplified binding moiety is 
available for the interaction, but several studies proved this to be sufficient for specific 
interactions. [110] 
Immobilization of neurotransmitters on gold nanoparticles is little explored and the biological 
functionality of the conjugates even less. The amines were coupled onto 14 nm gold 
nanoparticles with a carboxylic acid terminated shell via the EDC/NHS method (Figure 39). 
 
 
Figure 42: Bioactive amines histamine, dopamine, serotonin (5-hydroxytryptamine) and carbachol. 
 
Immobilization of the amines was accomplished in aqueous solution. MUDA-functionalized 
gold nanoparticles were mixed with EDC/NHS and NaOH forming the active ester. 
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Subsequently the bioactive amine was added. All chemicals were added in large amount to 
ensure complete coupling of the free carboxylic acid. 
 
 
Figure 43: UV/Vis spectra of gold nanoparticles (14 nm) functionalized with histamine (HA), dopamine (DA), 
serotonin (5HT) and carbachol (CB). Au-MUDA is plotted for comparison with the precursor solution. 
 
Coupling with the molecules histamine and serotonin gave stable nanoparticles; the plasmon 
resonance maxima are clearly visible in the UV/Vis spectra. Compared to Au-MUDA the 
maxima shift only slightly to longer wavelengths. Only the maximum of dopamine 
functionalized gold nanoparticles lost its shape indicating a change of particle dispersity (Figure 
43). Also Au-MUDA-CB were stable despite a broadened maximum. This can be explained 
because of the positively charged ligand shell responsible for electrostatic interactions between 
the nanoparticles. The colloidal solution is prone to aggregation and the pH value has to be 
adjusted at values between 8 and 10. Additionally, gold nanoparticles of 7 nm and 25 nm size 
were functionalized with histamine and dopamine. Histamine functionalized gold nanoparticles 
were fully characterized in the publication chapter 4.10. 
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Histamine functionalized gold nanoparticles 
 
 
   
Figure 44: Histamine functionalized gold nanoparticles with three different core sizes: reaction scheme and 
TEM images. A dTEM = 7.3 ± 0.9 nm, dhydr = 11 ± 2 nm; B dTEM = 14.7 ± 1.2 nm, dhydr = 26 ± 6 nm; 
C dTEM = 25.7 ± 1.2 nm, dhydr = 32 ± 8 nm. 
 
Histamine functionalized gold nanoparticles were synthesized with three different core sizes 
(Figure 44). All three core sizes are suitable for biological applications. In the tests of biological 
functionality the effect of the mean diameter shall be investigated. The relative number of active 
epitopes depends on the surface provided for immobilization and should effect the potency of 
the nanoparticles. The histamine functionalized gold nanoparticles are stable at a neutral pH 
value in contrast to the other gold nanoparticles which need basic conditions. This might be 
explained by to the buffering capacity of the imidazole moiety. 
  
A B C 
Gold Nanoparticles 
52 
Dopamine functionalized gold nanoparticles 
 
 
  
Figure 45: Dopamine functionalized gold nanoparticles with two different core sizes: reaction scheme and 
TEM images. A dTEM = 7.8 ± 1.2 nm, dhydr = 9 ± 2 nm; B dTEM = 15 ± 1 nm, dhydr = 26 ± 6 nm. 
 
Only for dopamine functionalization transformation of the nanoparticles was observed. After 
some hours the nanoparticles agglomerate and the solution turned brown, but is still clear. 
Figure 45 shows a TEM image after the functionalization. NMR analysis confirms immobilized 
dopamine molecules at the gold nanoparticles (see Experimental Section). The brown color 
arises from the formation of polydopamine (Figure 46). The catechol moiety of dopamine is 
oxidized to a quinone under aerobic conditions and intramolecular cyclization takes place. 
Another oxidative step and isomerization leads to a 5,6-dihydroxylindole, which can then be 
oxidized to the analogue quinone.  
A B 
Gold Nanoparticles 
53 
 
Figure 46: Mechanism of the formation of polydopamine under aerobic conditions. [135] 
 
The surface of the nanoparticles is coated with the polymer but they are still water-soluble. This 
is formed when dopamine is exposed to an aerobic environment in solution. Oxidation to 
quinone and intramolecular cyclization leads to 5,6-indolequinone which appears brownish. It 
forms a non-covalent polymer with supramolecular aggregation. [135] NMR analysis of the 
ligand shell did not indicate a polymeric layer but only signals from immobilized dopamine. No 
further investigations on this phenomenon were performed. The synthesized gold nanoparticles 
with dopamine at the surface were tested for their biological functionality.  
There are some applications for dopamine-coated inorganic and organic materials. [136] Noble 
metal nanoparticles can be used as optical sensing agents for the detection of dopamine. [137] 
Dopamine can also serve as a reducing agent. [138] Besides the amino group dopamine also 
contains a catechol moiety. This functional group can also interact with surfaces; the reversed 
anchor has a free amino moiety where biomolecule can be attached. Iron oxide nanoparticles 
can be synthesized or functionalized via this method. [139–141] Gold nanoparticles were used 
as synthesized for the biological applications. 
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Serotonin functionalized gold nanoparticles 
 
 
Figure 47: Serotonin functionalized gold nanoparticles: reaction scheme and TEM image. Diameter 
dTEM = 14.1 ± 0.9 nm, dhydr = 16 ± 4 nm. 
 
Gold nanoparticles with serotonin were also synthesized. Figure 47 shows a TEM image of the 
nanoparticles after functionalization. The hydroxylated indolamine backbone is also prone for 
oxidation and all reaction steps were performed in degassed water and under argon atmosphere. 
No change in color of the solution was observable. The plasmon resonance maximum clearly 
appears at 528 nm (Figure 43). With NMR analysis immobilization of serotonin at the gold 
nanoparticles surface can be confirmed. 
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Carbachol functionalized gold nanoparticles 
 
 
Figure 48: Carbachol functionalized gold nanoparticles: reaction scheme and TEM image. Diameter 
dTEM = 14.5 ± 0.7 nm, dhydr = 17 ± 6 nm. 
 
Gold nanoparticles were also functionalized with the small molecule carbachol. It is a derivate 
of acetylcholine and can be applied as a drug for the activation of acetylcholine receptors. The 
molecule possesses a positive charge at the quaternary amine. Immobilization is difficult due to 
repulsion between the nanoparticles. Figure 48 shows a TEM image of the gold nanoparticles 
after the functionalization indicating no difference in particle size and dispersity. So the 
immobilization on gold nanoparticles was indeed successful. NMR analysis confirms 
immobilized carbachol at the gold nanoparticles (see Experimental Section). Due to interaction 
with the material of the dialysis tube purification must be done carefully. Time for dialysis 
should not be longer than 1 hour after which the sample has to be transferred into a new tube. 
The functionalized gold nanoparticles should be stored in an Eppendorf cup. This phenomenon 
could also be observed with the amine-modified nanoparticles also inheriting a positive charge. 
Interactions with both the dialysis material and glass vessel could be observed. 
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Functionalization of amine-modified gold nanoparticles 
 
 
Figure 49: L-Dopa functionalized gold nanoparticles: reaction scheme and TEM image. Diameter 
dTEM = 30.7 ± 7.2nm, dhydr = 45 ± 9 nm. 
 
Coupling partners for gold nanoparticles with free carboxylate moieties need to possess either 
an amino group for peptide coupling or an alcohol group for esterification. Vice versa, bioactive 
molecules with a free carboxylic acid moiety can be coupled on gold nanoparticles, but 
requirement for the nanoparticles is a free amino moiety. As mentioned previously nanoparticles 
with a positively charged ligand shell are relatively instable and particle growth is difficult to 
control. Yet the synthesis of 30 nm gold nanoparticles with cysteamine at the surface was 
successful. Structurally amino acids are very similar to the biogenic amines, because they 
possess both a carboxylic group and an amino group. Subsequent reaction of amino acids results 
in peptides which are coupled via peptide (amide) bonds. The immobilization of such small 
peptides on gold nanoparticles is also an interesting field of research. [142] Here L-Dopa was 
coupled successfully to the amine-free gold nanoparticles successfully. Figure 49 shows a TEM 
image after functionalization and NMR analysis confirmed the immobilization (See 
Experimental Section). Once again a brown coloring of the solution was observed resulting 
from the autooxidation of the catechol moiety.  
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4.9 Biological Functionality 
 
The biological functionality of the four synthesized gold nanoparticles was tested. Like many 
other bioactive substances the neurotransmitters exert their effects by binding to receptors 
located at the cell surface. The native ligands, molecular histamine, dopamine, serotonin and 
carbachol, address their particular receptors and subunits. The newly developed conjugates of 
ligand and gold nanoparticle were tested for the same effects and compared to the native 
analogues where applicable. Investigations on the ability to induce chloride secretion at 
receptors on a tissue were done in the research group of Prof. Marin Diener, Institute for 
Veterinary Physiology at the Justus-Liebig-University Giessen. Gold nanoparticles were 
administered to rat mucosa mounted in an Ussing Chamber. When receptors are stimulated an 
increase in chloride secretions takes place and a rise in the short circuit (Isc) is observed. 
Histamine functionalized gold nanoparticles were tested with three different core sizes. All 
types were able to stimulate the receptors but for the bigger 25 nm nanoparticles the signals 
were unstable and too low for evaluation. Both 7 nm and 14 nm gold nanoparticles clearly 
induce a chloride secretion. After the addition of the gold nanoparticles the tissue is treated with 
the secretagogue forskolin. The cAMP-dependent stimulator is a messenger for proper 
biological functionality. As it induced a prompt rise in Isc the tissue is not harmed by the 
nanoparticles. The results from 14 nm gold nanoparticles with histamine were published in Org. 
Biomol. Chem. (see chapter 4.10). The dose-effect curve of 7 nm gold nanoparticles is shown in 
Figure 50.  
 
Figure 50: Au-MUDA-HA 7 nm at the serosal side induced a time-dependent increase in the Isc, forskolin was 
added for the control of proper biological functionality; each peak is an addition of gold nanoparticle samples. 
Five different samples were tested. 
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To verify the signals only coming from histamine-receptor interactions the gold nanoparticles 
with a free carboxylate moiety were tested. Unfortunately Au-MUDA also evokes an increase in 
Isc (Figure 51). Gold nanoparticles without derivatized neurotransmitter are able to stimulate 
receptors. Still, activation concentrations are lower when multivalently presented. Gold 
nanoparticles with a sulfated epitope were used to verify the signals. Indeed they are only 
evoked by multivalently presented histamine. 
 
 
Figure 51: Au-MUDA at the serosal side induced a time-dependent increase in Isc, forskolin was added for the 
control of proper biological functionality; each peak is an addition of gold nanoparticles. Four different 
samples were tested. 
 
Gold nanoparticles with dopamine were tested for two different sizes (Figure 52). Again the 
colloidal solution was added at the serosal side and the increase in Isc was measured. Both 7 nm 
and 14 nm gold nanoparticles were not able to induce chloride secretion at the administered 
concentrations. As seen in the results for histamine-coated gold nanoparticles the concentration 
of effective active moieties is sufficient for the receptor activation. The addition of forskolin 
confirmed the viability of the tissue.  
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Figure 52: Au-MUDA-DA 7 nm (left) and 14 nm (right) at the serosal side induced a time dependent increase 
in Isc, forskolin was added for the control of biological functionality. 
 
One possible explanation for the absent signals might be the autooxidation of the catechol 
moiety. Both colloidal solutions turned brown after exposure to air which indicates the 
formation of the quinone. Nevertheless there was no cyclization visible in the NMR spectra, up 
to now no further experiments were done to prove this assumption. 
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Figure 53: Au-MUDA-5HT at the serosal side induced a time-dependent increase in Isc, forskolin was added 
for the control of proper biological functionality; each peak is an addition of gold nanoparticles. Four different 
samples were tested; n = 7. 
Serotonin-coated 14 nm gold nanoparticles were also tested for the activation of receptors 
(Figure 53). They induce a concentration-dependent increase in the Isc as did the histamine-
coated. The signals correspond more likely to chloride secretion. Since native serotonin 
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activates different receptor types no definite classification can be made from results. Compared 
to native serotonin the concentrations for activation are much lower at nanomolar 
concentrations. Again multivalent presentation of the active moiety enhances the interactions. 
Serotonin receptors belong to the group of G protein-coupled receptors and ligand-gated ion 
channels and found in a variety of organisms. Serotonin plays diverse roles in normal 
physiology, including for example developmental, cardiovascular, gastrointestinal, and 
endocrinal functions. [143] Studies on multivalent effects on the activation of the 5-HT3-
receptor showed enhanced activity for bivalent ligands. [144] Dendrimeric ligands also showed 
enhanced affinity at the 5-HT3 receptor. [145] These are examples for multivalency enhancing 
activities of natural processes.  
Last but not least carbachol-capped 14 nm gold nanoparticles were tested. The stable 
actelycholine derivative showed excellent affinity to the receptors. The results were compared 
directly to native carbachol (Figure 54). Both Au-MUDA-CB and native CB induce a 
concentration-dependent increase in Isc corresponding to chloride secretion.  
 
 
 
Figure 54: Au-MUDA CB induced an increase in the Isc, native carbachol induced an increase in the Isc at 
different concentrations; n = 6. 
 
The observed activation concentrations are in picomolar, nearly half as much as for the native 
analogue. A nearly equivalent response is evoked by 1 pM potency between Au-MUDA-CB in 
comparison to 500 nM native CB indicating a strong increase in potency (Figure 55). The effect 
of these gold nanoparticles is again supported by the multivalent presentation. The high local 
density and the special arrangement allow simultaneous binding which enhances the effects. 
 
Au-MUDA-CB (x 10
-12
 mol/L) Native CB (x 10
-6
 mol/L) 
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Figure 55: Potency of Au-MUDA-CB versus native carbachol; an equivalent potency between Au-MUDA-CB 
and carbachol was obtained at 1 pM Au-MUDA-CA and 500 nM CB. 
  
Au-MUDA-CB 1 pM Native CB 500 nM 
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4.10 Effects of Multivalent Histamine Supported on Gold 
Nanoparticles: Activation of Histamine Receptors by Derivatized 
Histamine at Subnanomolar Concentrations 
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Abstract 
Colloidal gold nanoparticles with a functionalized ligand shell were synthesized and used as 
new histamine receptor agonists. Mercaptoundecanoic acid moieties were attached to the 
surface of the nanoparticles and derivatized with native histamine. The multivalent presentation 
of the immobilized ligands carried by the gold nanoparticles resulted in extremely low 
activation concentrations for histamine receptors on rat colonic epithelium. As a functional 
read-out system, chloride secretion resulting from stimulation of neuronal and epithelial 
histamine H1 and H2 receptors was measured in Ussing chamber experiments. These responses 
were strictly attributed to the histamine entities as histamine-free particles Au-MUDOLS or the 
monovalent ligand AcS-MUDA-HA proved to be ineffective. The vitality of the tissues used 
was not impaired by the nanoparticles. 
 
Introduction 
During the past 20 years, the number of applications of nano- and microdevices in the fields of 
biotechnology and biomedicine has been increased drastically. [3, 146] Most promising tools 
are nanoparticles. [147] They represent nanoscale materials with unique chemical and physical 
properties due to their size. These are for example optical absorption (metal nanoparticles), 
photoluminescence (semiconductor quantum dots) or magnetic behavior (iron oxides). Their 
applicability derives not only from the fact that their dimension range is in the size of some 
biomolecules like proteins or receptors, but also that through simple surface modification a huge 
variety of interactions can be achieved. The basic requirement for every application is the 
proper surface functionalization of the particles, which determines their interaction with the 
environment. In this study we chose gold nanoparticles as a template because of their well-
known synthesis and functionalization with small molecules. [14, 112] Moreover they are 
biocompatible. We took these particles and applied the concept of multivalency for the 
interaction with biological tissue. Multivalent presentation of immobilized ligands is a common 
concept in ligand–receptor interactions and can result in high affinities of ligands that possess 
only moderate binding constants in a similar concentration range when they are presented in 
their monovalent form. [105, 106, 148] Simplifying binding structures reduces the synthetic 
complexity of the molecules immobilized on the nanoparticles and has the advantage of being 
synthetically well accessible. Multivalent carriers can either inhibit or activate biological 
processes in a different way than the monovalent analogue. Usually the effective concentration 
is much lower. [110] There are only few examples where this concept is applied on receptor–
ligand interactions with neurotransmitters. Paolino et al. synthesized dendrimeric tetravalent 
ligands for the activation of ligand-gated ion channels. [145] Indeed they found activation 
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concentrations in the low picomolar range. Saada et al. synthesized gold nanoparticles coated 
with histamine and applied the conjugates for enzyme activation. [111] They also found an 
enhancement of the activation properties for these conjugates. Mediators such as histamine are 
key regulators of physiological processes such as ion transport across epithelial barriers. 
Chloride secretion is one of these processes occurring for example at the colonic epithelium. 
[149, 150] Such a secretion can be activated via stimulation of histamine H1 and/or H2 receptors 
as previously shown. [151–153] The receptor activity can also be blocked by inhibitors, which 
are well-known for the histaminic receptors. Mediators or neurotransmitters represent an 
interesting class of bioactive molecules and yet there is no study on multivalent ligand 
presentation on biological systems. In this paper we report the immobilization and multivalence 
of the biogenic amine histamine on gold nanoparticles as well as its biological function in 
receptor activation. 
 
Results and Discussion 
Synthesis of the gold nanoparticles 
By attaching histamine derivatives on gold nanoparticles we developed a new conjugate for the 
interaction with compatible receptors. Water soluble gold nanoparticles with a terminally 
functionalized thiol shell were prepared and used as a scaffold for the multivalent presentation 
of histamine. Gold nanoparticles with an average diameter of 14 nm were synthesized by a 
modification of a well-known method developed by Turkevich et al. (Figure 56). [16, 116] In an 
aqueous solution Au(III) was reduced by sodium citrate which serves not only as reducing agent 
but also as a ligand to prevent aggregation of the formed particles. Even if the solvent is limited 
to water or polar equivalents like DMSO, the resulting size of the particles can be defined by the 
molar ratios of the starting materials, the reaction temperature and time. By this method, gold 
nanoparticles with a diameter of 14 nm (NP 1, Figure 56) could be obtained. Depending on the 
size of the particles, the surface is coated with several thousand ligands with respect to the steric 
demand of a single ligand. The resulting nanoparticles are stabilized by electrostatic repulsion of 
the negatively charged citrate ions adsorbed on their surface. This layer can be easily replaced 
by ligands with a stronger binding affinity, such as for example thiols. [70, 118] Thus, in a 
second step the ligand shell was substituted by a bivalent ligand. Bivalent ligands give access to 
further functionalization steps at the ligand periphery. One end binds to the surface and gives 
stability to the particle whereas the other end is exposed to the solution. Depending on the free 
moiety, the particles possess different stabilities at different pH values.  
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Figure 56: Synthetic procedure for gold nanoparticles with a mean diameter of 14 nm (NP 1) followed by 
ligand exchange with 11-mercaptoundecanoic acid (NP 2) and functionalization with histamine (NP 3, Au–
MUDA–HA). Double arrows at the Au core represent the ligand. 
 
There is a wide variety of ligands suitable for exchange still providing stability in aqueous 
media. Often poly(ethylene glycol) (PEG) is used as a ligand as it provides enough colloidal 
stability and reduces nonspecific adsorption. Besides “PEGylation”, ω-functionalized thiol 
surfactants with free carboxylic acid groups are a versatile type of ligand and are often used in 
aqueous solution. They offer an additional anchor point for further attachments of biological 
molecules. Herein we chose 11-mercaptoundecanoic acid (MUDA). On the one hand, a new 
bond between Au and S with high affinity is built upon transfer, ensuring a complete 
replacement of citrate due to strong binding affinities. On the other hand, the free carboxylic 
acid can serve as an anchor for further coupling reactions with amines. In addition, the long 
alkyl chain provides enough flexibility for the active moiety to interact multivalently with the 
receptor. The ligand exchange with MUDA giving NP 2 proceeded completely as it is indicated 
in the infra-red (IR) spectra (Figure 57). The final step towards the fully functionalized 
nanoparticle was accomplished by peptide coupling with EDC (1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide) and NHS (N-hydroxysuccinimide). The free carboxylic 
acid is activated by EDC and forms with NHS in situ a so called ‘active ester’. This reacts easier 
with amine moieties of e. g. amino acids or peptides. 
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Figure 57: IR spectra of (a) Au–Citrate NP 1, (b) Au–MUDA NP 2 and (c) Au–MUDA–HA NP 3; vibration for 
the amide bond is found at 1641 cm−1. 
 
Although the prepared NHS ester is sufficiently stable for the reaction, it hydrolyses within 
hours depending on the pH of the reaction solution. To ensure the coupling, another equivalent 
of histamine, EDC and NHS were added after two hours. The excess of coupling agents and 
byproducts of the reaction were removed by purification with dialysis against water (MWCO 
3500, three times). The characterization of the synthesized and functionalized nanoparticles NP 
1–3 was performed with different methods. For the characterization of the core transmission 
electron microscope (TEM) images, dynamic light scattering (DLS) measurements and UV/Vis 
spectroscopy were used. The images shown in Figure 58 indicate that the synthesized 
nanoparticles have mostly a spherical shape; the average diameter determined by TEM is 
14.0 ± 0.9 nm. The hydrodynamic diameter of the nanoparticles in solution obtained by DLS 
measurements was determined by 16.7 ± 3.0 nm. The absorption maximum was found at 
524 nm. The position and form of the maximum is also a hint for the size of the nanoparticles, 
as it derives from a distinctive plasmon resonance at the gold surface depending on the shape of 
the material. The obtained data confirmed that the average diameter of the particles cores and 
the maxima of absorption remained unchanged after ligand exchange reaction and 
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functionalization. The slight shift can be explained due to the new ligand. The affinity to a gold 
surface is higher for thiolated ligands than for citrate and therefore effects on the plasmon 
resonance of the particle. Nonetheless, neither the exchange of the ligands nor the purification 
via dialysis had an effect on the agglomeration state. Also the functionalization at the ligand 
periphery did not alter the particles significantly. In addition to these methods, the success of the 
ligand exchange was verified by IR spectroscopy (Figure 57). Identification of the newly 
formed amide bond at 1641 cm−1 gives evidence for the successful coupling. Again the colloidal 
solution was purified by dialysis. Unlike the particles with MUDA as ligand shell, the final 
functionalization with histamine provides a good stability at physiological pH value and in a 
standard buffer solution for the Ussing chamber experiments (see below). The number of the 
ligands at the surface determined by TGA is about 10.000 for 14 nm gold nanoparticles, 
however determination is difficult due to small amounts of product. In order to find out whether 
the size of the nanoparticles could be a limiting factor for their properties, two other sizes were 
investigated. Following the same synthetic procedure as described above but with different 
reaction conditions, 25 nm nanoparticles were obtained. Also, 7 nm nanoparticles were prepared 
using dodecanethiol-protected particles from the Stucky method as basic material. [26] 
 
 
Figure 58: (A) UV/Vis spectra of the stepwise functionalization of Au–Citrate NP 1, Au–MUDA NP 2 and Au–
MUDA–HA NP 3 nanoparticles. (B) TEM images and DLS measurements with values for the distribution of 
the hydrodynamic diameters of (i) Au–Citrate NP 1 d = 14.0 ± 0.9 nm, dhydr = 16.7 ± 3.0 nm, (ii) Au–MUDA NP 
2 d = 14.5 ± 1.2 nm, dhydr = 24.1 ± 6.7 nm and (iii) Au–MUDA–HA NP 3 d = 14.3 ± 0.7 nm, 
dhydr = 19.3 ± 2.9 nm; d = diameter. 
 
As a negative control for the biochemical application, gold nanoparticles NP 4 (Figure 59) with 
a sulfated ligand shell were synthesized. We already reported from sulfated ligands for the 
inhibition of selectin binding. [133] A structurally similar and simple ligand is sulfated 11-
mercaptoundecanol (MUDOLS), which can be immobilized on gold nanoparticles in the same 
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way as mentioned before. Again citrate-stabilized gold nanoparticles NP 1 served as basic 
material. 
 
 
Figure 59: (A) Synthetic procedure for the preparation of Au–MUDOLS NP 4, (B) UV/Vis spectra of Au–
Citrate NP 1 and Au–MUDOLS NP 4, (C) TEM images and DLS measurements with values for the 
distribution of the hydrodynamic diameters of (i) Au–Citrate NP 1 d = 14.0 ± 0.9 nm, dhydr = 16.7 ± 3.0 nm, (ii) 
Au–MUDOLS NP 4 d = 14.3 ± 1.3 nm, dhydr = 18.6 ± 2.5 nm; d = diameter. 
 
The sulfated ligand was synthesized separately and then attached to the surface via ligand 
exchange reaction. TEM images, DLS measurements and UV/Vis spectra (Figure 59) indicated 
that the colloidal solution was intact and the nanoparticles were stable. Sulfated nanoparticles 
showed excellent stability over a wide range of pH value due to interparticle repulsion through a 
negatively charged ligand shell. Unlike the unsulfated Au-MUDA particles they are perfectly 
stable at physiological pH. 
 
 
Figure 60: Synthesis of the monovalent analogue AcS–MUDA–HA (3) starting from 11-bromoundecanoic acid 
1. Reaction conditions: (a) KSOAc, DMF, 2 h, rt, (b) NHS, DCM, 18 h, rt, (c) EDC, HA·2HCl, NEt3, DCM, 6 h, 
rt. 
 
When looking at multivalent effects, the monovalent ligand 3 (Figure 60) also has to be 
investigated. Thus the complete ligand was synthesized separately. To prevent the formation of 
a disulfide bond between two molecules, the thiol moiety was protected with an acetyl group. 
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Functionality of the histamine-nanoparticles 
From all the synthesized nanoparticles of different sizes, only the 14 nm nanoparticles yielded 
consistent effects on short-circuit current (Isc) when they were administered to rat colonic 
mucosa mounted in Ussing chambers. Therefore, this type of particles was used for all 
subsequent experiments. To investigate the functionality of the Au-MUDA-HA nanoparticles, 
their ability to induce chloride secretion was compared with that of native histamine, which 
induces a strong chloride secretion across rat colonic epithelium. [151, 152] Indeed, the 
histamine-conjugated nanoparticles induced a concentration-dependent increase in Isc, which is a 
measure for net ion transport across the epithelium (Figure 61). 
 
 
Figure 61: Au–MUDA–HA (10−11 mol l−1 at the serosal side, arrow) induced an increase in Isc (A), which was 
almost abolished in the absence of chloride (0 Cl−; black bar, (B). At the end of the experiments, the 
secretagogues carbachol (5 × 10−5 mol l−1 at the serosal side, white bars) and forskolin (forsk; 5 × 10−6 mol l−1 at 
the mucosal and the serosal side, grey bars, (A & B), known to induce chloride secretion, were administered. 
Line interruptions are caused by omission of time intervals in order to synchronize the tracings of individual 
records to the administration of drugs. Values are means (symbols) ± SEM (parallel continuous lines), n = 6–8. 
 
These changes in Isc reflect a secretion of chloride ions as they were abolished in Cl
−-free buffer 
solution (Figure 61). However, repetitive administration of these particles led to a 
desensitization of the tissue (Table 7). Thus in all subsequent experiments, each tissue was only 
exposed once to a single concentration of the Au-MUDA-HA nanoparticles (10−11 mol l−1 at the 
serosal side). The tissue conductance (Gt) was not significantly changed by the nanoparticles 
(10−11 mol l−1 at the serosal side); Gt amounted to 14.4 ± 1.87 mS cm
−2 before and 
14.7 ± 1.96 mS cm−2 after administration of the particles (n = 6; difference not significant). 
Viability of the tissue was also not impaired by the Au-MUDA-HA nanoparticles as both the 
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Ca2+-dependent secretagogue carbachol (5 × 10−5 mol l−1 at the serosal side), i.e. a stable 
derivative of acetylcholine, [154], [151] as well as the cAMP-dependent secretagogue forskolin 
(5 × 10−6 mol l−1 at the mucosal and the serosal side), which stimulates the intracellular 
production of cAMP, [155] induced a prompt rise in Isc in all tissues (Figure 61). As the 
response to histamine evokes chloride secretion in part via stimulation of histamine receptors 
located on submucosal neurons, the effect of the inhibitory neurotoxin tetrodotoxin, which 
inhibits the propagation of action potentials via blockade of voltage-dependent Na+ channels, on 
the Isc evoked by the Au-MUDA-HA nanoparticles was investigated. [151, 156] Indeed, in the 
presence of tetrodotoxin (10−6 mol l−1 at the serosal side), the Isc evoked by Au-MUDA-HA 
(10−11 mol l−1 at the serosal side) only amounted to 0.69 ± 0.20 μEq h−1 cm−2 (n = 6) in 
comparison to 2.92 ± 0.64 μEq h−1 cm−2 in untreated control tissues (P < 0.05, n = 6). 
 
Table 7: Effects of additive concentrations of Au–MUDA–HA 14 nm on Isc and H1 and H2 receptors. 
 Increase in short-circuit current ΔIsc (μEq h
−1
 cm
−2
) 
 Au-MUDA-HA 14 nm 
No inhibitor 1.09 ± 0.43b 0.61 ± 0.11a,b 0.42 ± 0.11a,b 
Mepyramine + cimetidine 0.083 ± 0.041a 0.13 ± 0.033a 0.13 ± 0.02
a
 
Cumulative administration of gradually increased concentrations (10
−11
, 5 × 10
−11
, 10
−10
 mol l
−1
, 
at the serosal side) of Au–MUDA–HA induced an increase in Isc concomitant with an obvious 
desensitization of the tissue as indicated by the reduced Isc response after repeated 
administration. Given is the control response in the absence of any inhibitors and the response 
to Au–MUDA–HA in the combined presence of mepyramine (10−4 mol l−1 at the serosal side) 
and cimetidine (10
−4 
mol l
−1
 at the serosal side). Values are given as difference to the baseline in 
Isc just before administration of the corresponding agonist (ΔIsc) and are means ± SEM, n = 6. 
Different letters (a, b, c) indicate statistically homogenous groups (analysis of variances 
followed by post hoc test of Tukey). 
 
The response to native histamine is mediated by stimulation of histamine H1 and histamine H2 
receptors. [155] In accordance with that observation, the increase in Isc evoked by 
Au-MUDA-HA (10
−11
 mol l
−1
 at the serosal side) was strongly inhibited by a combination of the 
histamine H1 receptor blocker, mepyramine (10
−4
 mol l
−1
 at the serosal side), and the histamine 
H2 receptor blocker, cimetidine (10
−4
 mol l
−1
 at the serosal side, Table 7). Mepyramine is a 
substituted ethylamine derivative, whereas cimetidine has an imidazole ring system similar to 
native histamine. [157] Both drugs act as competitive inhibitors of the G-protein coupled 
histamine receptors type 1 [157] and type 2, [158] respectively. Viability of the tissue was not 
altered, as forskolin, the activator of adenylate cyclase(s), [155] evoked an increase in Isc of 
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11.90 ± 1.10 μEq h−1 cm−2 (n = 6) in the absence and of 10.72 ± 1.18 μEq h−1 cm−2 (n = 6, 
difference not significant) in the presence of the histamine receptors antagonists. 
Controls with histamine-free nanoparticles 
In order to make sure that the effects of the nanoparticles are not unspecific artefacts resulting 
from the assembly components of the particles, controls were performed either with the 
conjugator AcS-MUDA-HA or with the sulfated moiety Au-MUDOLS. As shown in Figure 62, 
these components failed to induce a rise in Isc. Furthermore, Au-MUDOLS impaired the 
viability of the epithelium as it prevented the secretion induced by a subsequent administration 
of forskolin (5 × 10−6 mol l−1 at the mucosal and the serosal side). 
 
 
Figure 62: Au–MUDA–HA (10−11, 5 × 10−11, 10−10 mol l−1, administered cumulatively at the serosal side, 
arrows) induced an increase in Isc. (B) AcS–MUDA–HA (10
−7, 5 × 10−7, 10−6 mol l−1, at the serosal side, arrows) 
was ineffective. (C) Au–MUDOLS (10−12, 5 × 10−12, 10−11 mol l−1, at the serosal side, arrows) failed to change 
the Isc. All particles except Au–MUDOLS preserved the secretory function of the tissues as they did not impair 
the effect of the secretagogue forskolin (forsk; 5 × 10−6 mol l−1 at the mucosal and the serosal side, grey bars). 
Values are means (symbols) ± SEM (parallel continuous lines), n = 4–8. 
 
Potency of the Au–MUDA–HA nanoparticles 
The highest changes in the Isc or the Gt induced by the nanoparticles were obtained at the 
concentration 10−11 mol l−1. For the Isc, the change amounted to 1.09 ± 0.42 μEq h
−1 cm−2. When 
comparing this response with a concentration-response curve of native histamine (Figure 63) it 
turned out that a comparable increase in Isc (1.05 ± 0.24 μEq h
−1 cm−2) was obtained with 
histamine in a concentration of 10−5 mol l−1 (Figure 63). Assuming a maximum of 10 000 
histaminic units at the surface determined by TGA, the relative potency is still some magnitudes 
higher. In other words, the conjugation to the 14 nm nanoparticles strongly enhanced the 
potency of histamine to evoke anion secretion. 
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Figure 63: (A) Histamine induced a concentration-dependent increase in Isc. (B) shows the potency of Au–
MUDA–HA versus histamine; an equivalent potency between Au–MUDA–HA and histamine was obtained 
with 10−11 mol l−1 and 10−5 mol l−1, respectively. Values are given as increase in Isc above baseline in short-
circuit current (ΔIsc) just before administration of the corresponding drug and are means ± SEM, n = 6–8. 
 
Conclusion 
The gold nanoparticles with an average diameter of 14 nm were loaded with the histamine 
derivative and showed excellent activation properties in the Ussing chamber experiments. 
Compared to native histamine, the nanoparticles were more effective at extremely low 
concentrations. It was found that the newly developed conjugate was able to induce a 
concentration-dependent chloride secretion across rat colonic epithelium via stimulation of 
histamine H1 and H2 receptors. These receptors, which are composed of 487 or 359 amino acids, 
respectively, belong to the class of G-protein coupled receptors with seven transmembrane 
spanning regions. Upon binding of the agonist, these receptors induce the exchange of 
guanosine diphosphate (GDP) against guanosine triphosphate (GTP) at the a-subunit of trimeric 
GTP-binding proteins. The consequence is the dissociation of the G-protein in the GTP-binding 
a-subunit and a b/g-complex and the activation of intracellular enzymes such as phospholipase 
C or adenylate cyclase, which then activate intracellular second messenger pathways. [159] An 
explanation for this stimulation might be the high local density of the immobilized ligand. The 
molecular recognition between the receptors on the surface and ligands bound to the 
nanoparticles is strengthened through the geometric arrangement given by the spherical shape. 
The density of the binding moieties allows simultaneous binding resulting in a lower activation 
concentration. [107] The interaction can be blocked with same inhibitors used for native 
histamine. To ensure the response originated only from multivalent histamine supported on gold 
nanoparticles and not from any unspecific interactions with the biological tissue, the 
monovalent ligand AcS-MUDA-HA or the gold nanoparticles with a simple sulfated moiety 
from 11-mercaptoundecanol were synthesized and tested in parallel. Indeed, no chloride 
secretion could be observed. All particles tested in this study preserved the basic functions of 
the tissues except for Au-MUDOLS. Only the particles with the sulfated moiety harmed the 
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tissues irreversibly. Among the three sizes of particles tested (7 nm, 14 nm and 25 nm), only the 
intermediate size 14 nm showed consistent effects on transepithelial Cl− secretion, indicating a 
size-dependence. The smaller nanoparticles exhibited unspecific interactions whereas the bigger 
particles evoked no signal in the Ussing chamber experiments. The observed size dependence 
might correlate with the number of histamine molecules at the surface. The density of 
immobilized histamine moieties at 14 nm core size and the spatial arrangement are both 
essential for the activation of histaminic receptors bound on an epithelium. For a detailed insight 
into the mechanisms of receptor activation further experiments will be conducted on the ligand–
receptor-complex which is formed during the activation process. But also the length of the 
spacer between the particle core and the active moiety influences the interplay, as it was shown 
in one of our previous studies on multivalent interactions of gold nanoparticles in selectin 
binding. [133] Further investigations shall be conducted on this influence. In summary the 
present work is another example for the influence of multivalent interactions in biological 
systems. This concept can also be transferred to other receptor antagonists and to different 
neurotransmitters. 
 
Experimental section 
All reactions of nanoparticles in aqueous solution were carried out in purified Millipore water. 
Organic solvents were distilled before use. All chemicals were purchased from commercial 
sources and used as received. The ligand exchange reactions and coupling reactions were done 
under inert conditions. All glass vessels were washed with aqua regia and distilled water prior to 
use. NMR spectra were recorded on Bruker BioSpin Avance III AV600 (600 MHz), AV400 
(400 MHz) or AV200 (200 MHz) spectrometers using tetramethylsilane (TMS) as an internal 
standard with chemical shifts given in ppm relative to TMS (δ = 0.00 ppm) or the respective 
solvent peaks. 1H NMR data are reported as follows: chemical shifts (multiplicity [ppm], 
coupling constants [Hz], integration, classification). Multiplicity is recorded as s = singlet, br s 
= broadened singlet, d = doublet, t = triplet, q = quartet, m = multiplet. For 13C NMR, chemical 
shifts and structural assignments are reported where applicable. Because of the rigidity of the 
alkyl chains in the thiol shells and the resulting large differences in the relaxation times of 
different protons, no integrals are given for the proton NMR data of the gold colloids. IR spectra 
were obtained on a Bruker IFS48 spectrometer in ATR mode. Electrospray ionization mass 
spectra (ESI-MS) were recorded on a Finnigan LCQDuo spectrometer using methanol solutions 
of the respective. TEM measurements were performed on a Philips CM30 STEM (300 kV, 
LaB6-cathode) equipped with a GATAN digital camera. TEM images were recorded using a 
digital micrograph. The average particle core sizes were determined by measuring at least 100 
individual particles from recorded TEM images. The UV/Vis spectra were plotted with an 
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Agilent 8453 spectrophotometer (Agilent Technologies Inc., Santa Clara, CA, USA). Dynamic 
light scattering measurements were performed with a StabiSizer PMX 200C from Particlemetrix 
(Meerbusch, Germany).  
Chemical syntheses 
Citrate-coordinated gold nanoparticles NP 1 (Au–Citrate Ø 14 nm). Citrate-coordinated gold 
nanoparticles were synthesized by a variation of a procedure first published by Turkevich. A 
solution of 50 mg (0.127 mmol) HAuCl4·3H2O in 195 mL of Millipore water was heated to 
reflux for 20 min. Under vigorous stirring a solution of 224 mg (0.52 mmol) of sodium citrate in 
5 mL of Millipore water was added quickly. The reaction mixture was held at 80 °C for 2 h. 
Then the solution was cooled to 0 °C in an ice bath and filtered (0.2 μm pore size). A clear red 
solution with a particle concentration of 2.7 nM was obtained and stored at 4 °C.  
1
H NMR (400 MHz, D2O): δ/ppm = 2.61 (bs, CH2); IR (KBr disc, ν/cm
−1
): 3426.8 (νO–H), 
1598.2 (νC=O), 1397.6, 1258.4, 618.0; TEM: d = 14.0 ± 0.9 nm; UV/Vis: λmax = 522 nm; DLS: 
dhydr = 16.7 ± 3.0 nm. 
11-Mercaptoundecanoic acid coordinated gold nanoparticles NP 2 (Au–MUDA Ø 14 nm). An 
amount of 21 mg 11-mercaptoundecanoic acid (0.1 mmol, 10
5
 equiv.) was dissolved in 8.5 mL 
Millipore water under the addition of 50 μL tetramethylammonium hydroxide (TMAH). 5 mL 
of a 2.7 nM solution of citrate-protected gold nanoparticles in water was added dropwise and 
the solution was stirred for 24 h. The nanoparticles solution was dialysed against 300 mL water 
three times (3500 MWCO). A clear red solution with a particle concentration of 1 nM was 
obtained and stored at 4 °C.  
1
H NMR (400 MHz, D2O): 3.17 (s, 16H, TMAH), 2.76 (t, CH2), 2.16 (t, CH2), 1.73 (quin, CH2), 
1.54 (m, CH2), 1.40 (m, CH2), 1.30 (bs, CH2); IR (KBr disc, ν/cm
−1
): 3422.8, 3018.5, 2920.1 & 
2849.8 (νC-H), 1583.5 (νC O), 1487.9, 1396.2, 1274.9, 956.8, 948.2, 625.0; TEM: d = 
14.5 ± 1.2 nm, UV/Vis: λmax = 527 nm, DLS: dhydr = 24.1 ± 6.7 nm. 
Sodium 11-mercaptoundecyl sulfate coordinated gold nanoparticles NP 4 (Au–MUDOLS Ø 
14 nm). An amount of 30 mg 11-mercaptoundecanyl sulfate was dissolved in 8.5 mL Millipore 
water and 50 μL tetramethylammonium hydroxide (TMAH) was added. 5 mL of a 2.7 nM 
solution of citrate-protected gold nanoparticles in water was added dropwise and the solution 
was stirred for 24 h. The nanoparticles solution was dialysed against 300 mL water three times 
(3500 MWCO) and stored at 4 °C.  
1
H NMR (400 MHz, D2O): δ/ppm = 4.00–3.89 (m, CH2), 2.70–2.60 (m, CH2), 1.68–1.51 (m, 
CH2), 1.37–1.23 (m, CH2); IR (KBr disc, ν/cm
−1
): 2918.7 & 2849.9 (νC–H), 1614.8 (νC O), 
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1470.0, 1261.7 & 1205.1 & 1128.1 (νR–OSO2–OR), 1068.8, 966.4, 831.8, 718.9, 628.7, 586.3; 
TEM: d = 14.3 ± 1.3 nm; UV/Vis: λmax = 525 nm; DLS: dhydr = 18.6 ± 2.5 nm. 
Synthesis of histamine functionalized gold nanoparticles NP 3 (Au–MUDA–HA Ø 14 nm). 
10 mL of a 1 nM solution Au–MUDA were set in a glass vessel washed with aqua regia and 
distilled water. 18 mg histamine dihydrochloride (0.1 mmol), 17 mg EDC (0.11 mmol) and 
15 mg HOBt (0.11 mmol) and 50 μL NEt3 were added to the nanoparticle solution. The reaction 
mixture was stirred overnight and subsequently dialysed against water three times 
(3500 MWCO) and stored at 4 °C.  
1
H NMR (400 MHz, D2O): 7.55 (s, 1H, CH), 6.81 (s, 1H, CH), 2.73–2.86 (m, 2H, CH2(HA)), 
2.57–2.71 (m, 3H, CH2(HA) + NH)), 2.41–2.53 (m, 2H), 2.21–2.34 (m, 4H), 2.10–2.21 (m, 3H), 
2.03 (t, J = 7.7, 1H), 1.52–1.68 (m, 1H), 1.36–1.48 (m, 1H), 1.18 (bs, 8H, CH2), IR (KBr disc, 
ν/cm−1): 3018.8, 2921.4 & 2850.0 (νC–H), 1641.1 (νC O, amide), 1596.3 (νCO–NH), 1488.2, 1404.2, 
957.1, 948.6, TEM: d = 14.3 ± 0.7 nm, UV/Vis: λmax = 528 nm, DLS: dhydr = 19.3 ± 2.9 nm. 
Sodium 11-mercaptoundecyl sulfate (MUDOLS). In a flame-dried vessel under argon 
atmosphere, 353 mg of 11-mercaptoundecanol (1.72 mmol, 1 equiv.) was dissolved in 3 ml dry 
DMF. Separately, 395 mg of SO3·DMF complex (2.5 mmol, 1.5 equiv.) were dissolved in 1 mL 
dry DMF and added to the solution. After stirring for 1 h at room temperature the solvent was 
removed under reduced pressure (OPV) and the residue was dissolved in 4 mL of 1 M NaOH. A 
white precipitate appeared. 15 mL of ethanol were added and washed three times. The product 
was dried in vacuum. 280 mg of a colorless solid (0.91 mmol, 53%) could be obtained. The 
dimer was formed.  
1
H NMR (200 MHz, DMSO-d6): δ/ppm = 3.68 (t, J = 6.6 Hz, 2 H, CH2), 3.35 (t, J = 6.3 Hz, 2H, 
CH2), 2.27–2.61 (m, 4H, CH2), 2.56–2.49 (m, 2H, CH2), 1.67–1.52 (m, 4H, CH2), 1.36–1.24 (m, 
10H, CH2); 
13
C NMR (200 MHz, DMSO-d6): δ/ppm = 65.6, 60.7, 32.5, 29.1, 29.0, 28.9, 28.8, 
28.6, 28.5, 27.7, 25.5; ESI-MS: m/z = 633.1593 ([M + Na]
+
, calcd 633.1612). 
11-(Acetylthio)undecanoic acid (AcS–MUDA). 500 mg 11-bromoundecanoic acid (1.89 mmol, 
1 equiv.) were dissolved in 70 mL absolute DMF under argon atmosphere. Separately 520 mg 
potassium thioacetate (4.56 mmol, 2.4 equiv.) were suspended in 8 mL absolute DMF under 
argon atmosphere and added dropwise to the first solution. The reaction mixture was stirred for 
2 hours at room temperature. The precipitate was filtered off, washed several times with water 
and dried in vacuum. 414 mg of a colorless solid (1.59 mmol, 84%) could be obtained.  
1
H NMR (200 MHz, CDCl3): δ/ppm = 2.79 (t, J = 7.17, 2H, CH2), 2.27 (t, J = 7.17, 2H, CH2), 
2.25 (s, 3H, CH3), 1.61–1.52 (m, 2H, CH2), 1.52–1.44 (m, 2H, CH2), 1.32–1.16 (m, 12H, CH2); 
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13
C NMR (100 MHz, CDCl3): δ/ppm = 196.2 (Cq, C O, acetyl), 179.4, 33.9, 30.7, 29.5, 29.4, 
29.3, 29.2, 29.1, 29.1, 29.0, 28.8, 24.7; ESI-MS: m/z = 283.1335 ([M + Na]
+
, calcd 283.1344). 
2,5-Dioxopyrrolidin-1-yl-11-(acetylthio-)undecanoate (AcS–MUDA–NHS). 195 mg NHS 
(1.7 mmol, 1.1 equiv.) and 700 mg AcS–MUDA (1.55 mmol, 1 equiv.) were dissolved in DCM 
under stirring at room temperature. 350 mg DCC (1.7 mmol, 1.1 equiv.) were separately 
dissolved in 5 mL DCM and added slowly. After 30 min a white precipitate appeared. The 
reaction mixture was stirred overnight. The solvent was removed under reduced pressure. 
506 mg (1.42 mmol, 92%) of a colorless powder were obtained.  
1
H NMR (400 MHz, CDCl3): δ/ppm = 2.81–2.77 (m, CH2), 2.53 (t, J = 7.34, 2H, CH2), 2.25 (s, 
3H, CH3), 1.71–1.63 (m, 2H, CH2), 1.52–1.47 (m, 2H, CH2), 1.38–1.17 (m, 12H, CH2); 
13
C NMR (100 MHz, CDCl3): δ/ppm = 196.1 (Cq, C O, acetyl), 169.3 (2 × Cq, C O), 168.7 
(Cq, C=O), 30.9 (CH3), 30.7, 29.5, 29.3, 29.2, 29.2, 29.1, 29.0, 28.8, 28.7, 25.6 (2 × CH2), 24.6; 
ESI-MS: m/z = 380.1502 ([M + Na]
+
, calcd 380.1508). 
S-(11-((2-(1H-Imidazol-4-yl)ethyl)amino)-11-oxoundecyl) ethanethioate 4 (AcS–MUDA–HA). 
97 mg AcS–MUDA (0.27 mmol, 1 equiv.) were dissolved in DMF to form a clear solution. 
34 mg HA·2HCl (0.30 mmol, 1.1 equiv.) and a few drops NEt3 were added and the solution was 
stirred overnight. Subsequently 50 mL water were added and a white solid appeared. The 
precipitate was filtered off and washed three times with water. The crude product was dissolved 
in CHCl3, filtered again and purified via column chromatography (CHCl3/MeOH 9/1 Rf = 0.7). 
After evaporation 70 mg (0.19 mmol, 70%) of a colorless powder were obtained.  
1
H NMR (400 MHz, CDCl3): δ/ppm = 7.50 (s, 1H, CH), 6.75 (s, 1H, CH), 6.33 (br s, 1H, NH), 
3.52–3.42 (m, 2H, CH2(HA)), 2.79–2.69 (m, 2H, CH2(HA)), 2.53–2.39 (m, 2H, CH2), 2.56 (s, 
3H, CH3), 2.10 (t, J = 7.24 Hz, 2H, CH2), 1.59–1.43 (m, 4H, CH2), 1.26–1.14 (m, 12H, CH2); 
13
C NMR (100 MHz, CDCl3): δ/ppm = 196.4 (Cq, C O, acetyl), 173.7 (Cq, C O, amide), 134.8 
(CH, Car), 127.6 (Cq, Car), 118.6 (CH, Car), 39.2 (CH2(HA)), 36.9 (CH2 (HA)), 30.7 (CH3), 29.5, 
29.3, 29.3, 29.2, 29.1, 28.7, 28.4, 26.9, 25.7; ESI-MS: m/z = 354.2221 ([M + H]
+
, calcd 
354.2210). 
Animals 
Female and male Wistar rats with a body mass of 200–250 g were used. The animals were bred 
and housed at the institute for Veterinary Physiology and Biochemistry of the Justus-Liebig-
University Giessen at an ambient temperature of 22.5 °C and air humidity of 50–55% on a 12 h
: 12 h light–dark cycle with free access to water and food until the time of the experiment. 
Experiments were approved by the named animal welfare officer of the Justus Liebig University 
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(administrative number 487_M) and performed according to the German and European animal 
welfare law.  
Solutions 
The standard solution for the Ussing chamber experiments was a buffer solution containing 
(mmol l−1): NaCl 107, KCl 4.5, NaHCO3 25, Na2HPO4 1.8, NaH2PO4 0.2, CaCl2 1.25, MgSO4 1 
and glucose 12. The solution was gassed with carbogen (5% CO2 in 95% O2, v/v); pH was 7.4. 
For the Cl−-free buffer, NaCl and KCl were substituted by Na gluconate and K gluconate 
(KGluc), respectively. The Ca2+ concentration in the Cl−-free buffer was increased to 5.75 mmol 
l−1 to compensate for the Ca2+-buffering properties of gluconate. [160]  
Tissue preparation 
Animals were killed by stunning followed by exsanguination. The serosa and tunica muscularis 
were stripped away by hand to obtain a mucosa–submucosa preparation of the distal colon. 
Briefly, the colon was placed on a small plastic rod with a diameter of 5 mm. A circular incision 
was made near the anal end with a blunt scalpel, and the serosa together with the tunica 
muscularis was gently removed in a proximal direction. Two segments of the distal colon of 
each rat were prepared.  
Short-circuit current measurements 
The mucosa–submucosa preparation was fixed in a modified Ussing chamber bathed with a 
volume of 3.5 ml on each side of the mucosa. The tissue was incubated at 37 °C and short-
circuited by a computer-controlled voltage-clamp device (Ingenieur Büro für Mess- und 
Datentechnik Mussler, Aachen, Germany) with correction for solution resistance. Tissue 
conductance (Gt) was measured every minute by the voltage deviation induced by a current 
pulse (± 50 μA, duration 200 ms) under open-circuit conditions. Short-circuit current (Isc) was 
continuously recorded on a chart-recorder. Isc is expressed as μEq h
−1 cm−2, i.e. the flux of a 
monovalent ion per time and area, with 1 μEq h−1 cm−2 = 26.9 μA cm−2. At the end of each 
experiment, tissue viability was tested by administration of the cholinergic agonist, carbachol 
(5 × 10−5 mol l−1 at the serosal side) and/or the administration of forskolin (5 × 10−6 mol l−1 at the 
mucosal and the serosal side), an activator of adenylate cyclase(s), which induce a strong Ca2+-
respective cAMP-dependent Cl− secretion. [154, 155] 
Drugs 
Au–MUDOLS, Au–MUDA–HA, carbachol, cimetidine, histamine dihydrochloride, and 
mepyramine were dissolved in aqueous stock solutions. Forskolin (Calbiochem, Bad Soden, 
Germany) was dissolved in ethanol (final maximal concentration 0.25%, v/v). Tetrodotoxin was 
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dissolved in 2 × 10−2 mol l−1 citrate buffer. If not indicated otherwise, drugs were from Sigma, 
(Taufkirchen, Germany).  
Statistics 
Results are given as means ± SEM, with the number (n) of investigated tissues. When means of 
several groups had to be compared, an analysis of variance was performed followed by post hoc 
Tukey's-test. For the comparison of two groups, a Mann-Whitney U-test was applied. P < 0.05 
was considered to be statistically significant.  
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5. Quantum Dots 
 
5.1 Quantum Dots for Cellular Imaging 
 
Due to their unique optical properties quantum dots (QDs) consisting of CdTe were synthesized and 
applied as new cell dyes. Preliminary work was done on the development of a synthesis for the 
preparation of monodisperse quantum dots of Cd and Te or Se. [161] Based on the developed 
method the chalcogenide precursor was added to a aqueous solution of Cd
2+
 and 
mercaptocarboxylic acid. Three different types were applied: 2-Mercapto-1-acetic acid (thioglycolic 
acid, TGA), 3-mercapto-1-propanoic acid (MPA) and 3-mercapto-1-propanesulfonic acid (MPSA) 
(Figure 64). 
 
 
Figure 64: Mercaptocarboxylic acids and -sulfonic acid used for the synthesis of quantum dots. 
 
The reaction mixture was stirred at 100 °C for 3 hours and then cooled down with an ice bath, 
subsequently the colloidal solution was purified carefully via dialysis against water. Within the 
molar ratios of 2:1:4.8 for Cd:Te:ligand different rates for the growth of the nanoparticles could be 
observed. Depending on the ligand the size of the resulting quantum dots can be tuned. [161] The 
longer the alkyl chain of the ligand the smaller the particles get within the same reaction time. With 
increasing reaction time the nanoparticles grow larger. 
 
 
Figure 65: Reaction scheme for the synthesis of CdTe quantum dots in aqueous solution. 
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CdTe quantum dots with three different surface ligands (Figure 65). All of them showed high 
emission intensities. For the shortest chain length (TGA) the longest wavelength for the absorption 
and emission maxima were achieved, indicating different particle growth with different ligands 
(Figure 66).  
 
Absorption Emission 
  
Figure 66: Absorption and emission spectra of CdTe quantum dots. 
 
Additionally CdSe quantum dots were synthesized via the same procedure, but only two different 
ligands were applied (Figure 67). 
 
 
Figure 67: Reaction scheme for the synthesis of CdSe quantum dots in aqueous solution. 
 
The selenide precursor solution is very sensitive to air and must be handled carefully under argon 
atmosphere. The spectra show only for MPA-stabilized quantum dots absorption properties and 
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emission intensity (Figure 68). TGA-capped quantum dots could not be obtained. In the absorption 
spectra a red shift can also be observed for shorter chain length indicating the same particle growth 
as for CdTe quantum dots. 
 
Absorption Emission 
  
Figure 68: Absorption and emission spectra of CdSe quantum dots. 
 
Furthermore, CdS quantum dots were synthesized via the previously described method (Figure 69). 
No precursor solution with NaBH4 needed to be synthesized but Na2S was dissolved and used 
directly for the synthesis. Again all reaction steps were carried out under argon atmosphere. 
 
 
Figure 69: Reaction scheme for the synthesis of CdS quantum dots in aqueous solution. 
 
Both spectra show absorption and emission properties of the colloidal solution indicating the 
formation of quantum dots (Figure 70), the intensities are however only weak. No further 
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characterizations of the solution or the nanoparticles were performed. Thus the synthetic parameters 
must be optimized for creation of CdS quantum dots via the approach in aqueous solution.  
 
Absorption Emission 
  
Figure 70: Absorption and emission spectra of CdS quantum dots. 
 
Subsequently, CdTe quantum dots capped with TGA and MPA were covered with a ZnS-shell. This 
prevents the QDs from the leakage of cytotoxic Cd
2+
 ions, which is essential for biological 
applications. The passivation was done directly in solution. Precursor solutions of Zn
2+
 and S
2-
 were 
added and the reaction mixture was stirred at 60 °C. Again dialysis was done for purification. From 
TEM images a mean thickness of 1 nm for the shell can be determined; EDX spot analysis 
confirmed the layer of ZnS around the quantum dot. The reaction time determines the thickness of 
the shell.  
 
 
Figure 71: Reaction scheme for the passivation of CdTe quantum dots with a ZnS shell. 
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The QDs were characterized by TEM and DLS for the determination of the core size and with 
UV/Vis and fluorescence spectroscopy for the analysis of the optical properties.  
For further biological application the optical properties of the synthesized ODs were examined and 
compared with each other. The properties of the core materials CdTe and CdSe with different 
ligands were used for comparison and the optical properties before and after passivation were 
compared. 
 
 
Absorption Emission 
  
Figure 72: Summary of absorption and emission spectra of CdTe and CdSe quantum dots with different ligands. 
 
The absorption and emission maxima of the QDs with different surface ligands differ as shown in 
Figure 72. CdTe-based QDs absorb light between 478 nm and 540 nm, the maximum of CdSe-
based QDs lies at 473 nm. The emission maximum lies between 544 nm and 594 nm for CdTe QDs 
and for CdSe at 543 nm. The intensities are also different. 
Additionally, passivated QDs were compared to their precursors. Comparing the absorption and 
emission spectra of both ZnS covered QDs and their unpassivated analogues, the growth and 
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thickness of the shell has no significant effect on the position of both absorption and emission 
maxima but on the intensities (Figure 73). The absorption abilities decrease and the emission 
abilities are higher for both TGA- and MPA-stabilized quantum dots. The spectra are plotted as 
measured and the concentrations of the sample are similar. 
 
 
Absorption Emission 
  
Figure 73: Summary of absorption and emission spectra of passivated CdTe quantum dots and their precursors. 
 
The ZnS-shell is very thin and has only a slight influence on the optical properties. The maxima are 
shifted to a longer wavelength. Table 8 summarizes the values for absorption and emission maxima 
of the compared quantum dots. The corresponding diameters determined via TEM and DLS are also 
shown. 
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Table 8: Quantum dots stabilized with different ligands and the analogues passivated with a ZnS shell. 
 dTEM dhydr λabs λem 
CdTe-TGA 4.1 ± 0.3 nm 8 ± 2 nm 540 nm 594 nm 
CdTe-MPA 4.4 ± 0.4 nm 6 ± 1 nm 498 nm 574 nm 
CdTe-MPSA 4.9 ± 0.4 nm 5 ± 1 nm 478 nm 544 nm 
CdSe-MPA 3.9 ± 0.2 nm 5 ± 1 nm 473 nm 543 nm 
CdTe/ZnS-TGA 4.2 ± 0.2 nm 11 ± 2 nm 542 nm 590 nm 
CdTe/ZnS-MPA 4.5 ± 0.4 nm 6 ± 1 nm 500 nm 574 nm 
 
CdTe quantum dots functionalized with three different ligands and the passivated CdTe/ZnS 
analogues were applied as new cell dyes (Figure 74). The effect of the ligand shell and core 
composition was investigated in cell uptake studies. Free carboxylic acid moieties were compared 
with sulfonated moieties and the effect of passivation was investigated. All quantum dots have 
almost the same diameter and were dispersed in basic solution, the concentration of the stock 
solution was 9 µmol/L. All QDs were stable in the buffer solution and could be used in biological 
media. 
 
 
Figure 74: Overview of CdTe quantum dots used for biological applications. 
 
The tests were done by Ervice Pouokam, research group Prof. Diener, Institute of Veterinary 
Physiology, Justus-Liebig University Giessen. The tested cells were rat colonic epithelial cells 
forming crypts. Mucosa-submucosa preparations obtained from rat colon were fixed on a plastic 
holder with tissue adhesive and incubated for about 7 min in an EDTA solution, then vibrated for 
about 30 s in order to obtain crypts. A stock solution of the QDs was diluted to 2.25 µmol/L. The 
QDs were collected in a high-K
+
 gluconate Tyrode buffer and pipetted onto poly-L-lysine-coated 
cover glasses (Ø = 23 mm). The crypts were allowed to settle down at room temperature and attach 
onto the surface of the cover glasses for about 30 min. The cover glass was then mounted in a 
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chamber and the volume adjusted to 2 ml. After selecting at least nine regions of interest (ROIs; 3 
in the depth of the crypt, 3 in the middle and 3 at the surface), corresponding each approximately to 
a cell, five excitation flashes were launched at 350 nm with the following durations: 5 ms, 10 ms, 
20 ms, 50 ms and 100 ms. The resulting fluorescence was recorded live and the data stored. Then 
the stock solution of the QDs was added into the chamber to yield a final concentration of 
2.25 µmol/L without changing the volume. After an incubation period of 1 hour at room 
temperature, the chamber was rinsed twice with fresh Tyrode buffer to remove excess QDs and the 
same excitation protocol as before incubation was run. This allowed for tracking the changes of the 
fluorescence in the same ROIs. 
 
 
Figure 75: Crypts incubated with the QDs for 1 h in a Tyrode buffer solution; fluorescence intensity before and 
afterwards was compared. X-axis exposure time, Y-axis in arbitrary units. 
 
All quantum dots tested showed a cell uptake after 1 hour incubation. TGA stabilized quantum dots 
also showed coloration of the background. This suggests unspecific interactions with biological 
tissues. The different core sizes seem not to effect the interactions. The experiments showed that 
QDs with a carboxylic acid terminated shell have a better cell uptake than their sulfonated 
analogues (Figure 75). The negative charge of the sulfonate group seems to restrain the quantum 
dots from entering the cells. Depending on the pH value of the cellular environment carboxylic acid 
moieties are both protonated and deprotonated. The reduced amount of effective charge seems to 
support the uptake. 
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Figure 76: Crypts incubated with the QDs for 1 h in a Tyrode buffer solution; fluorescence intensity before and 
afterwards was compared. X-axis exposure time, Y-axis in arbitrary units. 
 
The experiments showed that the passivated quantum dots had a faster uptake, but did not change 
significantly after time (Figure 76). Passivated QDs gave better results, which proves the shell 
prevents of Cd
2+
 leakage. CdTe/ZnS with thioglycolic acid at the surface gave best results in the cell 
uptake studies.  
 
 
Figure 77: Crypts incubated with the QDs for 1 h in a buffer solution (tyrode).  
 
Figure 77 shows an image of the cells incubated with quantum dots for one hour. It shows on the 
left hand an image of the cells incubated with quantum dots for one hour. Areas of high 
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fluorescence intensity are shown in red. Compared with the autofluorescence of the cells on the 
right hand, it appears that QDs have crossed the cell membrane and accumulated within the cells.  
Further experiments must show where the quantum dots are located in the cell. Higher resolution of 
the images is needed to explain the mechanism behind this. The experiments show that 
mercaptocarboxylic acid terminated quantum dots are suitable for cell imaging but need to be 
passivated with a ZnS shell. These results also indicate that no further functionalization at the ligand 
periphery is needed for cell uptake. With specific epitopes however these quantum dots might be 
able to target cellular compartments. The synthesized quantum dots are equivalent to organic dyes 
for cellular imaging with several advantages: Within the choice of ligand, core material or core 
composition optical properties of the QDs can be tuned easily. 
 
5.2 The Ternary System CdTexSe1-x-MPA 
 
The ternary system of CdTexSe1-x was synthesized with different molar ratios of tellurium and 
selenium. For stabilization of the nanoparticles the short ligand MPA was chosen. The CdTexSe1-x 
quantum dots were prepared via the conventional synthesis in aqueous solution under inert 
conditions. The precursor solutions were prepared out of tellurium or selenium powder reduced in 
situ with NaBH4 under inert conditions. Different molar ratios of NaHTe and NaHSe were added at 
the beginning, the reaction temperature and time were held constant at 100 °C and 4 h, subsequently 
the resulting nanoparticles were purified via dialysis in water  
 
Figure 78: Synthetic procedure for the mixed crystal system CdTexSe1-x. 
 
The structural and optical properties of the resulting quantum dots were determined. 
Characterization was done by UV/Vis and emission spectroscopy, XRD analysis and EDX spot 
analysis. With an increasing percentage of telluride anions in the system the absorption maximum 
shifts to a higher and the emission maximum shifts to a lower wavelength (Figure 79). For CdSe-
MPA QDs an absorption maximum of 485 nm and an emission maximum of 585 nm was observed, 
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and for CdTe-MPA 520 nm and 555 nm respectively. A linear correlation for the mixed analogues 
was found (Figure 79). 
 
 
 
Figure 79: Emission (λex = 350 nm) and absorption maxima of CdTexSe1-x-MPA with x = 0.0 to x = 1.0 Inset: 
Photography of CdTexSe1-x-MPA with x = 0.1 to x = 1 under the UV lamp (λex = 366 nm). 
 
XRD patterns of MPA-capped CdTexSe1-x show that the reflections shift linearly between those of 
the binary compounds of CdTe and CdSe according to Vegard’s law (Figure 80). This indicates a 
solid solution meaning both compounds form a mixed crystal system without miscibility gap. This 
is possible due to the fact that both CdTe and CdSe have a cubic crystal structure with tellurium and 
selenium atoms statistically occupying the anion sub lattice. The reflections in the XRD patterns are 
broadened due to nanostructuring. A mean diameter of 3 nm can be calculated using the Scherrer 
equation. [162] 
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Figure 80: XRD patterns of CdTexSe1-x-MPA with x = 0.0 to x = 1. Both binary compounds CdTe and CdSe are 
also shown for comparison with the mixed crystal system. 
 
TEM measurements show monodisperse nanoparticles with a mean diameter between 2.3 nm and 
2.9 nm and nearly monodisperse. Thus, the growth mechanism for the quantum dots does not 
depend on the precursor solution. EDX spot analysis revealed a homogeneous distribution of the 
constituting elements within the particles. The values found correspond to the nominal composition 
of the mixed crystals (Table 9). 
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Table 9: Overview CdTexSe1-x-MPA quantum dots: diameter, composition, absorption and emission maxima. 
x dTEM EDX Te/Se λabs λem 
0 2.6 ± 0.2 nm 0.00/1.00 485 nm 584 nm 
0.1 2.4 ± 0.3 nm 0.13/0.87 487 nm 598 nm 
0.2 2.9 ± 0.2 nm 0.24/0.76 486 nm 581 nm 
0.3 2.3 ± 0.3 nm 0.30/0.70 488 nm 579 nm 
0.4 2.5 ± 0.2 nm 0.38/0.62 492 nm 573 nm 
0.5 2.6 ± 0.2 nm 0.61/0.39 498 nm 567.5 nm 
0.6 2.5 ± 0.3 nm 0.68/0.32 500 nm 564 nm 
0.7 2.3 ± 0.3 nm 0.68/0.32 498 nm 564 nm 
0.8 2.5 ± 0.2 nm 0.60/0.40 506 nm 560.5 nm 
0.9 2.5 ± 0.2 nm 0.88/0.12 518 nm 559 nm 
1.0 2.6 ± 0.2 nm 1.00/0.00 520 nm 555 nm 
 
Because of their already given water solubility and stability, these quantum dots are versatile tools 
for biological applications such as cell imaging. They can also be functionalized with bioactive 
substances via peptide coupling at the carboxylic acid. 
Within this work different methods for the tuning of optical properties of quantum dots were 
presented. On the one hand different ligands used in the synthesis can result in different QDs. On 
the other hand different core materials can be used. Synthesis of mixed crystal systems can combine 
elements and shift the absorption and emission maxima between both compounds. 
Another aspect responsible for optical properties is the crystallinity of the inorganic core. 
Experiments showed that with higher crystallinity the maxima are shifted to longer wavelengths. 
This can be achieved by the use of microwave irradiation, high temperatures and high pressures. 
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6. Summary/Zusammenfassung 
 
6.1 Summary 
 
In conclusion this work presents a successful application of newly developed conjugates of 
bioactive molecule and nanoparticle. A remarkable enhancement of receptor activation was 
achieved by multivalent presentation of active moieties supported on gold nanoparticles. 
For this purpose diverse gold nanoparticles were synthesized and functionalized with biogenic 
amines. Different synthetic approaches were used to obtain gold nanoparticles between 4 nm and 25 
nm. Small gold nanoparticles of 4 nm, 6 nm and 7 nm were synthesized in organic solution; larger 
gold nanoparticles of 14 nm and 25 nm were synthesized by citrate reduction of the precursor salt in 
aqueous solution. All types were rather monodisperse in size. Next they were equipped with 
mercaptocarboxylic acids of different chain lengths via ligand exchange reaction making all gold 
nanoparticles water soluble. This kind of ligand provides an additional group for functionalization 
at the ligand periphery. Only with 11-mercaptoundecanoic acid (MUDA) was the resulting colloidal 
solution stable and could be used for further modifications. Molecules possessing an amino group 
can be coupled onto the gold nanoparticles via EDC/NHS (1-ethyl-3-(3-
dimethymaminopropyl)carbodiimide/N-hydroxysuccinimide) mediated peptide coupling reaction. 
Four different amines were immobilized on gold nanoparticles of 14 nm diameter: histamine (Au-
MUDA-HA), dopamine (Au-MUDA-DA), serotonin (Au-MUDA-5HT) and carbachol (Au-
MUDA-CB).  
Histamine functionalized 14 nm gold nanoparticles were applied as new agonists in ligand-receptor 
interaction (Figure 81). As a functional read-out system, chloride secretion resulting from 
stimulation of neuronal and epithelial histamine H1 and H2 receptors was measured in Ussing 
chamber experiments. Compared to native histamine the multivalent presentation of histamine 
resulted in a potentiation of activation ability. Extremely low concentrations were necessary to 
induce a chloride secretion across rat colonic epithelium. For comparison the monovalent analogue 
AcS-MUDA-HA and gold nanoparticles without an active moiety Au-MUDOLS were also 
synthesized and tested. The measured effects could be attributed to Au-MUDA-HA as both 
references showed no activity at low concentrations. Only Au-MUDOLS harmed the tissue 
irreversibly. The observed effects could be explained by a high local density of histaminic moieties 
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in close proximity. Tests with 7 nm and 25 nm gold nanoparticles did not show consistent results in 
the experimental setup and no statement of size dependence can be made. 
 
 
 
Figure 81: Histamine functionalized gold nanoparticles and native histamine. 
 
Dopamine functionalized gold nanoparticles Au-MUDA-DA were not able to induce a chloride 
secretion at the administered concentrations. The colloidal solution changed color indicating an 
alteration. However multivalent presentation of serotonin on the gold nanoparticles Au-MUDA-
5HT was effective. Chloride secretion could be measured in Ussing chamber experiments. Again 
very low concentrations were needed for activation of receptors. The stable acetylcholine derivative 
carbachol immobilized at the gold nanoparticles Au-MUDA-CB also showed excellent results in 
Ussing chamber experiments. Au-MUDA-CB evoked a response at picomolar concentrations. Gold 
nanoparticles with only free carboxylate moieties Au-MUDA were not inert in the experimental 
setup and they were able to activate receptors unspecifically. Again all enhanced interactions can be 
referred to the multivalent supporting of the active moieties.  
In a further part of this work quantum dots (QDs) for cellular imaging were synthesized. CdTe and 
CdSe based nanoparticles emit in the visible spectrum of light when their core size is smaller than 
the Exciton bohr radius. QDs were synthesized directly in aqueous solution using different 
mercaptocarboxylic acids as capping ligands. The optical properties were determined. For 
biological application the QDs were covered with a ZnS shell. The presence of the additional shell 
has only slight influence on the optical properties of the QDs. Both passivated and unpassivated 
nanoparticles were applied for cell imaging. Carboxylic acid terminated QDs showed a better cell 
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uptake than the sulfonated analogue, passivated QDs showed a faster cell uptake. CdTe/ZnS-TGA 
(thioglycolic acid) showed the best results in the cell imaging study. 
Additionally the ternary system consisting of both parts of CdTe and CdSe was synthesized and 
characterized. Optical properties of the mixed crystal system shift linearly between both binary 
compounds. The size of the QDs did not differ significantly. This synthetic method can be used for 
fine tuning of emitting-properties without changing the particle size, which is necessary in some 
biological applications. 
 
6.2 Zusammenfassung 
 
In dieser Arbeit wurde eine erfolgreiche Anwendung von neu entwickelten Konjugaten aus 
bioaktivem Molekül und Nanopartikel vorgestellt. Es konnte eine erhebliche Verbesserung in der 
Rezeptoraktivierung durch multivalente Präsentation von aktiven Substanzen auf Goldnanopartikeln 
erzielt werden. 
Hierzu wurden diverse Goldnanopartikel synthetisiert und funktionalisiert. Verschiedene 
synthetische Ansätze wurden ausgewählt, um Goldnanopartikel zwischen 4 nm und 25 nm zu 
erhalten. Kleine Goldnanopartikel mit 4 nm, 6 nm und 7 nm Größe wurden in organischer Lösung 
hergestellt, größere Goldnanopartikel mit 14 nm und 25 nm Größe wurden mittels Citrat-Reduktion 
eines Goldsalzes synthetisiert. Alle dargestellten Partikel waren relativ monodispers in ihrer Form. 
Anschließend wurden Mercaptocarbonsäuren verschiedener Kettenlängen mittels 
Ligandenaustauschreaktion auf die Partikel gebracht, wodurch auch die Partikel aus der organischen 
Synthese wasserlöslich wurden. Diese Art Liganden beinhaltet eine zusätzliche funktionelle Gruppe 
zur Funktionalisierung an der Ligandenperipherie. Nur mit 11-Mercaptoundecansäure (MUDA) 
konnten stabile kolloidale Lösungen erhalten werden, die für weitere Modifikationen genutzt 
werden können. Moleküle mit einer Aminogruppe können über EDC/NHS (1-Ethyl-3-(3-
dimethymaminopropyl)carbodiimide/N-Hydroxysuccinimide) vermittelte Peptidkupplung auf den 
Goldnanopartikeln angebracht werden. Vier verschiedene Amine wurden auf Goldnanopartikel mit 
14 nm Durchmesser immobilisiert: Histamin (Au-MUDA-HA), Dopamin (Au-MUDA-DA), 
Serotonin (Au-MUDA-5HT) und Carbachol (Au-MUDA-CB). 
Histamin-funktionalisierte Goldnanopartikel mit 14 nm Größe wurden als neue Agonisten in der 
Ligand-Rezeptor-Wechselwirkung (Abbildung 81) angewendet. Gemessen wurde die Chlorid-
Sekretion durch die Stimulierung von neuronalen und epithelialen Histamin H1 und H2 Rezeptoren 
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in Ussing-Kammer-Experimenten gemessen. Im Vergleich zu nativem Histamin führte die 
multivalente Präsentation von Histamin zu einer Potenzierung der Aktivierungsfähigkeit. Es waren 
extrem niedrigen Konzentrationen notwendig, um eine Chlorid-Sekretion am Ratten Kolonepithel 
zu induzieren. Zum Vergleich wurden auch das monovalente Analogon AcS-MUDA-HA und 
Goldnanopartikel ohne eine aktive Einheit Au-MUDOLS synthetisiert und getestet. Die 
gemessenen Effekte konnten so Au-MUDA-HA zugeschrieben werden, da beide Referenzen keine 
Aktivität bei geringen Konzentrationen zeigten. Nur Au-MUDOLS zerstörte das Gewebe 
irreversibel. Die beobachteten Effekte können durch eine hohe lokale Dichte von Histamin-
Einheiten in unmittelbarer Nähe erklärt werden. Die ebenfalls getesteten Goldnanopartikel mit 7 nm 
und 25 nm Größe zeigten keine konsistenten Ergebnisse und es kann keine Aussage über die 
Größenabhängigkeit gemacht werden. 
Dopamin-funktionalisierte Goldnanopartikel Au-MUDA-DA waren nicht in der Lage, ein Chlorid-
Sekretion bei den verabreichten Konzentrationen zu induzieren. Die Farbänderung der kolloidalen 
Lösung deutet darauf hin, dass eine Veränderung der Struktur stattgefunden hat. Allerdings zeigte 
die multivalente Präsentation von Serotonin auf den Goldnanopartikeln Au-MUDA-5HT eine 
Wirkung. Eine Chlorid-Sekretion konnte in den Ussing-Kammer-Experimenten gemessen werden. 
Auch hier wurden sehr geringe Konzentrationen für die Aktivierung der Rezeptoren benötigt. Das 
stabile Acetylcholin-Derivat Carbachol immobilisiert auf Goldnanopartikeln Au-MUDA-CB zeigte 
auch hervorragende Ergebnisse in den Ussing-Kammer-Experimenten. Au-MUDA-CB zeigte eine 
Antwort im pikomolaren Bereich auf. Goldnanopartikel mit nur freien Carboxylat-Einheiten Au-
MUDA waren nicht inert; sie waren in der Lage, Rezeptoren unspezifisch zu aktivieren. Alle 
gemessenen Effekte können der multivalenten Präsentation der aktiven Einheiten zugeschrieben 
werden. 
Im anderen Teil dieser Arbeit wurden Quantenpunkte (QDs) für zelluläre Bildgebung synthetisiert. 
CdTe- und CdSe- basierte Nanopartikel emittieren im sichtbaren Bereich des Lichtes, wenn ihre 
Kerngröße kleiner als der Exciton-Bohr-Radius ist. QDs wurden direkt in wässriger Lösung unter 
Verwendung verschiedener Mercaptocarbonsäuren als Capping-Liganden synthetisiert. Die 
optischen Eigenschaften wurden bestimmt. Für die biologischen Anwendungen wurden die QDs mit 
einer ZnS-Schale ummantelt. Das Vorhandensein der zusätzlichen Hülle hat nur geringen Einfluss 
auf die optischen Eigenschaften der Quantenpunkte. Beide passivierten und nicht passivierten 
Nanopartikel wurden zur zellulären Bildgebung angewendet. Carbonsäuren terminierte QDs zeigten 
eine bessere Zellaufnahme als die sulfonierten Analogen, passivierte QDs zeigten eine schnellere 
Zellaufnahme. CdTe/ZnS-TGA (Thioglycolsäure) wiesen die besten Ergebnisse in der Studie auf. 
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Zusätzlich wurde das ternäre System, bestehend aus CdTexSe1-x, synthetisiert und charakterisiert. 
Die optischen Eigenschaften des Mischkristallsystems liegen zwischen den beiden binären 
Verbindungen und korrelieren linear mit der Zusammensatzung. In der Größe der QDs lag keine 
signifikante Abweichung. Diese Synthesemethode kann für die Feinabstimmung der Emissions-
Eigenschaften genutzt werden, ohne dass die Partikelgröße dabei verändert wird, was in einigen 
biologischen Anwendungen notwendig ist. 
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7. Outlook 
 
After the successful immobilization of the four neurotransmitters and the ability of these conjugates 
to activate receptors, further experiments will be done to explain these multivalent interactions as 
there is little research in this field of interest. Histamine functionalized gold nanoparticles with a 
diameter of 14 nm were proved to act as their monovalent analogues and were excellent activators 
for receptor functionality. Another attempt can be made on the synthesis of dopamine 
functionalized gold nanoparticles. These conjugates have versatile applications. Because of the 
basic pH value, the catechol moiety oxidized in situ, reaction conditions and synthetic strategy must 
be optimized. The multivalent presentation of carbachol on 14 nm gold nanoparticles also showed 
encouraging first results. The effect of those conjugates on the cholinergic systems should be 
studied in depth. 
Investigations ought to be done on the reactivity of receptor blockers immobilized on gold 
nanoparticles. It can be presumed that the activation concentration of multivalently presented 
blockers is also lower than that of the molecular agents. The use of receptor blockers is far more 
widespread and applied in therapy. Atropine is an interesting representative of receptor blockers. It 
addresses muscarinic receptors and is an anticholinergic blocking the effect of acetylcholine in the 
body. Immobilization cannot be accomplished as before, the molecule first has to be modified and 
provided with a linker anchoring at the gold surface. 
Moreover the size dependence of the effects should be investigated in detail. A variety of 
nanoparticles with different core sizes but the same ligands at the surface can be compared in their 
activating ability. The core materials can also be exchanged for cheaper materials or materials with 
additional properties and used for biological tests. Iron oxide based nanoparticles can also be 
synthesized relatively easily in different core sizes from affordable precursors and their 
biocompatibility is also very high. Furthermore they inherit the property of superparamagnetism. A 
direct synthesis in aqueous solution yielding monodisperse nanoparticles could be developed. 
Another closer look ought to be taken at the molecular interactions at the interface between 
nanoparticle and receptor. The multivalent interactions contributing to the huge potency of the 
conjugates can be determined in detail helping to understand the mechanisms. Sophisticated cell 
analysis can be used to gain insight in subcellular structures and reactions. This might help to 
develop new nanomaterials for therapy. For this purpose the nanoparticles can be equipped with a 
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fluorescent dye. With the help of fluorescence microscopy the location of the nanoparticles in the 
tissue can be visualized. It should also be examined whether the gold nanoparticles are able to 
overcome barriers like cell walls. The surface can be covered with ligands favoring a cross over 
membranes. If this is successful it might be possible to set a controlled transport across the barrier. 
Here again a size dependency should be investigated. Functionalized quantum dots can also be 
applied for cell imaging to give information about the remains of the nanoparticulate materials. 
Besides all these applications also the toxicity of the nanoparticles should be kept in mind. Size and 
ligand dependent cytotoxicity can often be observed for nanoparticles in biological systems. 
Especially the gold core and the time in the body after the reaction should be investigated in detail. 
Biocompatibility of the nanoparticles is crucial for further applications. 
Multivalent presentation of active substances proved to enhance the interactions and gives 
promising outlook. Systematic investigations and the synthesis of novel conjugates will open the 
door to new developments in nanomedicine and nanomaterial based applications.  
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8. Experimental Section 
 
8.1 Chemicals, Solvents and Consumables 
 
All chemicals were purchased from Acros Organics, Alfa Aesar, Sigma Aldrich, Merck, 
Novabiochem or Fluka at the highest purity grade available, solvents were purchased anhydrous and 
with 99.9% purity unless otherwise noted. All solvents were distilled prior to use. All reactions 
under inert conditions were carried out in argon atmosphere (99.99%, Messer Griesheim) 
employing oven- and flame-dried glassware. 
 
Dry DMF was prepared as followed: DMF was refluxed under argon with sodium and 
benzophenone for several hours until the solution turned blue. Anhydrous DMF was stored over 
molecular sieve 4 Å under argon. 
 
For the synthesis of nanoparticles ultrapure water from Millipore was used. 
 
For dialysis of the particle solution a membrane of regenerated cellulose with different pore size by 
Roth was used. The membrane was treated according to the producer which means soaking for 
30 min in distilled water followed by washing. All dialyses were prepared at room temperature in 
the given solvent for a given time. 
 
Flash column chromatography and filtration was performed using Merck silica gel 60 Å (0.040 – 
0.063 mm mesh size). Analytical thin-layer chromatography (TLC) was performed using pre-coated 
polyester sheets Polygram® SIL G/UV254 Machery-Nagel, 0.2 mm silica gel with fluorescent 
indicator. 
 
8.2 Analytics 
 
NMR Analysis: 
1
H and 
13
C NMR spectra were recorded on Bruker BioSpin Avance III AV600 (600 MHz), AV400 
(400 MHz) or AV200 (200 MHz) spectrometers using TMS as an internal standard with chemical 
shifts given in ppm relative to TMS (δ = 0.00 ppm) or the respective solvent peaks. 1H NMR data 
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are reported as follows: chemical shifts (multiplicity [ppm], coupling constants [Hz], integration, 
classification). Multiplicity is recorded as s = singlet, br s = broadened singlet, d = doublet, t = 
triplet, q quartet, m = multiplet. For 
13
C NMR, chemical shifts and structural assignments are 
reported where applicable. 
 
IR: 
The IR measurements were performer on a Bruker Alpha IR spectrometer utilizing KBr cells 
(d = 0.5 mm). 
 
UV/Vis: 
The UV/Vis spectra were recorded with an Agilent 8453 spectrophotometer (Agilent Technologies 
Inc., Santa Clara, CA, USA). 
 
CHN-Analysis: 
Elemental analyses were obtained with a Carlo Erba 1106 (balance: Mettler Toledo UMX-2) 
analyzer. 
 
ESI: 
Mass spectra were recorded on a Finnigan LCQDuo spectrometer using methanol solutions of the 
respective compounds. 
 
TEM: 
The characterization of the particle cores was accomplished by a transmission electron microscope 
CM30/STEM by Philps with a LaB6 cathode, 300 kV equipped with a GATAN digital camera. 
10 µL of the colloidal solution was placed on a carbon-coated copper grid, followed by natural 
evaporation of the solvent at room temperature. For determination of the size and standard deviation 
100 particles were measured. 
 
DLS and ζ-potential: 
The hydrodynamic radius in solution was determined by a STABISIZER PMX-200 from Particle 
Metrix GmbH via dynamic light scattering setting set zero 20 s, 3 x 180 s per run, 3 runs. Zeta-
potentials were measured on a NanoZS by Malvern. 
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XRD: 
The crystal structure of the nanoparticles was verified by powder X-ray diffraction in reflection 
mode on a PANalytical X’Pert PRO instrument with Cu Kα radiation (λ = 1.54 Å) at an operating 
voltage of 40 kV and a current of 40 mA (divergence aperture 2°).  
Crystallite size was calculated with Scherrer equation (d = crystallite size, k = shape factor 0.9, λ = 
irradiation wavelength, β1/2 = reflection width at half height, θ = diffraction angle). 
 
𝑑 =  
𝑘 ∙ 𝜆
𝛽1/2 ∙ cos 𝜃
 
 
TGA:  
Thermogravimetric measurements were done with a Netzsch STA409PC thermoscale with an 
attached quadrupole mass spectrometer QMG421 by Balzers, ionization energy 70 eV. 
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8.3 Synthesis of the Nanoparticles 
 
Citrate-coordinated gold nanoparticles (Au-Citrate Ø 14 nm) 
 
A solution of 50 mg (0.127 mmol) HAuCl4∙3 H2O in 195 mL of 
Millipore water was heated to reflux for 20 min. Under vigorous 
stirring a solution of 224 mg (0.52 mmol) of sodium citrate in 5 mL of Millipore water was added 
quickly. The reaction mixture was held at 80 °C for 2 h. Then the solution was cooled to 0 °C in an 
ice bath and filtered (0.2 µm pore size). A clear red solution with a particle concentration of 2.7 nM 
was obtained and stored at 4 °C. 
 
1
H NMR (400 MHz, D2O): δ/ppm = 2.61 (bs, CH2); IR (KBr disc): ν/cm
-1
 = 3426.8 (νO-H), 1598.2 
(νC=O), 1397.6, 1258.4, 618.0; TEM: d = 14.0 ± 0.9 nm; UV/Vis: λmax = 522 nm; DLS: 
dhydr = 17 ± 3 nm. 
 
Citrate-coordinated gold nanoparticles (Au-Citrate Ø 25 nm) 
 
A solution of 2.5 mg (0.018 mmol) HAuCl4·3 H2O in 72 mL of 
Millipore water was heated to reflux for 10 min. Under vigorous 
stirring a solution of 9 mg (0.03 mmol) of sodium citrate in 0.9 mL of Millipore water was added 
quickly. The reaction mixture was held at 80 °C for 30 min. The solution turned first blue then 
purple. Subsequently the solution was cooled to 0 °C in an ice bath and filtered (0.2 µm pore size). 
A clear red solution with a particle concentration of 0.5 nM was obtained and stored at 4 °C.  
 
1
H NMR (400 MHz, D2O): δ/ppm = 3.12 (bs, OH), 2.75 (d, J = 15.4 Hz, 2 H, CH2), 2.64 (d, J = 
15.4 Hz, 2 H, CH2); IR (KBr disc): ν/cm
-1
 =  3426.8 (νO-H), 1598.2 (νC=O), 1397.6, 1258.4, 618.0; 
TEM: d = 25.3 ± 2.4 nm; UV/Vis: λmax = 529 nm; DLS: dhydr = 26  ± 10 nm. 
 
DT-coordinated gold nanoparticles (Au-DT Ø 4 nm) 
 
62 mg AuPPh3Cl (0.125 mmol) were mixed with 0.06 mL 1-dodecanethiol 
(0.25 mmol, 2 equiv.) in 10 mL chloroform to form a clear solution. An amount of 108 mg 
(1.25 mmol, 10 equiv.) of tert-butylamin-borane complex was added and the solution turned dark 
red. The mixture was heated with stirring at 65 °C for 5 h and then cooled down to room 
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temperature. Then 40 mL of ethanol were added and the precipitate separated by centrifugation. The 
black powder was washed with ethanol three times, dried under vacuum. The gold nanoparticles 
were resolved in 10 mL of chloroform to give a dark red solution with a particle concentration of 
6.3 µM. 
 
1
H NMR (400 MHz, CDCl3): δ/ppm = 1.59-1.52 (m, 6 H, CH2), 1.43-1.39 (m, 2 H, CH2), 1.30-1.22 
(m, 10 H, CH2), 1.13-1.09 (m, 4 H, CH2), 0.88 (t, J = 6.9 Hz, 3 H, CH3); IR (KBr disc): ν/cm
-1
 = 
2921.8 (s, νC-H), 2850.9 (s, νC-H), 1488.0, 1385.6, 948.3; TEM: d = 4.0 ± 1.0 nm; UV/Vis: 
λmax = 507 nm, DLS: dhydr = 5  ± 1 nm. 
 
DT-coordinated gold nanoparticles (Au-DT Ø 7 nm) 
 
247 mg AuPPh3Cl (0.5 mmol) were mixed with 0.25 mL 1-dodecanethiol 
(1 mmol, 2 equiv.) in 40 mL toluene to form a clear solution. An amount of 435 mg (5 mmol, 
10 equiv.) of tert-butylamin-borane complex was added and the solution turned dark red. The 
mixture was heated with stirring at 55 °C for one hour and then cooled down to room temperature. 
Then 40 mL of ethanol were added and the precipitate separated by centrifugation. The black 
powder was washed with ethanol three times, dried under vacuum. The gold nanoparticles were 
resolved in 10 mL of chloroform to give a dark red solution with a particle concentration of 7.5 µM. 
The use of benzene instead of toluene results in gold nanoparticles with a mean diameter of 6 nm.  
 
1
H NMR (400 MHz, CDCl3): δ/ppm = 1.60-1.49 (m, 10 H, CH2), 1.33-1.19 (m, 12 H, CH2), 0.88 (t, 
J = 7.2 Hz, 3 H, CH3); IR (KBr disc): ν/cm
-1
 = 2917.1 (s, νC-H), 2844.2 (s, νC-H), 1454.8, 1432.8, 
716.1, 687.7, 517.7; TEM: d = 7.1 ± 0.8 nm; UV/Vis: λmax = 518 nm; DLS: dhydr = 8  ± 1 nm. 
 
DMAP-coordinated gold nanoparticles (Au-DMAP Ø 6 nm) 
 
An aqueous solution of HAuCl4 (24 mg in 2 mL) was added to a solution of 
tetraoctylammonium bromide (TOAB) in toluene (153 mg in 5 mL) and the mixture was stirred 
until all the tetrachloroaurate had transferred into the organic phase, to give a deep orange solution. 
A fresh solution of NaBH4 (27 mg in 1.5 mL) was added slowly whilst stirring. The toluene phase 
immediately turned to ruby red. After stirring for 18 hours, the toluene phase containing TOAB-
stabilized gold NPs was washed with 0.1 M H2SO4, 0.1 M NaOH and H2O (each three times). 
Subsequently, an aqueous solution of DMAP (300 mg in 24 mL) was added to the TOAB-stabilized 
gold NP solution. Phase transfer of the solution took place simultaneously and a ruby red aqueous 
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solution of DMAP-Au NPs was isolated. Purification was done with dialysis against water (three 
times for three hours).The stock solution was stored at 4 °C. 
1
H NMR (400 MHz, CDCl3): 7.86 (d, J = 6.9 Hz, 2 H, CH), 6.40 (d, J = 6.9 Hz, 2 H, CH), 2.76 (s, 
3 H, CH3); TEM: d = 8.6 ± 2.9 nm; UV/Vis: λmax = 522 nm; DLS: dhydr = 30 ± 3 nm. 
 
 
Alloyed gold/silver nanoparticles (Au/Ag-Citrate): 
 
An amount of HAuCl4 was dissolved in 150 mL of Millipore 
water and heated to reflux. The respective amount of AgNO3 was added under vigorous stirring 
immediately followed by the amount of sodium citrate. The temperature of the reaction mixture was 
lowered to 80 °C and stirred for 2 h. Subsequently the solution was cooled to 0 °C in an ice bath 
and filtered (0.2 µm pore size). A clear solution was obtained. The nanoparticles were characterized 
with TEM and UV/Vis spectroscopy. 
 
 mHAuCl4 nHAuCl4 mAgNO3 nAgNO3 mNa3Cit dTEM λabs 
Au 14.18 mg 36 µmol - - 78.15 mg 14.0 ± 0.9 nm 521 nm 
Au/Ag 3:1 10.64 mg 27 µmol 1.55 mg 9 µmol 78.15 mg 31.5 ± 2.9 nm 500 nm 
Au/Ag 1:1 7.09 mg 18 µmol 3.1 mg 18 µmol 78.15 mg 32.7 ± 4.1 nm 465 nm 
Au/Ag 1:3 3.55 mg 9 µmol 4.65 mg 27 µmol 78.15 mg 33.4 ± 2.3 nm 432 nm 
Ag - - 6.2 mg 36 µmol 78.15 mg 31.5 ± 2.6 nm 413 nm 
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8.4 Ligand Exchange Reactions 
 
General procedure for ligand exchange reaction in water: 
 
I Two-phase system: The ligand (6∙105 equiv.) was dissolved in 5 mL of water and under vigorous 
stirring 1 mL of organic solvent including the nanoparticles was added. The reaction mixture was 
stirred for 16 h at room temperature whilst a phase transfer could be observed. The organic phase 
was removed and the aqueous phase was dialysed against water. The purified colloidal solution was 
stored at 4 °C. 
 
II One-phase system: 10 mL of the nanoparticle solution were stirred at room temperature and 6∙105 
equivalents of the ligand were added. NaOH was added until a basic solution was obtained. After 
16 h the solution was purified via dialysis against water and stored at 4 °C. 
 
 
Ligand exchange at Au-Citrate 14 nm with different ligands: 
 
According to the general procedure II ligand exchange reactions at Au-
Citrate nanoparticles were performed with 11-mercaptoundecanoic acid (MUDA), 
6-mercaptohexanoic acid (MHA), 3-mercaptopropionic acid (MPA), lipoic acid (LA). The resulting 
nanoparticles were characterized via UV/Vis. 
 
 Ligand amountligand λabs 
Au-MPA MPA 9 µL xx 
Au-MHA MHA 15 mg xx 
Au-MUDA MUDA 22 mg 524 nm 
Au-LA LA 20 mg 531 nm 
 
 
Ligand exchange with MUDA at Au-DT and Au-Citrate: 
 
According to the general procedure I 1 mL of Au-DT (4 nm or 7 nm) 
were added to a solution of 44 mg MUDA (0.2 mmol) and 20 mg NaOH (0.5 mmol, pH>8) in 9 mL 
water. Dialysis against water three times with 300 mL (MWCO 3500) was performed. 
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According to general procedure II 10 mL 44 mg MUDA (0.2 mmol) and 20 mg NaOH (0.5 mmol, 
pH>8) were added to a solution of Au-Citrate (14 nm or 25 nm). Dialysis against water three times 
with 300 mL, MWCO 3500) was performed. 
The nanoparticles were characterized with TEM, DLS and UV/Vis. Au-MUDA 14 nm was 
synthesized for the publication and characterized additionally with 
1
H NMR and IR. 
 
 dTEM dDLS λabs cNP 
4 nm 3.8 ± 0.7 nm 5  ± 1 nm 507 nm 1.26 µM 
7 nm 7.5 ± 0.4 nm 8  ± 2 nm 524 nm 1.5 µM 
14 nm 14.5 ± 1.2 nm 24 ± 7 nm 527 nm 1 nM 
25 nm 25.9 ± 2.3 nm 32 ± 8 nm 532 nm 0.5 nM 
 
 
Ligand exchange with MUDA at alloyed Au/Ag nanoparticles:  
 
According to general procedure II 10 mL 44 mg MUDA (0.2 mmol) and 
20 mg NaOH (0.5 mmol, pH>8) were added to citrate-stabilized gold, silver and the alloyed 
nanoparticles. Dialysis against water three times with 300 mL (MWCO 3500) was performed. 
The nanoparticles were characterized with UV/Vis.  
 
 Particle λabs 
Au  Au-MUDA 524 nm 
Au/Ag 3:1 Au0.75Ag0.25-MUDA 499 nm 
Au/Ag 1:1 Au0.5Ag0.5-MUDA 473 nm 
Au/Ag 1:3 Au0.25Ag0.75-MUDA 444 nm 
0:1 Ag-MUDA 424 nm 
 
 
Ligand exchange with MUDOLS at Au-DT and Au-Citrate: 
 
The ligand MUDOLS was synthesized separately. 
According to the general procedure I 1 mL of Au-DT (7 nm) were added to a solution of 60 mg 
MUDOLS (0.2 mmol) and 20 mg NaOH (0.5 mmol, pH>8) in 9 mL water. Dialysis against water 
three times with 300 mL (MWCO 3500) was performed. 
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According to general procedure II 10 mL 60 mg MUDOLS (0.2 mmol) and 20 mg NaOH 
(0.5 mmol) were added to a solution of Au-Citrate (14 nm or 25 nm). Dialysis against water three 
times with 300 mL (MWCO 3500) was performed. 
The nanoparticles were characterized with TEM, DLS and UV/Vis. Au-MUDOLS 14 nm was 
synthesized for the publication and characterized additionally with 
1
H NMR and IR. 
 
 dTEM dDLS λabs cNP 
7 nm 7.3 ± 0.9 nm 19 ± 4 nm 524 nm 1.5 μM 
14 nm 14.3 ± 1.3 nm 19 ± 3 nm 525 nm 1 nM 
25 nm 28.4 ± 4.0 nm 18 ± 5 nm 528 nm 0.5 nm 
 
 
8.5 Dithiocarbamate Functionalized Gold Nanoparticles 
 
Au-DDT-GABA (Ø 14 nm): 
 
The dithiocarbamate-functionalized gold nanoparticles were 
synthesized out of citrate-stabilized particles (see above) followed by 
ligand exchange. 1 µL CS2, 5 µL NEt3 and 1 mg GABA were dissolved in 0.5 mL of Millipore 
water and sonicated for 5 min. The solution was added to Au-Citrate nanoparticles and stirred at 
room temperature. The reaction mixture was dialysed against water three times, 300 mL water, 
MWCO 3500. The solution was stored at 4 °C. 
 
IR (KBr disc): ν/cm-1 = 3418.0 (νO-H), 2974.9 (s, νC-H), 2938.1 (s, νC-H), 2738.7, 2677.7, 2492.0, 
2184.3, 2108.5, 1589.9 (νC=O), 1397.8, 1252.1, 1171.2, 1079.9, 1036.3, 948.7, 895.6, 842.3, 804.5, 
665.0, 619.2; TEM: d = 28.4 ± 4.0 nm; UV/Vis: λmax = 526 nm; DLS: dhydr = 25 ± 6 nm. 
 
Au-DDT-DA (Ø 14 nm): 
 
The dithiocarbamate-functionalized gold nanoparticles were 
synthesized out of citrate-stabilized particles (see above) followed by ligand exchange. 1 µL CS2, 
5 µL NEt3 and 1 mg dopamine were dissolved in 0.5 mL of Millipore water and sonicated for 
5 min. The solution was added to Au-Citrate nanoparticles and stirred at room temperature. The 
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reaction mixture was dialysed against water: three times, 300 mL water, MWCO 3500. The solution 
was stored at 4 °C. 
IR (KBr disc): ν/ cm-1 = 3431.7 (νO-H), 2922.3 (s, νC-H), 2851.1 (s, νC-H), 1635.2 (νC=O), 1488.0, 
1403.4, 1045.2, 948.5, 771.7, 463.8; TEM: d = 25.9 ± 1.1 nm; UV/Vis: λmax = 543 nm; DLS: 
dhydr = 35 ± 7 nm. 
 
 
8.6 Positively Charged Gold Nanoparticles 
 
Au-CA-NAc (Ø 14 nm) 
 
According to the general procedure II 12 mg NAc-CA∙HCl (0.1 mmol) 
were added to a solution of Au-Citrate (cNP = 1 nM) and stirred for 20 hours. The reaction mixture 
was dialysed against water: three times, 300 mL water, MWCO 3500. The solution was stored at 
4 °C. A clear violet solution with a particle concentration of 1 nM was obtained and stored at 4 °C. 
 
1
H NMR (400 MHz, D2O): δ/ppm = 3.09 (s, 3H, CH3), 2.58 (d, J = 15.6 Hz, 2 H, CH2), 2.44 (d, J = 
15.6 Hz, 2 H, CH2); IR (KBr disc): ν/cm
-1
 = 3442.7 (νO-H), 2919.8 (s, νC-H), 2580.3, 2359.3, 2336.4, 
1636.7 (νC=O), 1384.3; TEM: d = 14.1 ± 3.6 nm, UV/Vis: λmax = 525 nm, DLS: dhydr = 14 ± 4 nm. 
 
Cysteamine-coordinated gold nanoparticles (Au-CA Ø 30 nm) 
 
Briefly, 16.4 mg of cysteamine hydrochloride (0.2 mmol) were dissolved in 
1 mL water. 400 µL (85 µmol) were added quickly to a solution of 22 mg HAuCl4∙3 H2O (65 µmol) 
in 20 mL water. The mixture was stirred for 20 min at room temperature in the dark. Then, 10 µL of 
freshly prepared NaBH4 solution (3.8 mg in 10 mL, 0.1 µmol) was added quickly under vigorous 
stirring. After 30 min the mixture turned red and was stirred for another 16 h. Due to instability and 
incompatibility with the dialysis material, the particles were subsequently functionalized. 
The nanoparticles were characterized with TEM, UV/Vis and DLS. 
 
TEM: d = 30.5 ± 5.3 nm; UV/Vis: λmax = 525 nm; DLS: dhydr = 60 ± 31 nm. 
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8.7 Mixed Ligand Shell 
 
Au-MUDA/MUDOLS (Ø 14 nm) 
 
Stock solutions of MUDA and MUDOLS in water with a 
concentration of 10 mM were prepared. Stoichiometric amounts of 
MUDA and MUDOLS were added to a solution of Au-Citrate under vigorous stirring. The reaction 
mixtures were purified via dialysis against water: 3 x 3 h with 300 ml, MWCO 3.5. Clear violet 
solutions were obtained and stored at 4 °C. 1: Au-MUDA, 2: Au-MUDA/MUDOLS 2:1, 3: Au-
MUDA/MUDOLS 1:1, 4: Au-MUDA/MUDOLS 1:2, 5: Au-MUDOLS. The nanoparticles were 
characterized with UV/Vis, DLS and ζ-potential. 
 
 Shell λabs dhydr ζ potential Conductivity  
Au-Citrate - 521 nm 17 ± 3 nm -28 ± 6 mV 1.11 µS/cm 
1 Au-MUDA 1:0 526 nm 24 ± 7 nm -57 ± 17 mV 8.91 µS/cm 
2 Au-MUDA/OLS 2:1 526 nm 34 ± 4 nm -58 ± 23 mV 0.67 µS/cm 
3 Au-MUDA/OLS 1:1 529 nm 38 ± 4 nm -63 ± 12 mV 0.58 µS/cm 
4 Au-MUDA/OLS 1:2 526 nm 32 ± 4 nm -68 ± 12 mV 0.55 µS/cm 
5 Au-MUDOLS 0:1 525 nm 19 ± 3 nm -70 ± 13 mV 0.23 µS/cm 
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8.8 Functionalization of the Particles Shell 
 
General procedure for the EDC/NHS mediated coupling in water: 
10 mL of the nanoparticle solution were transferred in a glass vessel washed with aqua regia and 
distilled water. 6∙105 equivalents of the respecting amine, EDC and NHS were dissolved in 0.5 mL 
of water with 12∙105 equiv. of NEt3 and added to the nanoparticle solution. The reaction mixture 
was stirred overnight and subsequently dialysed against water (3 x 3 h with 300 mL, MWCO 3500). 
 
Au-MUDA-DA 
 
According to the general procedure, dopamine was 
attached at Au-MUDA nanoparticles 14 nm. A clear red 
solution was obtained at stored at 4 °C. 
 
7 nm: 
TEM: d = 7.8 ± 1.2 nm; UV/Vis: λmax = 526 nm; DLS: dhydr = 9 ± 2 nm. 
 
14 nm: 
1
H NMR (400 MHz, D2O): δ/ppm = 6.80 (d, J = 7.8 Hz, 1 H, CH), 6.74 (s, 1 H, CH), 6.54 (d, J = 
7.9 Hz, 1 H, CH), 5.84 (s, 1 H, NH), 3.46 (q, 2 H, CH2), 2,85 ( t, 2 H, CH2), 2.67 (t, 2 H, CH2), 2.32 
(s, 3 H, CH3), 2.14 (t, 2 H, CH2), 1.64-1.49 (m, 4 H, CH2), 1.39-1.17 (m, 14 H, CH2); IR (KBr 
disc): ν/cm-1 = 3431.1, 3018.7 (νO-H), 2919.7 (s, νC-H), 2849.9 (s, νC-H), 1704.4 (νC=O, amide), 1656.4, 
1488.1, 1404.3, 1384.9, 1290.3, 1231.9, 1081.1, 1003.7, 956.4, 948.6, 815.7, 720.4, 662.9; TEM: 
d = 14.7 ± 1.2 nm; UV/Vis: λmax = 525 nm; DLS: dhydr = 26 ± 6 nm. 
 
Au-MUDA-HA 
 
According to the general procedure, histamine was attached at 
Au-MUDA nanoparticles with three different sizes. A clear red 
solution was obtained at stored at 4 °C. 
 
7 nm: 
1
H NMR (400 MHz, D2O): δ/ppm = 7.62 (s, 1 H, CH), 7.30 (s, 1 H, CH), 6.90 (m, 1 H, NH), 3.15 
(m, 2 H, CH2), 2.99 (m, 2 H, CH2), 2.84 (m, 2 H, CH2), 2.79-2.70 (m, 6 H, CH2), 2.09-2.03 (m, 1 H, 
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CH2), 1.85-1.74 (m, 2 H, CH2), 1.66-1.58 (m, 1 H, CH2), 1.52-1.37(m, 1 H, CH2), 1.33-1.11 (m, 
10 H, CH2); TEM: d = 7.3 ± 0.9 nm; UV/Vis: λmax = 524 nm; DLS: dhydr = 11 ± 2 nm. 
 
14 nm: 
1
H NMR (400 MHz, D2O): δ/ppm = 7.55 (s, 1 H, CH), 6.81 (s, 1 H, CH), 2.73-2.86 (m, 2 H, CH2 
(HA)), 2.57-2.71 (m, 3 H, CH2 (HA) + NH)), 2.41-2.53 (m, 2 H), 2.21-2.34 (m, 4 H), 2.10-2.21 (m, 
3 H), 2.03 (t, J = 7.7 Hz, 1 H), 1.52-1.68 (m, 1 H), 1.36-1.48 (m, 1 H), 1.18 (bs, 8 H, CH2); IR (KBr 
disc): ν/cm-1 = 3421.1 (νO-H), 3018.8, 2921.4 (s, νC-H), 2850.0 (s, νC-H), 1641.1 (νC=O, amide), 
1596.3 (νC-NH), 1488.2, 1404.2, 957.1, 948.6; TEM: d = 14.3 ± 0.7 nm; UV/Vis: λmax = 528 nm; 
DLS: dhydr = 19 ± 3 nm 
 
25 nm: 
1
H NMR (400 MHz, D2O): δ/ppm = 7.55 (s, 1 H, CH), 6.81 (s, 1 H, CH), 2.86-2.72 (m, 2 H, CH2), 
2.70-2.57 (m, 2 H, CH2), 2.50-2.43 (m, 2 H, CH2), 2.33-2.22 (m, 4 H, CH2), 2.20-2.11 (m, 3 H, 
CH2), 2.10-2.00 (m, 1 H, CH2), 1.66-1.50 (m, 1 H, CH2), 1.46-1.36 (m, 1 H, CH2), 1.31-1.12 (m, 
8 H, CH2);TEM: d = 25.7 ± 1.2 nm; UV/Vis: λmax = 534 nm; DLS: dhydr = 32 ± 8 nm 
 
 
Au-MUDA-5HT 
 
According to the general procedure, serotonin (5-
hydroxytryptamine) was attached at Au-MUDA 
nanoparticles 14 nm. The reaction mixture was stirred under argon atmosphere. The solution was 
dialysed with degassed water under argon atmosphere and stored under argon atmosphere. A clear 
red solution was obtained at stored at 4 °C. 
 
1
H NMR (400 MHz, D2O): δ/ppm = 7.40-7.30 (m, 1 H, CH), 7.25-7.16 (m, 1 H, CH), 7.08-7.00 (m, 
1 H, CH), 6.68-6.75 (m, 1 H, CH), 3.28-3.21 (m, 2 H, CH2), 2.99-2.92 (m, 2 H, CH2), 2.15-2.08 (m, 
2 H, CH2), 1.88-1.80 (m, 2 H, CH2), 1.55-1.42 (m, 4 H, CH2), 1.36-1.31 (m, 1 H, CH2), 1.29-1.22 
(m, 2 H, CH2); IR (KBr disc): ν/cm
-1
 = 3439.5 (νO-H), 2921.3 (s, νC-H), 2848.0 (s, νC-H), 1629.3 (νC=O, 
amide), 1488.1, 1384.4, 948.3, 617.1; TEM: d = 14.1 ± 0.9 nm; UV/Vis: λmax = 528 nm; DLS: 
dhydr = 16 ± 4 nm. 
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Au-MUDA-CB 
 
According to the general procedure, carbachol was 
attached at Au-MUDA nanoparticles 14 nm. The solution 
was dialysed three times for 2 hours each. The solution was stored under argon atmosphere in an 
Eppendorf cup. 
 
1
H NMR (400 MHz, D2O): δ/ppm = 4.47-4.41 (m, 2 H, CH2), 3.66-3.60 (m, 2 H, CH2), 3.14 (s, 
3 H, CH3), 3.09-3.00 (m, 4 H, CH2), 1.88-1.78 (m, 2 H, CH2), 1.40-1.16 (m, 12 H, CH2), 1.03-0.98 
(m, 2 H, CH2); IR (KBr disc): ν/cm
-1
 = 3426.7 (νO-H), 2921.0 (s, νC-H), 2848.8 (s, νC-H), 1640.8 (νC=O, 
amide), 1576.0, 1487.8, 1465.0, 1408.3, 1342.9, 1238.0, 1099.6, 948.7, 721.5, 663.4; TEM: 
d = 14.5 ± 0.7 nm; UV/Vis: λmax = 532 nm; DLS: dhydr = 17 ± 6 nm. 
 
 
Au-CA-His: 
 
According to the general procedure, L-histamine was 
attached at Au-CA nanoparticles 30 nm. A clear red 
solution was obtained at stored at 4 °C. 
 
1
H NMR (400 MHz, D2O): δ/ppm = 7.73 (s, 1 H, CH), 7.64 (s, 1 H, CH), 7.39 (s, 1 H, CH), 3.11-
3.08 (m, 2 H, CH2), 2.80-2.75 (m, 1 H, CH2), 1.80-1.77 (m, 4 H, CH2); TEM: d = 30.7 ± 7.2 nm; 
UV/Vis: λmax =527 nm; DLS: dhydr = 45 ± 9 nm.  
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8.9 Synthesis of the Ligands 
 
11-(Acetylthio)undecanoic acid (AcS-MUDA): 
 
11-(Acetylthio)undecanoic acid was synthesized as reported in the literature 
[163]: 500 mg 11-bromoundecanoic acid (1.88 mmol) were dissolved in 10 mL dry DMF. 
Separately, 322 mg KSAc (2.82 mmol, 1.5 equiv.) were dissolved in 5 mL dry DMF and added 
dropwise to the solution. After stirring for 1.5 h 50 mL of water was added and a white solid 
appeared. The precipitate was filtered off, washed three times with water and dried in vacuum. 
413.2 mg of a colorless solid (1.6 mmol, 84%) could be obtained. 
 
1
H NMR (400 MHz, CDCl3): δ/ppm = 2.78 (t, J = 8 Hz, 2 H, CH2), 2.28 (m, 5 H, CH2 + CH3), 
1.61-1.52 (m, 2 H, CH2), 2.52-2.26 (m, 2 H, CH2), 1.32-1.16 (m, 12 H, CH2); 
13
C-NMR (100 MHz, 
CDCl3): δ/ppm = 196.3 (Cq, C=O, acetyl), 179.5 (Cq, C=O), 33.9, 31.0 (CH3), 29.5, 29.4, 29.3, 29.2, 
29.2, 29.1, 29.0, 28.8, 24.7; IR (KBr disc): ν/cm-1 = 2920.4 (s, νC-H), 2849.9 (s, νC-H), 1697.5 (νC=O, 
amide), 1432.7, 1408.9, 1290.6, 1138.8, 950.4, 926.1, 631.5; ESI: [M+Na]
+
 = 283.1335 (calcd: 
[M+Na]
+
 = 283.1338); CHN: found C 59.84%, H 9.22% (calcd C 59.96%, H 9.29%) 
 
2,5-Dioxopyrrolidin-1-yl-11-(acetylthio)undecanoate (AcS-MUDA-NHS): 
 
195 mg NHS (1.7 mmol, 1.1 equiv.) and 700 mg AcS-MUDA 
(1.55 mmol) were dissolved in DCM under stirring at room 
temperature. 350 mg DCC (1.7 mmol, 1.1 equiv.) were separately dissolved in 5 mL DCM and 
added slowly. After 30 min a white precipitate appeared. The reaction mixture was stirred 
overnight. The solvent was removed under reduced pressure. 506 mg (1.42 mmol, 92%) of a 
colorless powder were obtained. 
 
1
H NMR (400 MHz, CDCl3): δ/ppm = 2.81-2.77 (m, 6 H, CH2), 2.53 (t, J = 7.3 Hz, 2 H, CH2), 2.25 
(s, 3 H, CH3), 1.71-1.63 (m, 2 H, CH2), 1.52-1.47 (m, 2 H, CH2), 1.38-1.17 (m, 12 H, CH2); 
13
C NMR (100 MHz, CDCl3): δ/ppm = 196.1 (Cq, C=O, acetyl), 169.3 (2 x Cq, C=O), 168.7 (Cq, 
C=O), 30.9 (CH3), 30.7, 29.5, 29.3, 29.2, 29.2, 29.1, 29.0, 28.8, 28.7, 25.6 (2 x CH2), 24.6; IR (KBr 
disc): ν/cm-1 = 2917.6 (s, νC-H), 2848.4 (s, νC-H), 1817.2, 1788.4 (νC=O), 1736.4 (νC=O), 1682.1 (νC=O, 
amide), 1541.1, 1465.0, 1425.9, 1413.9, 1366.9, 1208.1, 1129.6, 1076.0, 639.1; ESI: [M+Na]
+
 = 
380.1502 (calcd: [M+Na]
+
 = 380.1600); CHN: found C 56.22%, H 7.71%, N 4.82% (calcd C 
57.12%, H 7.61%, N 3.92%) 
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S-(11-((2-(1H-imidazol-4-yl)ethyl)amino)-11-oxoundecyl) ethanethioate (AcS-MUDA-HA): 
 
97 mg AcS-MUDA-NHS (0.27 mmol) were dissolved in DMF 
to form a clear solution. 34 mg HA∙2 HCl (0.30 mmol, 
1.1 equiv.) and a few drops NEt3 were added and the solution was stirred overnight. Subsequently 
50 mL water were added and a white solid appeared. The precipitate was filtered off and washed 
three times with water. The crude product was dissolved in CHCl3 and filtered again. After 
evaporation 70 mg (0.19 mmol, 70%) of a colorless powder was obtained. 
 
1
H NMR (400 MHz, CDCl3): δ/ppm = 7.50 (s, 1 H, CHar), 6.75 (s, 1 H, CHar), 6.33 (br s, 1 H, NH), 
3.52-3.42 (m, 2 H, CH2 (HA)), 2.79-2.69 (m, 2 H, CH2 (HA)), 2.53-2.39 (m, 2 H, CH2), 2.56 (s, 
3 H, CH3), 2.10 (t, J = 7.2 Hz, 2 H, CH2), 1.59-1.43 (m, 4 H, CH2), 1.26-1.14 (m, 12 H, CH2); 
13
C NMR (100 MHz, CDCl3): δ/ppm = 196.4 (Cq, C=O, acetyl), 173.7 (Cq, C=O, amide), 134.8 
(CH, Car), 127.6 (Cq, Car), 118.6 (CH, Car), 39.2 (CH2 (HA)), 36.9 (CH2 (HA)), 30.7 (CH3), 29.5, 
29.3, 29.3, 29.2, 29.1, 28.7, 28.4, 26.9, 25.7; IR (KBr disc): ν/cm-1 = 2920.7 (νC-H), 2850.6 (νC-H), 
1691.9 (νC=O), 1638.9 (νC=O), 1575.2 (νCN-H), 1466.1, 1452.7, 1255.8, 1090.7, 623.3; ESI: [M+H]
+
 = 
354.2221 (calcd: [M+H]
+
 = 354.2210); CHN: found C 59.72%, H 8.67%, N 11.37% (calcd C 
61.15%, H 8.84%, N 11.89%) 
 
S-(11-((2-(5-hydroxy-1H-indol-3-yl)ethyl)amino)-11-
oxoundecyl) ethanethioate (AcS-MUDA-5HT): 
 
97 mg AcS-MUDA-NHS (0.27 mmol) were dissolved in 
DMF to form a clear solution. 64 mg 5HT∙ HCl (0.30 mmol, 1.1 equiv.) and a few drops NEt3 were 
added and the solution was stirred overnight. Subsequently 50 mL water were added and a white 
solid appeared. The precipitate was filtered off and washed three times with water. The crude 
product was dissolved in CHCl3 and filtered again. After evaporation 33 mg (0.08 mmol, 29%) of a 
colorless powder were obtained. 
 
1
H NMR (400 MHz, CDCl3): δ/ppm = 8.02 (s, 1 H, NH), 7.19-7.12 (m, 1 H, CH), 6.99-6.88 
(m,2 H, CH), 6.78-6.72 (m, 1 H, CH), 6.27 (s, 1 H, NH), 5.59 (bs, 1 H, OH), 3.54-3.46 (m, 2 H, 
CH2), 2.85-2.75 (m, 4 H, CH2), 2.25 (s, 3 H, CH3), 2.05 (t, J = 7.5 Hz, 2 H, CH2), 1.93-1.82 (m, 4 H, 
CH2), 1.23-1.15 (m, 12 H, CH2); 
13
C NMR (100 MHz, CDCl3): δ/ppm = 195.5, 172.4, 155.9, 149.1, 
130.4, 127.0, 121.9, 111.1, 110.8, 102.1, 48.0, 38.6, 35.9, 32.9, 29.9, 29.6, 28.5, 28.3, 28.2, 28.1, 
28.0, 24.6, 23.9. 
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S-(11-((3,4-dihydroxyphenethyl)amino)-11-oxoundecyl) ethanethioate (AcS-MUDA-DA): 
 
97 mg AcS-MUDA-NHS (0.27 mmol) were dissolved in 
4 mL DMF to form a clear solution. 57 mg DA∙HCl 
(0.30 mmol, 1.1 equiv.) in 1 mL DMF were added and the solution was stirred overnight. 
Subsequently 50 mL water were added and a white solid appeared. The precipitate was filtered off 
and washed three times with water. The crude product was dissolved in CHCl3 and filtered again. 
After evaporation 54 mg (0.14 mmol, 52%) of a colorless powder were obtained. 
 
1
H NMR (400 MHz, CDCl3): δ/ppm = 6.80 (d, J = 7.80 Hz, 1 H, CH), 6.74 (s, 1 H, CH), 6.54 (d, J 
= 7.92, 1 H, CH), 5.84 (s, 1 H, NH), 3.46 (q, J = 6.28 Hz, 2 H, CH2), 2.85 (t, J = 7.39 Hz, 2 H, 
CH2), 2.67 (t, J = 7.03 Hz, 2 H, CH2), 2.32 (s, 3 H, CH3), 2.14 (t, J = 8.10 Hz, 2 H, CH2), 1.64-1.49 
(m, 4 H, CH2), 1.39-1.17 (m, 4 H, CH2); 
13
C NMR (100 MHz, CDCl3): δ/ppm = 196.7, 174.5, 
144.5, 143.2, 130.5, 120.4, 115.4, 115.1, 40.9, 36.8, 34.9, 30.7, 29.5, 29.3, 29.3, 29.2, 29.1, 29.1, 
29.0, 28.7, 28.3; IR (KBr disc): ν/cm-1 = 2919.7 (νC-H), 2849.9 (νC-H), 1704.4 (νC=O), 1656.4 (νC=O, 
amide), 1488.1, 1404.3, 1384.9, 1231.9, 956.4, 948.6; 662.9; ESI: [M+H]
+
 = 418.27 (calcd: 
[M+Na]
+
 = 418.20); CHN: found C 63.22%, H 8.49%, N 3.66% (calcd: C 63.76%, H 8.41%, N 
3.54%) 
 
Sodium 11-mercaptoundecyl sulfate (MUDOLS): 
 
In a flame-dried vessel under argon atmosphere, 353 mg of 11-
mercaptoundecanol (1.72 mmol) were dissolved in 3 ml dry DMF. Separately, 395 mg of SO3∙DMF 
complex (2.50 mmol, 1.5 equiv.) were dissolved in 1 mL dry DMF and added to the solution. After 
stirring for 1 h at room temperature the solvent was removed under reduced pressure (OPV) and the 
residue was dissolved in 4 mL of 1 M NaOH. A white precipitate appeared. 15 mL of ethanol were 
added and washed three times. The product was dried in vacuum. 280 mg of a colorless solid 
(0.91 mmol, 53%) could be obtained, the dimer was formed. 
 
1
H NMR (200 MHz, DMSO-d6): δ/ppm = 3.68 (t, J = 6.6 Hz, 2 H, CH2), 3.35 (t, J = 6.3 Hz, 2 H, 
CH2), 2.27-2.61 (m, 4 H, CH2), 2.56-2.49 (m, 2 H, CH2), 1.67-1.52 (m, 4 H, CH2), 1.36-1.24 (m, 
10 H, CH2); 
13
C NMR (200 MHz, DMSO-d6): δ/ppm = 65.6, 60.7, 32.5, 29.1, 29.0, 28.9, 28.8, 28.6, 
28.5, 27.7, 25.5; IR (KBr disc): ν/cm-1 = 2918.7 (s, νC-H),, 2849.9 (s, νC-H), 1614.8, 1470.0, 1261.7 
& 1205.1 & 1128.1 (s, νR-OSO2-OR), 1068.8, 966.4, 831.8, 718.9, 628.7, 586.3; ESI: [M+Na]
+
 = 
633.16 (calcd: [M+Na]+ = 633.16); CHN: C11H23ClNa2O4S2 found C 35.68%, H 6.01% (calcd: C 
36.21%, H 6.35%).  
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8.10 Synthesis of Quantum Dots 
 
Mercaptocarboxylic acid functionalized cadmium telluride 
nanoparticles (CdTe-ligand) 
 
55 mg of Te powder (0.43 mmol, 2 equiv.) and 42 mg NaBH4 
(1.11 mmol, 5.3 equiv.) were dissolved in 5 mL of degassed water under argon atmosphere and 
heated to 70 °C for 1.5 h. In parallel 56 mg Cd(OAc)2∙2H2O (0.21 mmol) and 4.8 equiv. of the 
respective ligand were dissolved in 12 mL of degassed water, NaOH was added until the solution 
cleared up. Both precursor solutions were combined and heated up to 100 °C for 4 h and then 
quenched with an ice bath. The solution was dialysed against water three times (MWCO 3500) and 
stored at 4 °C. The particles were characterized with TEM, DLS, UV/Vis and fluorescence 
spectroscopy. 
 
 Ligand Amount dTEM dDLS λabs λem 
CdTe-TGA TGA 33 µL 4.1 ± 0.3 nm 8 ± 1 nm 540 nm 594 nm 
CdTe-MPA MPA 42 µL 4.3 ± 0.4 nm 7 ± 1 nm 498 nm 574 nm 
CdTe-MPSA MPSA 180 mg 4.9± 0.4 nm 5 ± 1 nm 478 nm 544 nm 
 
 
Mercaptocarboxylic acid functionalized cadmium selenide 
nanoparticles (CdSe-ligand) 
 
34 mg of Se powder (0.43 mmol, 2 equiv.) and 42 mg NaBH4 
(1.11 mmol, 5.3 equiv.) were dissolved in 5 mL of degassed water under argon atmosphere at rt for 
1.5 h. In parallel 56 mg Cd(OAc)2∙2 H2O (0.21 mmol) and 4.8 equiv. of the respective ligand were 
dissolved in 12 mL of degassed water, NaOH was added until the solution cleared up. Both 
precursor solutions were combined and heated up to 100 °C. The reaction was quenched with an ice 
bath after 4 hours. The solution was dialysed against water three times (MWCO 3500) and stored at 
4 °C. The particles were characterized with TEM, DLS, UV/Vis and fluorescence spectroscopy. 
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 Ligand Amount dTEM dDLS λabs λem 
CdSe-TGA TGA 33 µL 3.5 ± 0.4 nm 7 ± 2 nm 540 nm 670 nm (br) 
CdSe-MPA MPA 42 µL 3.9 ± 0.2 nm 5 ± 1 nm 473 nm 543 nm 
 
 
Mercaptocarboxylic acid functionalized cadmium sulfide nanoparticles 
(CdS-ligand) 
 
34 mg of Na2S (0.4 mmol, 2 equiv.) were dissolved in 10 mL of 
degassed water under argon atmosphere. In parallel 54 mg Cd(OAc)2∙2H2O (0.2 mmol) and 42 µL 
of MPA (0.48 mmol, 2.4 equiv.) were dissolved in 20 mL of degassed water, NaOH was added until 
the solution cleared up. The sulfide precursor solution was added and the reaction mixture was 
heated up to 100 °C. The reaction was quenched with an ice bath after 4 h. The particle solution was 
dialysed against water three times (MWCO 3500) and stored at 4 °C. The particles were 
characterized with TEM and DLS measurements, UV/Vis and fluorescence spectroscopy. 
 
 Ligand Amount dTEM dDLS λabs λem 
CdS-MPA MPA 42 µL 3.7 ± 0.5nm 5 ± 1 nm 430 nm 616 nm 
 
 
Passivation with ZnS of mercaptocarboxylic acid functionalized 
quantum dots (CdTe/ZnS-ligand) 
 
To a purified quantum dot solution in water 17 mg ZnCl2 
(0.12 mmol), 9 mg Na2S (0.12 mmol) and 0.48 mmol ligand were added and stirred under argon for 
3 hours. The pH was adjusted to ≥8 with NaOH. The reaction mixture was heated to 60 °C for 3 h. 
The particle solution was purified with dialysis against water (MWCO 3500) and stored at 4 °C. 
The particles were characterized with TEM and DLS measurements, UV/Vis and fluorescence 
spectroscopy and XRD analysis 
 
 Ligand Amount dTEM dDLS λabs λem 
CdTe/ZnS-TGA TGA 33 µL 4.3 ± 0.2 nm 11 ± 2 nm 542 nm 590 nm 
CdTe/ZnS-MPA MPA 42 µL 4.5 ± 0.3 nm 6 ± 1 nm 500 nm 574 nm 
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Synthesis of CdTexSe1-x quantum dots  
 
CdTexSe1-x quantum dots were synthesized using standard Schlenk 
technique. The precursor solutions of NaHTe and NaHSe were freshly prepared For NaHTe 52 mg 
Te powder (0.4 mmol) and 37 mg NaBH4 (1 mmol, 2.5 equiv.) were dissolved in 10 mL of 
degassed water and under argon atmosphere. The reaction mixture was heated to 75 °C for 1 h and 
then cooled to room temperature giving a red solution. For NaHSe 34 mg Se powder (0.4 mmol) 
and 37 mg NaBH4 (1 mmol, 2.5 equiv.) were dissolved in 10 mL of degassed water and under argon 
atmosphere, cooled in an ice bath for 3 h and then heated up to room temperature giving a colorless 
solution. In the meantime a third flask was loaded with 54 mg Cd(OAc)2∙2H2O (0.2 mmol) , 42 µL 
MPA (0.48 mmol) and 20 mL of water. NaOH was added until the solution cleared up. The mixture 
was heated up to 100 °C. Then both precursor solutions were added simultaneously to the Cd
2+
 
precursor solution in different molar rations (x = 0.1 to 0.9) and stirred for 4 h. The reaction mixture 
was quenched with an ice bath and the particle solution was dialyses against water (three times, 
MWCO 3500). The particles were characterized with TEM and DLS, UV/Vis and fluorescence 
spectroscopy, XRD analysis and EDX spot analysis. 
 
 x dTEM dDLS EDX Te/Se λabs λem 
CdSe-MPA 0 2.6 ± 0.2 nm 5 ± 1 nm 0.00/1.00 485 nm 584 nm 
CdTe0.1Se0.9-MPA 0.1 2.4 ± 0.3 nm 6 ± 2 nm 0.13/0.87 487 nm 598 nm 
CdTe0.2Se0.8-MPA 0.2 2.9 ± 0.2 nm 8 ± 2 nm 0.24/0.76 486 nm 581 nm 
CdTe0.3Se0.7-MPA 0.3 2.3 ± 0.3 nm 7 ± 2 nm 0.30/0.70 488 n 579 nm 
CdTe0.4Se0.6-MPA 0.4 2.5 ± 0.2 nm 7 ± 2 nm 0.38/0.62 492 nm 573 nm 
CdTe0.5Se0.5-MPA 0.5 2.6 ± 0.2 nm 6 ± 2 nm 0.61/0.39 498 nm 567.5 nm 
CdTe0.6Se0.4-MPA 0.6 2.5 ± 0.3 nm 6 ± 1 nm 0.68/0.32 500 nm 564 nm 
CdTe0.7Se0.3-MPA 0.7 2.3 ± 0.3 nm 5 ± 2 nm 0.68/0.32 498 nm 564 nm 
CdTe0.8Se0.2-MPA 0.8 2.5 ± 0.2 nm 6 ± 2 nm 0.60/0.40 506 nm 560.5 nm 
CdTe0.9Se0.1-MPA 0.9 2.5 ± 0.2 nm 8 ± 2 nm 0.88/0.12 518 nm 559 nm 
CdTe-MPA 1.0 2.6 ± 0.2 nm 7 ± 1 nm 1.00/0.00 520 nm 555 nm 
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8.11 Biological Functionality 
Animals 
Female and male Wistar rats with a body mass of 200 - 250 g were used. The animals were bred 
and housed at the institute for Veterinary Physiology and Biochemistry of the Justus-Liebig-
University Giessen at an ambient temperature of 22.5 °C and air humidity of 50 - 55% on a 12 h : 
12 h light-dark cycle with free access to water and food until the time of the experiment. 
Experiments were approved by the named animal welfare officer of the Justus-Liebig-University 
(administrative number 487_M) and performed according to the German and European animal 
welfare law. 
Solutions 
The standard solution for the Ussing chamber experiments was a buffer solution containing: NaCl 
107 mmol l
−1
, KCl 4.5 mmol l
−1
, NaHCO3 25 mmol l
−1
, Na2HPO4 1.8 mmol l
−1
, NaH2PO4 0.2 mmol 
l
−1
, CaCl2 1.25 mmol l
−1
, MgSO4 1 mmol l
−1 
and glucose 12 mmol l
−1
. The solution was gassed with 
carbogen (5% CO2 in 95% O2, v/v); pH was 7.4. For the Cl
−
-free buffer, NaCl and KCl were 
substituted by Na gluconate and K gluconate (KGluc), respectively. The Ca
2+
 concentration in the 
Cl
−
-free buffer was increased to 5.75 mmol l
−1
 to compensate for the Ca
2+
-buffering properties of 
gluconate. 
Tissue preparation 
Animals were killed by stunning followed by exsanguination. The serosa and tunica muscularis 
were stripped away by hand to obtain a mucosa-submucosa preparation of the distal colon. Briefly, 
the colon was placed on a small plastic rod with a diameter of 5 mm. A circular incision was made 
near the anal end with a blunt scalpel, and the serosa together with the tunica muscularis was gently 
removed in a proximal direction. Two segments of the distal colon of each rat were prepared.  
Short-circuit current measurements 
The mucosa-submucosa preparation was fixed in a modified Ussing chamber bathed with a volume 
of 3.5 mL on each side of the mucosa. The tissue was incubated at 37 °C and short-circuited by a 
computer-controlled voltage-clamp device (Ingenieur Büro für Mess- und Datentechnik Mussler, 
Aachen, Germany) with correction for solution resistance. Tissue conductance (Gt) was measured 
every minute by the voltage deviation induced by a current pulse (±50 μA, duration 200 ms) under 
open-circuit conditions. Short-circuit current (Isc) was continuously recorded on a chart-recorder. Isc 
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is expressed as μEq h−1 cm−2,e. g. the flux of a monovalent ion per time and area, with 
1 μEq h−1 cm−2 = 26.9 μA cm−2. At the end of each experiment, tissue viability was tested by 
administration of the cholinergic agonist, carbachol (5 × 10
−5 
mol l
−1
 at the serosal side) and/or the 
administration of forskolin (5 × 10
−6 
mol l
−1
 at the mucosal and the serosal side), an activator of 
adenylate cyclase(s), which induce a strong Ca
2+
-respective cAMP-dependent Cl
−
 secretion. 
Drugs 
Au-MUDOLS, Au-MUDA-HA, carbachol, cimetidine, histamine dihydrochloride, and mepyramine 
were dissolved in aqueous stock solutions. Forskolin (Calbiochem, Bad Soden, Germany) was 
dissolved in ethanol (final maximal concentration 0.25%, v/v). Tetrodotoxin was dissolved in 
2 × 10
−2
 mol l
−1
 citrate buffer. If not indicated otherwise, drugs were from Sigma (Taufkirchen, 
Germany).  
Statistics 
Results are given as means ± SEM, with the number (n) of investigated tissues. When means of 
several groups had to be compared, an analysis of variance was performed followed by post hoc 
Tukey's-test. For the comparison of two groups, a Mann-Whitney U-test was applied. P < 0.05 was 
considered to be statistically significant. 
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10. Appendix 
10.1 Abbreviations and Symbols 
 
5HT Serotonin, 5-hydroxytryptamine 
CA Cysteamine 
CB Carbachol 
d Diameter; doublet (NMR) 
DA Dopamine 
DLS Dynamic light scattering 
DTC Dithiocarbamate 
e. g.  Exempli gratia for example 
EDC 1-Ethyl-3-(3-dimethylamino-
propyl)carbodiimide 
EDX Energy dispersive X-ray 
spectroscopy 
equiv. Equivalent 
FDA Food and drug administration 
GABA γ-Aminobutanoic acid 
HA Histamine 
IC50 Half maximal inhibitory 
concentration 
IR Infra-red 
Isc Short circuit current 
LA Lipoic acid, 6,8-dithioocatnoic 
acid 
L-Dopa Levodopa, L-3,4-dihydroxy -
phenylalanine 
LED Light emitting diode 
m Meter; multiplett (NMR) 
MHA 6-Mercapto-1-hexanoic acid 
min Minute 
MPA 3-Mercapto-1-propanoic acid 
MPSA 3-Mercapto-1-propanesulfonic 
acid soldium salt 
MR Magnetic resonance 
MS Mass spectrometry 
MUDA 11-Mercapto-1-undecanoic  
acid 
MUDOL 11-Mercapto-1-undecanol 
MUDOLS 11-Mercaptoundecyl sulfate 
sodium salt 
MWCO Molecular weight cut off 
NAc-CA N-Acetylcysteamine 
NEt3 Triethylamine 
NHS N-Hydroxysuccinimide 
nm Nanometer, 10
-9
 m 
NMR Nuclear magnetic resonance 
NP Nanoparticle 
PEG Poly(ethylene glycol) 
o/n Over night 
q Quartet (NMR) 
QY Quantum yield 
QD Quantum dot 
RT Room temperature 
s Singlet 
SAM Self-assembled monolayer 
SPION Superparamagnetic iron oxide 
nanoparticle 
t Triplet 
TEM Transmission electron 
microscopy 
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TGA 2-Mercaptoacetic acid, 
thioglycolic acid; 
thermogravimetric analysis 
TMAH Tetramethylammonium 
hydroxide 
TMS Trimethylsilane 
TOAB Tetraoctylammonium bromide 
TOP Trioctylphosphine 
TOPO Trioctylphosphine oxide 
UV/Vis Ultraviolett/visible 
XRD X-Ray diffraction 
ζ 
potential 
Zeta-potential 
λ Wavelength [nm] 
ν Vibration [cm
-1
] 
 
 
10.2 Calculation of core diameters 
 
The concentration of the particle solution was determined under the assumption that a fully 
conversion of used salt amounts took place. The average radius of the NP is taken from TEM 
analysis counting 100 particles. 
An example is given for Au nanoparticles: 
 
Volume per particle 𝑉 =
4
3
· 𝜋 · 𝑟3  
Mass per particle 𝑚 =  𝜌 · 𝑉 𝜌(𝐴𝑢) = 19.32 g/cm3 
Mol per particle 𝑛Au pro NP = 𝑚 · 𝑀 𝑀 (𝐴𝑢) = 196.97 g/mol 
Number NP 𝑁NP =  
𝑛Au ges
𝑛Au per NP
  
Mol NP 𝑀NP =
𝑁NP
𝑁𝐴
 𝑁𝐴 = 6.022 × 10
23 mol−1 
Concentration NP 𝑐(𝑁𝑃) =  
𝑀NP
𝑉
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